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1.1 Pseudorabies virus 
 
1.1.1 Introduction 
 Pseudorabies virus (PRV) is a member of the Alphaherpesvirinae and is the 
causative agent of Aujeszky’s disease in its natural host, the pig. The disease was first 
described in the beginning of the 19th century in cattle and was called “mad itch” 
because the symptoms resembled rabies very well. The causative agent, however, was 
only discovered in the early 20th century by the Hungarian physician Aujeszky 
(Aujeszky, 1902) and some years later, the disease was proven by filtration 
experiments to be caused by a virus (Schmitthofer, 1910). Most mammals, except 
higher primates, are susceptible for PRV. Of the susceptible animals, only pigs are 
known to survive an infection and therefore represent the natural reservoir of PRV 
(Mettenleiter, 1996). Whereas until the 1970s disease outbreaks occurred rather 
sporadically in pigs, an increase in case numbers and severity was reported from that 
time point on, probably correlated with an intensified pig husbandry (Gustafson, 
1986). PRV causes a large spectrum of symptoms in its natural host with the age of 
the affected pig and the virulence of the infecting strain determining the onset and 
severity of the clinical signs. The symptoms consist of fever, lethargy, respiratory and 
neurological disorders, abortion and infertility (Wittmann & Rziha, 1989). 
 
1.1.2 The virus 
 PRV, also designated suid herpesvirus type 1 (SHV-1) or Aujeszky’s disease virus, 
belongs to the Herpesviridae, a family containing over 100 members, which are found 
both in warm- and cold-blooded vertebrates and invertebrates (Roizman, 1982). The 
herpesvirus family is divided into three subfamilies Alpha (α)−, Beta (β)− and 
Gamma (γ)−herpesvirinae (reviewed by Roizman, 1996). Alpha-herpesvirinae 
(including PRV) frequently have a broad host-range, a short replication cycle and 
establish latency in neuronal tissues. The β-herpesvirinae are characterized by a 
narrow host-range, a slow replication cycle and the frequent enlargement of infected 
cells (cytomegaly). These viruses can maintain a latent state in lymphoreticular cells. 
The host range of γ-herpesvirinae is almost exclusively restricted to one species and 
they replicate almost exclusively in either B- or T-lymphocytes. Latency is 
established in lymphoid tissues. Table 1 gives an overview of the three subfamilies of 
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the herpesvirus family with their genera and some of the best known members of each 
genus. 
 
Table 1. Subfamilies, genera and some species of Herpesviridae  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subfamily Genus Species 
α-herpesvirinae 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
β-herpesvirinae 
 
 
 
 
 
 
 
 
 
γ-herpesvirinae 
 
Simplexvirus 
 
 
 
 
Varicellovirus 
 
 
 
 
 
 
 
 
 
 
 
 
 
Marek’s disease-like viruses
 
Infectious laryngo-tracheitis-
like viruses 
 
Cytomegalovirus 
 
 
Muromegalovirus 
 
Roseolovirus 
 
Lymphocryptovirus 
 
 
Rhadinovirus 
 
 
 
 
 
 
 
 
 
Ictalurid herpes-like viruses
human herpesvirus 1&2 
(herpes simplex virus-1 &-2) 
 
bovine herpesvirus 2 
 
human herpesvirus 3 
(varicella zoster virus) 
 
equid herpesvirus 1&4 
 
suid herpesvirus 1 
(pseudorabies virus) 
 
bovine herpesvirus 1 
 
felid herpesvirus 1 
 
canid herpesvirus 1 
 
gallid herpesvirus 2 
 
gallid herpesvirus 1 
 
 
human herpesvirus 5 
(human cytomegalovirus) 
 
murid herpesvirus 1 
 
human herpesvirus 6 
 
human herpesvirus 4 
(Epstein-Barr virus) 
 
saimiriine herpesvirus 2 
 
bovine herpesvirus 4 
 
murid herpesvirus 4 
 
Ateline herpesvirus 2 
 
equid herpesvirus 2&5&7 
 
Ictalurid herpesvirus 1 
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 PRV, like most herpesviruses, is a complex virus of 150-180 nm in diameter and 
consists of four morphologically distinguishable structures (a schematic drawing of 
PRV is shown in Figure 1.) (reviewed by Mettenleiter, 1994). The interior of PRV 
consists of the nucleoprotein core, containing the linear double-stranded DNA of 
approximately 142 kbp and bound proteins. This nucleoprotein is enclosed in an 
icosahedral capsid, consisting of 162 capsomers (12 pentons, 150 hexons). The 
nucleoprotein and capsid form the nucleocapsid which is surrounded by the mostly 
amorphous tegument which is surrounded by the envelope, an irregularly shaped 
bilayer of phospholipids, in which different glycoproteins are embedded. For PRV, 11 
glycoproteins have been characterized and are named according to the unified 
nomenclature based on their homology to herpes simplex virus 1 (HSV-1). All 
glycoproteins are constituents of the virion, except gG, which is secreted into the 
medium by infected cells. An overview of the different PRV glycoproteins with their 
most important functions can be found in Table 2. 
 
 
envelope  
proteins DNA 
capsid 
tegument 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic representation of PRV 
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Table 2. Overview of the PRV glycoproteins and their most important functions 
 glycoprotein function references 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
gB 
 
 
 
 
 
gC 
 
 
 
 
 
gD 
 
 
 
 
gE 
 
 
 
 
 
gG 
 
 
gH 
 
 
 
 
gI 
 
 
gK 
 
 
 
gL 
 
 
 
gM 
 
gN 
 
Involved in attachment 
Essential for virus penetration, direct  
cell-to-cell spread and transneuronal spread  
Essential for efficient antibody-induced internalization of 
viral cell surface proteins 
 
Involved in initial non-essential binding 
Affects thermostability of the virus and virus  
release 
Binds with C3 of the complement cascade 
Major target protein for CTLs 
 
Essential for stable binding of virus to the host  
cell and subsequent fusion 
Essential for efficient antibody-induced internalization of 
viral cell surface proteins 
 
Involved in cell-to-cell spread and virus egress 
Very important in neuronal spread of the virus (anterograde 
transport) 
gE displays low affinity Fc receptor activity 
 
 
Its function remains unknown, may have a role  
in cell-to-cell spread 
 
Essential for fusion of virion envelope with  
host’s plasma membrane 
Essential for cell-to-cell and transneuronal  
spread 
 
Forms with gE a functional entity 
gE-gI displays high affinity Fc receptor activity 
 
Essential for virus egress 
Inhibits immediate re-infection of released  
virions 
 
Forms with gH a functional entity 
Essential for virus penetration, cell-to-cell  
spread and transneuronal spread 
 
Inhibitory effect on viral fusion 
 
Forms with gM a functional entity 
Involved in virus penetration 
 
Sawitzky et al., 1990 
Rauh & Mettenleiter, 1991 
Babic et al., 1993 
Favoreel et al., 1999b 
 
 
Mettenleiter et al., 1990 
Schreurs et al., 1988 
Huemer et al., 1992 
Zuckermann et al., 1990 
 
 
Rauh & Mettenleiter, 1991 
Peeters et al., 1992a 
Favoreel et al., 1999b 
 
 
Mettenleiter et al., 1987 
Zsák et al., 1989 
Card et al., 1992 
Kritas et al., 1995 
Favoreel et al., 1997 
 
Demmin et al., 2001 
 
 
Peeters et al., 1992b 
Babic et al., 1996 
 
 
 
Zuckermann et al., 1988 
Favoreel et al., 1997 
 
Klupp et al., 1998 
 
 
 
Klupp et al., 1994 
Klupp et al., 1997 
Flamand et al., 2001 
 
Klupp et al., 2000 
 
Jöns et al., 1998 
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1.1.3 Interaction with the host cell 
Infection of cells with PRV occurs either by free virions or by direct cell-to-cell 
spread from PRV-infected to adjacent non-infected cells. Although both processes are 
related, there are some differences e.g. gB and gH-gL are essential for both 
penetration of free virions and direct cell-to-cell spread, whereas gD is only essential 
for infection by free virions (Rauh & Mettenleiter, 1991; Peeters et al., 1992a; Peeters 
et al., 1992b; Heffner et al., 1993). A schematic representation of the replication cycle 
of PRV in its host cell can be found in Figure 2. 
 
Attachment: glycoprotein C is the major glycoprotein involved in primary attachment 
by binding to heparan sulfate-carrying proteoglycans on the cell membrane 
(Mettenleiter et al., 1990). This heparin-sensitive, labile attachment is followed by a 
heparin-resistant, stable secondary interaction, mediated by gD which binds to 
different isoforms of nectin-1 and nectin-2, also designated ‘Herpesvirus entry 
mediators’ (Hve) (Karger & Mettenleiter, 1993; Warner et al., 1998; Haarr et al., 
2001). 
 
Penetration: after a pH independent fusion of the viral envelope with the plasma 
membrane, capsids are released in the cytoplasm of the host cell (Spear, 1993). 
Glycoproteins gB, gD, gH and gL are essential for this process (Rauh & Mettenleiter, 
1991; Peeters et al., 1992a; Peeters et al., 1992b; Klupp et al., 1997), whereas gM and 
gN are merely modulatory for virus penetration (Dijkstra et al., 1996; Jöns et al., 
1998). 
 
Transport into the nucleus: the mechanism of transport to the nucleus and subsequent 
release of the genomic material in the nucleus is still poorly understood. The transport 
of the capsids to the nuclear membrane is assumed to occur along microtubules and it 
is suggested that DNA is extruded from the capsids and enters the nuclear pore via the 
vertex region (Granzow et al., 1997). More recently, UL25, a minor capsid protein, 
has been identified as being important during this transport to the nucleus (Kaelin et 
al., 2000). 
 
Intranuclear events: upon entry of the viral genome in the nucleus, the linear DNA 
circularises, and transcription is initiated. This transcription is regulated in a cascade-
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like fashion (reviewed by Mettenleiter, 1994). “Immediate-early genes” are expressed 
first and encode transcription factors, necessary for efficient transcription of early 
genes. For PRV, there is only one gene with immediate-early kinetics and it encodes 
the protein IE180 (Cheung et al., 1990). IE180 is a potent activator of “early genes”, 
which are expressed before DNA replication and encode proteins like thymidine 
kinase (McGregor et al., 1985) and ribonucleotide reductase (de Wind et al., 1993), 
important for mediating DNA replication. Transcription of “early-late genes” starts 
before DNA replication but reaches its maximum level after DNA replication has 
been initiated. This DNA replication proceeds mainly via a rolling circle mechanism 
leading to long head-to-tail concatameric DNA molecules which need to be cleaved 
into unique length genomes before or during packaging into capsids (Ben-Porat & 
Kaplan, 1985). Transcription of the “late genes” starts after DNA replication and 
these late genes encode several structural capsid and envelope (glyco) proteins. It has 
to be pointed out, however, that not all viral genes can be easily classified as 
‘immediate early’, ‘early’ or ‘late’ genes. 
 
Viral egress: capsids, containing the viral genome, leave the nucleus by budding 
through the inner nuclear membrane and this first viral envelope appears to contain no 
(mature) glycoproteins (Granszow et al., 1997). This primary envelope is then lost by 
fusion with the outer nuclear membrane, resulting in the release of naked capsids into 
the cytoplasm. A secondary envelopment process takes place in the trans-Golgi area 
where tegument is included and viral glycoproteins are clearly present in this 
secondary envelope (Granszow et al., 1997). The net result of this budding event is 
the presence of complete virus particles within exocytic vesicles which then fuse with 
the plasma membrane, thereby releasing the virus particles into the extracellular 
space. The glycoproteins gC and gE-gI seem to be required for efficient virus release 
(Mettenleiter et al., 1987; Zsak et al., 1989) and gK may prevent immediate re-
infection of the released virions (Klupp et al., 1998). 
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(7) capsid assembly  
late proteins
(e.g. gB, gC,
gD,…) 
early proteins 
(e.g. thymidine 
kinase, DNA 
polymerase) 
immediate early protein  
(IE180) 
(5c) late 
(5a) immediate 
early (5b) early 
(5) DNA 
transcription 
(3) capsid transport 
along microtubules 
(4) DNA release 
(6) DNA replication 
(8) primary 
envelopment 
(9) secondary
envelopment
(10) viral egress (vesicle-
mediated exocytosis) 
(2) penetration 
(membrane fusion) 
(1) attachment 
 
Figure 2. Schematic representation of the PRV replication cycle in the host cell (adapted from 
Mettenleiter, 2000). 
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1.2 Pathogenesis of pseudorabies virus infections 
 
1.2.1 Introduction 
 Pigs are the natural host in which the virus circulates, causing respiratory 
problems, central nervous disorders and reproductive failures. Other animal species, 
except higher primates, may become infected when they are exposed to high 
quantities of PRV excreted by PRV-infected pigs or present in organic material 
coming from PRV-infected pigs. Infection of these animals is lethal with central 
nervous disorders and death within 2 days. Since infected non-porcine animals usually 
die without having shed PRV, they are of minor importance for virus transmission to 
contact animals. 
 This sub-chapter will highlight the most important data on the pathogenesis of 
PRV infection, both in naive and immune pigs, since this information (especially the 
pathogenesis in immune animals) is important for the aims of the research performed 
in these studies. 
 
1.2.2 PRV infection in naive pigs 
 Under natural conditions, the primary site of replication is situated in the 
respiratory tract, including nasal cavity, tonsils, pharynx and lungs (Sabo et al., 1969; 
Baskerville, 1973; Miry & Pensaert, 1989a). Due to the broad range of susceptible 
host cells, the short replication cycle and the direct cell-to-cell spread, PRV is able to 
penetrate very quickly through the epithelium and underlying connective tissue. At 
24h post inoculation, PRV is already found in epithelial cells, fibrocytes and nerve 
cells of the nasal cavity; at 48h post inoculation, viral antigens are detected in large 
plaques in the epithelium and connective tissues, including nerves and endothelial 
cells of blood vessels (Wittmann et al., 1980). From these primary sites, PRV spreads 
to distant secondary replication sites via lymph, blood and nerves. Viraemia occurs 
both under a cell-free and cell-associated form (with monocytes as most susceptible 
for PRV infection) (Nauwynck & Pensaert, 1995). Virus replication at these 
secondary sites is detected starting from 48h post inoculation in draining lymph 
nodes, olfactory bulb, medulla, spleen, kidneys, ovaries and uterus (Sabo et al., 1969; 
Wittmann et al., 1980). This replication, however, is less extensive than in the 
primary sites and is clearly reduced with the onset of the immune response. 
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 The central nervous system (CNS) is an important secondary site of PRV 
replication, causing nervous disorders in neonatal pigs. The CNS is reached by PRV 
via some of the cranial nerves such as the olfactory and trigeminal nerves (McFerran 
& Dow, 1965; Sabo et al., 1969, Wittmann et al., 1980). More detailed studies 
revealed that after intranasal inoculation of pigs, PRV travels from the nasal mucosa 
via the nerves of both the olfactory and trigeminal nervous pathways towards the 
ganglia in a non-infectious form, then replicates in the neuronal cell bodies after 
which infectious virus is transported towards tissues of the CNS or back towards the 
nasal mucosa. This transport (away from neuronal cell bodies) is also called 
anterograde transport, with gE and gI as important viral proteins during this process 
(Kritas et al., 1994a; Kritas et al., 1994b; Kritas et al., 1995). 
 The genital organs also are important secondary sites of PRV infection. It is 
assumed that these organs are reached via blood or nerves (McFerran & Dow, 1965) 
(and to a much lesser extent via PRV-contaminated sperm, Bolin et al., 1985). 
Replication of PRV has been described in the mesorchium of boars, leading to a 
severe periorchitis with a temporal or permanent infertility as a result (Miry & 
Pensaert, 1989b). Replication has also been described in the ovaria and the uterus of 
sows (Hsu et al., 1980). When a pregant sow becomes infected with PRV in the first 
trimester of gestation, fetuses are resorbed and the sow returns to estrus. A 
transplacental PRV infection in the second or third trimester results in abortion or 
stillborn pigs (Kluge et al., 1999). Reproductive failure can occur in 20% of the 
pregant sows (Kluge & Maré, 1974). 
 
1.2.3 PRV infection in immune pigs 
 The immune response against PRV starts at 7 days post inoculation and consists of 
the action of multiple defence mechanisms leading to elimination of the virus. 
Immunity can be established after a natural infection or after vaccination. The 
immune mechanisms are roughly subdivided in an early aspecific defence and a late 
specific defence. The early aspecific defence consists of activities, which are not 
specifically directed against PRV. Important reactions are the production of interferon 
(Wittmann et al., 1980; Pol, 1990; Nauwynck & Pensaert, 1995), lysis of PRV-
infected cells via activation of the alternative/lectin-binding complement pathway (in 
the absence of antibodies) (Kimman et al., 1992a) and the spontaneous cell-mediated 
cytotoxicity (predominantly mediated by macrophages, neutrophils and natural killer 
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cells) (Martin & Wardley, 1984; Wittmann et al., 1985). The late specific defence 
consists of PRV-specific actions including PRV-specific antibodies and PRV-specific 
cytotoxic T-lymphocytes (CTLs). PRV-specific IgM and IgA are found in all fluids, 
whereas IgG1 and IgG2 antibodies are only present in serum (Rodak et al., 1987; 
Kimman et al., 1992a). These antibodies will bind envelope glycoproteins, expressed 
on virions as well as on the plasma membrane of PRV-infected cells, thereby 
rendering these virions and/or infected cells recognizable for activation of the 
classical pathway of complement and antibody-dependent cell-mediated cytotoxicity 
(mediated by macrophages, neutrophils and natural killer cells) (Ashworth et al., 
1979; van Oirschot et al., 1984; Wittmann et al., 1985; Kimman et al., 1992a). PRV-
specific CTLs, also designated CD8+ T cells, are found in the blood and lymphoid 
organs of PRV-infected pigs, together with PRV-specific T-helper lymphocytes or 
CD4+ T cells (Kimman et al., 1992b; Kimman, 1994). The viral glycoproteins gB and 
gC are major target proteins for the PRV-specific CTLs (Zuckermann et al., 1990; 
Kimman, 1994). 
 Immunity after a PRV-infection induces a short virological but a long clinical 
protection. Following a reinfection at one month after the primary infection, a 
restricted replication of PRV can be observed in tonsils and lungs (alveoli and 
alveolar macrophages) but not in the nasopharynx. A time interval of 3 months results 
in virus replication of both the upper and lower respiratory airways (Sabo & 
Blaskovic, 1970; Miry & Pensaert, 1989a). 
 Protection against PRV after vaccination is less efficient compared to the 
protection induced by a natural infection. Reinfection at one month after vaccination 
(with an inactivated vaccine parenterally or an attenuated vaccine intranasally) results 
not only in PRV replication in the lungs, but also in the pharynx, tonsils and nasal 
cavity (Wittmann et al., 1980; Miry & Pensaert, 1989a). Moreover, despite the 
presence of a vaccination-induced immunity (using an inactivated vaccine), a cell-
associated viraemia can still occur which allows PRV to reach the inner organs 
(Wittmann et al., 1980). Such a viraemia generally does not cause problems. 
However, abortion has been reported on well-vaccinated farms (Dieuzy et al., 1987; 
de Mûelenaere & Pensaert, 1989) and occurs as the result of cell-associated 
transplacental spread and intrafetal replication (Nauwynck & Pensaert, 1992). Porcine 
blood monocytes have been shown to be essential to transport the virus via the blood 
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to the pregnant uterus in vaccination-immune pigs (Nauwynck & Pensaert, 1992; 
Nauwynck & Pensaert, 1995). Exactly how these infected monocytes survive in the 
blood in the presence of an immunity is still poorly understood, although recently, a 
process of antibody-induced clearance of viral cell surface proteins has been 
demonstrated which may lower the susceptibility of PRV-infected cells towards 
antibody-dependent cell lysis (Favoreel et al., 1999a).  
Introduction  13 
 
1.3 Immune evasion strategies of pseudorabies virus 
 
1.3.1 Introduction 
 Herpesviruses are masters in avoiding destruction by the immune system. All 
members of this family are capable of replicating in immune animals and establishing 
long-term persistence. Many properties of these viruses minimize the chance of 
elimination by complement, phagocytes, cytotoxic T-lymphocytes and/or natural 
killer cells. This sub-chapter will give a brief overview on the recent knowledge of the 
specific immune evasion strategies used by PRV. 
 
1.3.2 Evasion of complement-mediated lysis  
Partly published in Journal of General Virology. Favoreel, H.W., Van de Walle, G.R., 
Nauwynck, H.J. & Pensaert, M.B. (2003) 
 Complement consists of an interacting set of enzymes which, upon activation, give 
rise to a cascade of reactions, finally resulting in destruction of invading 
microorganisms and infected cells. Evasion of this complement activation system is of 
particular importance for viruses since it makes part of both the innate immunity 
(alternative, antibody-independent complement activation and mannan-binding lectin 
pathway) and the adaptive immunity (classical, antibody-dependent complement 
activation). 
 
gC complement binding 
 PRV, as well as the other members of the α-herpesvirinae, encodes the conserved 
viral glycoprotein gC, a non-essential glycoprotein known to play a role in virus 
attachment, virus release and virulence (Schreurs et al., 1988; Mettenleiter et al., 
1990; Herold et al., 1991). Besides that, gC has also been reported to bind C3, the 
pivotal component of the alternative complement cascade, with highest affinity to C3 
of the natural host (Friedman et al., 1984; Huemer et al., 1993). This alternative 
pathway of the complement cascade can become activated in the absence of 
antibodies and is therefore very important during early infection when humoral 
immunity is not yet achieved (Tizard, 1992). Binding of gC on PRV virions with the 
complement component C3 presumably results in inhibition of further downstream 
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events of this alternative activation of complement (Huemer et al., 1992; Huemer et 
al., 1993), thereby protecting PRV from complement-mediated lysis (Maeda et al., 
2002). 
 
Virion incorporation of regulatory control proteins of complement activation (RCAs) 
 Complement activation is a potentially dangerous system and must therefore be 
very carefully regulated. Normal mammalian cells are protected from complement-
mediated destruction by the activities of “regulatory control proteins of complement 
activation” (RCAs), which are restricted predominantly to complement of the same 
species (Tizard et al., 1992). In a recent study, it was demonstrated that PRV grown in 
a porcine cell line, was protected against the actions of porcine complement, whereas 
the same PRV strain grown in a rabbit cell line, was extremely sensitive to lysis by 
porcine complement (Maeda et al., 2002). This resistance of the porcine cell line-
derived PRV strain was thought to occur via incorporation of RCAs into the viral 
envelope during egress from the host cell. However, the RCAs responsible for this 
protection have not been identified to date. 
 
1.3.3 Evasion of antibody-dependent cell lysis 
 PRV-infected blood monocytes express viral envelope proteins on their plasma 
membrane (Favoreel et al., 1999b). PRV-specific antibodies will bind to these viral 
glycoproteins, which should induce antibody-dependent lysis of the infected cells 
(Sissons & Oldstone, 1980). This, however, seems to occur inefficiently during a PRV 
infection, since PRV-infected monocytes are able to survive in the blood of 
vaccinated animals (Nauwynck & Pensaert, 1992). Several strategies have been 
described which may help to explain the inefficient antibody-dependent lysis of PRV-
infected cells. 
 
gE-gI Fc receptor activity 
The expression of a viral Fc receptor, consisting of the viral gE-gI complex, has been 
very intensively studied for herpes simplex virus (HSV), the prototypical member of 
the α-herpesvirinae (Favoreel et al., 2003). gE-gI of PRV has also been shown to 
display Fc receptor activity (Favoreel et al., 1997). Expression of a viral Fc receptor 
may interfere with efficient antibody-dependent immune effectors via (i) binding of 
non-immune immunoglobulin G (IgG) to the Fc receptor, expressed on virus or virus-
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infected cells, by which access of viral-specific immune IgG is sterically hindered 
(Dowler & Veltri, 1984) and (ii) “antibody bipolar bridging”, consisting of 
simultaneous binding of the Fab sides of an antibody to viral proteins in the viral 
envelope or on the surface of infected cells, and of the Fc side of the same antibody to 
viral Fc receptors (Frank & Friedman, 1989), resulting in inefficient complement-
mediated neutralization and antibody-dependent cellular cytotoxicity. 
Although not yet examined, PRV gE-gI Fc receptor activity may lower the 
susceptibility towards antibody-dependent cell lysis. 
 
Antibody-induced clearance of viral proteins in PRV-infected cells 
 A schematic representation of antibody-induced clearance of viral cell surface 
proteins can be found in Figure 3. This process was first described for PRV-infected 
swine kidney (SK)-cells and consisted of antibody-induced aggregation (patching), 
capping and shedding of the antigen-antibody complexes from the cell surface 
(Favoreel et al., 1997). More detailed studies revealed that microtubules, a component 
of the cellular cytoskeleton, are of critical importance during the initial polarization of 
the patches and the formation of an early cap; the development of this early cap into a 
more pronounced cap was shown to be actin-dependent (Favoreel et al., 1997). Viral 
glycoprotein gE was found to have a dual role during this process. First, the gE-
mediated Fc receptor function was found to be necessary for efficient patching of 
antigen-antibody complexes (Favoreel et al., 1997). Second, two tyrosine amino acid 
residues in the cytoplasmic tail of gE were found to be crucial for efficient 
polarization of the patched antigen-antibody complexes, possibly by mediating a 
signal transduction event (Favoreel et al., 1999b). Clearance of antigen-antibody 
complexes from the cell surface could also be demonstrated in PRV-infected 
monocytes (Favoreel et al., 1999a), the natural carrier cell of PRV in the blood of 
vaccinated animals (Nauwynck & Pensaert, 1992). Here, clearance consisted of 
clustering and subsequent internalization of the antigen-antibody complexes. Using 
PRV mutants, viral glycoproteins gB and gD were shown to be indispensable for 
efficient internalization (Favoreel et al., 1999a). Recently, it was demonstrated that a 
single tyrosine residue in the cytoplasmic tail of gB is crucial for efficient 
internalization, possibly by linking gB to endocytosis adaptor protein complexes (AP- 
 
P V i f ti
 Monocyte or 
SK cell 
16  Chapter 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Schematic representation of antibody-induced clearance of viral cell surface proteins in 
pseudorabies virus-infected cells (adapted from Favoreel et al., 2000) 
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2) as a first step in the formation of clathrin-coated endocytosis vesicles (Favoreel et 
al., 2002). Although the mechanism of clearance depends on the cell type infected by 
PRV, both clearance mechanisms finally result in PRV-infected cells without visually 
detectable levels of antigen-antibody complexes on the plasma membrane. Although 
not yet examined, this mechanism may lower the susceptibility of PRV-infected cells 
towards antibody-dependent cell lysis. 
 
1.3.4 Evasion of major histocompatibility complex (MHC) class I-dependent 
cell lysis 
 MHC class I glycoproteins are expressed on the plasma membrane of almost all 
nucleated cells and strictly control the activation of cytotoxic T-lymphocytes (CTL) 
and natural killer (NK) cells. These MHC class I molecules are produced in the 
endoplasmatic reticulum, become loaded with either a cellular or a viral peptide (after 
degradation in the cytoplasm by proteasome) and are finally transported to the plasma 
membrane. If the peptide originates from a cellular protein, CTLs will ignore the cell, 
if the peptide is derived from a foreign (e.g. viral) protein, specific CTLs will 
recognize this MHC class-I complex, triggering the CTLs to lyse or cure the infected 
cell (Harper, 1994; Pamer & Cresswell, 1998, Guidotti & Chisari, 2000). 
 PRV has been reported to down-regulate the porcine class I molecules on PRV-
infected cells (Mellencamp et al., 1991). One ore more early proteins of PRV appear 
to be responsible for this down-regulation by interfering with the peptide transport 
activity of ‘the Transporter Associated with Antigen Presentation’ (TAP) (Sparks-
Thissen & Enquist, 1999; Ambagala et al., 2000). Whether this downregulation of 
MHC class-I lowers the susceptibility of infected cells towards CTL’s has not yet 
been examined. Besides this process, Favoreel et al. (1999b) demonstrated that during 
the process of antibody-induced internalization of viral cell surface proteins in PRV-
infected monocytes (as described above), several cellular plasma membrane proteins, 
including MHC class-I molecules, are passively co-internalized. Moreover, it was 
shown that this co-internalization of MHC class-I complexes reduced the 
susceptibility of PRV-infected monocytes to lysis by cytotoxic T-lymphocytes 
(Favoreel, 1999). 
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1.3.5 Evasion of apoptosis 
 Apoptosis, also designated host cell suicide or programmed cell death, of an 
infected cell can be stimulated directly by replication of the virus in the cell or 
indirectly by CTLs and NK cells, which secrete cytotoxic cytokines such as tumor 
necrosis factors, perforine and granzyme proteins, or the Fas ligand. Such a premature 
cell death can limit the time available for the production of new virions and interrupt 
cycles of latency and reactivation used by persistent viruses (Dockrell, 2001). It is 
known that many viruses have acquired anti-apoptotic genes, which have been 
reported to render infected cells resistant to apoptosis (Thomson, 2001), but the PRV 
genome has to date not been reported to encode proteins with anti-apoptotic functions, 
although it has to be mentioned that some PRV proteins display amino acid sequence 
similarities to known HSV anti-apoptotic proteins like Us3, Us5 and LAT (Jerome et 
al., 1999; Perng et al., 2000; Nishiyama et al., 2002). In a recent study by Aleman et 
al. (2001) it was shown that PRV is able to block apoptosis of the majority of infected 
trigeminal ganglionic neurons during an acute infection of swine. The surrounding 
inflammatory cells on the other hand, did undergo apoptosis implying a suppression 
of cell-mediated immunity following PRV infection. More research, however, is 
necessary to get a better understanding of the underlying mechanisms of these 
interesting observations. 
 
1.3.6 Latency 
 A characteristic of herpesvirus infections is the ability of the virus to establish a 
lifelong persistence in their host after the acute phase of infection, designated as viral 
latency. The major site of PRV latency, like HSV latency, consists of the trigeminal 
ganglionic neurons and other sites, such as the olfactory bulb, tonsils, and to a lesser 
extent, cells of the haematopoietic system, have also been suggested to contain latent 
PRV (Wittmann et al., 1983; Mettenleiter, 1994; Cheung, 1995; Balasch et al., 1998). 
During latency, viral DNA persists, but infectious virus is not produced. In this state 
of virus infection, only a very specific subset of viral genes is transcribed, the so-
called latency-associated transcripts (LATs), usually at a very low level, without 
detectable protein expression, making latently infected cells very hard, if not 
impossible, to be recognized by the immune system (reviewed by Jones, 1998). Upon 
certain stimuli, such as stress, the virus can reactivate from latency, which may result 
in virus production, excretion and spread. Recently, it has been shown that for PRV, 
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the LAT gene can also be transcriptionally active during a productive, lytic infection 
(Jin & Scherba, 1999). 
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1.4 Aims of the study 
 
 It has been reported earlier that in the presence of a vaccination-induced immunity, 
pseudorabies virus (PRV) may still replicate in the respiratory tract and draining 
lymph nodes, resulting in a restricted viraemia (Wittmann et al., 1980). This limited 
replication in immune animals generally does not cause problems. However, abortion 
may occasionally occur as a result of cell-mediated transplacental spread and 
intrafetal replication (de Mûelenaere & Pensaert, 1989; Nauwynck & Pensaert, 1992). 
Porcine blood monocytes have been shown to be essential to transport the virus to the 
pregnant uterus in vaccination-immune pigs (Nauwynck & Pensaert, 1992; Nauwynck 
& Pensaert, 1995). These infected monocytes are able to spread in the blood of 
vaccinated animals, which implies that these cells can temporary or permanently 
avoid efficient lysis by the immune system. Recently, a process has been described 
how these PRV-infected monocytes in vitro may avoid efficient antibody-dependent 
lysis: addition of PRV-specific antibodies to PRV-infected monocytes results in 
aggregation of the majority of membrane-bound viral cell surface proteins, followed 
by internalization of these antigen-antibody complexes (Favoreel et al., 1999b). 
Although not yet examined, this process may interfere with efficient antibody-
dependent cell lysis. This potentially new immune evasion mechanism used by PRV 
is fast and efficient and is mediated by the viral proteins gB and gD (Favoreel et al., 
1999b; Favoreel et al., 2002). 
 The aims of the work described in this thesis were to investigate in detail in vitro 
the underlying mechanism of this antibody-induced internalization process and the 
consequences of this process with regard to susceptibility of the PRV-infected cells 
towards antibody-dependent cell lysis, viability of and viral protein expression in the 
infected cells, and spread of the virus to internal organs. 
 
 First, it was evaluated whether the antibody-induced internalization process indeed 
can have an effect on the efficiency of antibody-dependent cell lysis. Therefore, it was 
investigated if this potential immune-evasion mechanism renders the PRV-infected 
monocytes less susceptible towards antibody-dependent complement-mediated cell 
lysis (Chapter 2). 
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 Next, the underlying mechanism of this antibody-induced internalization process 
was studied in more detail. Viral proteins gB and gD are crucial to efficiently initiate 
the process, and the aim of this part of the thesis was to examine if the subsequent 
steps necessary to complete the process are also virus-mediated or, alternatively, 
mediated by the cellular components known to be important in physiological 
endocytosis processes. (Chapter 3). 
 
 The next aim of the study was to evaluate the long term fate of PRV-infected 
monocytes with internalized viral cell surface proteins in the continuous presence of 
PRV-specific antibodies with regard to cell viability and viral protein expression 
(Chapter 4). 
 
 The aim of the final part of the study was to evaluate how PRV-infected 
monocytes with internalized viral cell surface proteins may transmit virus to vascular 
endothelial cells in the presence of neutralizing antibodies (Chapter 5). 
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Summary 
 
 Pseudorabies virus (PRV)-infected blood monocytes are able to transport the virus 
throughout the body of vaccination-immune pigs. PRV-infected monocytes express 
viral proteins in their plasma membrane that can be recognized by virus-specific 
antibodies. Recently, it has been shown that addition of PRV-specific polyclonal 
immunoglobulins to PRV-infected monocytes at 37 °C induces internalization of the 
majority of plasma membrane-expressed viral proteins. This study investigated 
whether this process may interfere with efficient antibody-dependent complement-
mediated lysis (ADCML) of PRV-infected monocytes in vitro. Therefore, an ADCML 
assay was set up, using PRV-infected porcine blood monocytes, porcine anti-PRV 
antibodies and porcine complement, to simulate the in vivo situation. It was shown 
that cells with internalized viral glycoproteins are significantly less susceptible toward 
ADCML than cells that did not undergo internalization (p< 0.005): 47% of the cells 
without internalization of viral cell surface proteins were lysed by ADCML, 
compared to only 12% of the cells that had undergone internalization of viral cell 
surface glycoproteins. Furthermore, it was shown (i) that the PRV gE-gI complex, 
which, like certain other alphaherpesvirus orthologues, possesses IgG-binding 
capacity, aids in avoiding efficient ADCML of PRV-infected monocytes and (ii) that 
the efficiency of PRV gE-gI-mediated evasion of ADCML can be decreased by the 
presence of gE-gI specific antibodies. 
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Introduction 
 
 Pseudorabies virus (PRV), a member of the subfamily Alphaherpesvirinae, causes 
Aujeszky’s disease in its natural host, the pig. Clinical signs depend on the age of the 
pig and are characterised by nervous signs in newborn pigs, respiratory disorders in 
fattening pigs and reproductive failure in sows. Abortion may be an important 
consequence of PRV infection in pregnant sows (Pensaert & Kluge, 1989). In the 
presence of a vaccination-induced immunity, PRV may still replicate in the 
respiratory tract and draining lymph nodes, resulting in a restricted viraemia 
(Wittmann et al., 1980). The limited replication in immune animals generally does not 
cause problems. However, abortion may occur as a result of cell-mediated 
transplacental spread and intrafetal replication. It has been shown that blood 
monocytes are essential to transport the virus via the blood of vaccination-immune 
pigs to different internal organs, including the pregnant uterus (Nauwynck & 
Pensaert, 1992; Nauwynck & Pensaert, 1995a), but little is known on exactly how 
these infected monocytes can survive in the presence of virus-neutralizing antibodies. 
 PRV-infected monocytes (and PRV-infected cells in general) express viral 
envelope proteins on their plasma membrane (Favoreel et al., 1999). Antibodies bind 
to these viral cell surface proteins which should induce antibody-dependent lysis of 
the infected cells (Sissons & Oldstone, 1980). A major component of the antibody-
dependent immune system is the complement cascade (reviewed by Sim & Dodds, 
1997). Complement components bind to the Fc region of antibodies, which leads to a 
cascade of events and results finally in lysis of antibody-covered infected cells 
(antibody-dependent complement-mediated cell lysis = ADCML) (reviewed by 
Müller-Eberhard, 1984). 
 Recently, we described a process of how PRV-infected monocytes may avoid 
efficient lysis by ADCML. Addition of PRV-specific antibodies to PRV-infected 
monocytes in vitro results in aggregation of the majority of membrane-bound viral 
proteins, followed by internalization of these glycoprotein-antibody complexes 
(Favoreel et al., 1999). The use of wild type PRV and isogenic deletion mutants 
showed that the viral glycoproteins gB and gD play a crucial role during this 
antibody-induced internalization process (Favoreel et al., 1999; Van de Walle et al., 
2001). Recently, it was shown that a tyrosine-based motif in the cytoplasmic tail of 
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gB is crucial for the correct functioning of gB during the internalization process 
(Favoreel et al., 2002). The internalization process is fast and efficient and leaves the 
infected monocyte with only few viral protein-antibody complexes on its surface. The 
purpose of the current study was to create an ADCML assay in vitro to investigate 
whether this antibody-induced clearance of the majority of the plasma membrane-
anchored viral proteins results in inefficient ADCML of PRV-infected monocytes. 
 Furthermore, we also tested the importance of another potential strategy of PRV to 
resist ADCML: glycoprotein complex gE-gI Fc receptor activity. For herpes simplex 
virus (HSV), it has already been shown that this gE-gI Fc receptor binding is 
important for evasion of the antibody-dependent components of the immune system in 
vitro and in vivo (Johnson et al., 1988; Frank & Friedman, 1989; Nagashunmugam et 
al., 1998). PRV gE-gI has also been shown to display Fc receptor activity (toward 
porcine IgG) (Favoreel et al., 1997), but its role in antibody-dependent immune 
evasion had not yet been studied. Therefore, besides studying the effect of antibody-
induced internalization of viral cell surface glycoproteins on ADCML efficiency, we 
also investigated whether PRV gE-gI binding capacity interferes with efficient 
ADCML of PRV-infected monocytes. 
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Materials and Methods 
 
 Virus strains. PRV strains 89V87, NIA3, Becker (Be) and its gE-gI deletion 
mutant [BegE-gI null] and Kaplan (Ka) and its gE-gI deletion mutant [KagE-gI null] were 
used. All strains have been described earlier (Kaplan & Vatter, 1959; McFerran & 
Dow, 1975; Mettenleiter et al., 1987; Nauwynck et al., 1992; Whealy et al., 1993; 
Mulder et al., 1994). 
 
 Antibodies. In most experiments, unlabeled or FITC-labeled protein A-purified 
IgG antibodies were used, derived from a PRV (89V87) inoculated pig, originating 
from a PRV-negative farm (Nauwynck et al., 1995b). When mentioned, protein A-
purified IgG antibodies were used derived from convalescent sera, which were 
obtained from pigs, originating from a PRV-negative farm, at 21 days after 
inoculation with 106 TCID50 PRV (NIA3, Ka or KagE-gI null). All purified antibodies, at 
a standardized concentration of 0.9 mg/ml IgG, had a titer between 24 and 64 with a 
complement facilitated serum neutralization test (C-SN) (Bitsch & Eskilden, 1982) 
and a titer between 160 and 640 with an immunoperoxidase monolayer assay (IPMA). 
 
 Porcine complement. Serum from a pig, originating from a PRV-negative farm 
(C-SN titer of < 2), was used as a source for porcine complement. 
 
 Isolation of porcine blood monocytes. PRV-negative pigs were used as blood 
donors. Blood was collected from the vena jugularis on heparin (15U/ml) (Leo, 
Zaventem, Belgium). Blood mononuclear cells were separated on Ficoll Paque® 
(Amersham Pharmacia Biotech AB, Uppsala, Sweden) following the manufacturer’s 
instructions. Mononuclear cells were then resuspended in medium (A), based on 
RPMI-1640® (Gibco BRL, Life Technologies Inc., Paisley, Scotland) and 
supplemented with 10% fetal bovine serum (FBS), 0.3 mg/ml glutamine, 100 U/ml 
penicillin, 0.1 mg/ml streptomycin, 0.1 mg/ml kanamycin, 1 mM sodium pyruvate, 
1% non-essential amino acids 100x (Gibco BRL) and 10 U/ml heparin. Afterwards, 
cells were seeded on 4-well multidish (Nunc A/S, Roskilde, Denmark) at a 
concentration of 2.5x106 cells/ml and cultivated at 37°C with 5% CO2. At 24 h post-
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seeding, non-adhering lymphocytes were removed by washing the 4-well multidish 
three times with RPMI-1640 as described before (Favoreel et al., 1999). Purity of 
monocytes was always ≥70%, as assessed by flow cytometric analysis using the 
monocyte marker 74.22.15 (Pescovitz et al., 1984). 
 
 Inoculation of blood monocytes. Monocytes were inoculated with different PRV 
strains at a multiplicity of infection (m.o.i.) of 10 in 0.5 ml medium (A) without 
heparin (Favoreel et al., 1999). Cells were further incubated at 37°C with 5% CO2. 
For all strains used and for all experiments, between 80 and 90% of the monocytes 
were infected and less than 5% of the non-monocytes were infected. 
 
 Antibody-dependent complement-mediated cell lysis (ADCML) assay. In 
general, at 13 h post inoculation (p.i.) with PRV, cells were centrifuged for 10 min at 
500xg, washed, and resuspended in medium (A). Cells were incubated for 1 h at 37°C 
with IgG antibodies derived from porcine PRV-specific polyclonal hyperimmune 
serum (0.9 mg/ml, except where indicated otherwise). Cells were washed twice in 
RPMI-1640®, and incubated for 1h at 37°C with porcine complement (a 5% dilution 
in medium (A), except where indicated otherwise). Except where mentioned 
otherwise, 50 µg/ml of genistein (Sigma Chemical Company, St. Louis, Missouri, 
USA) was added 45 minutes before antibody addition and also during antibody and 
complement incubation. Genistein inhibits tyrosine kinase activity and therefore 
antibody-induced internalization of viral glycoproteins (Favoreel et al., 1999). After 
complement incubation, cells were washed again in RPMI-1640® and finally 
resuspended in 0.5 ml RPMI-1640® supplemented with 10 µg propidium iodide (PI) 
(Molecular Probes, Eugene, Oregon, USA), which specifically stains dead cells. 
Fluorescence intensity of the cells was analyzed by flow cytometry after 5 min 
incubation with PI. 
 To determine the percentage of infected cells lysed by ADCML, the following 
formula was used: 
 
% of dead cells after the ADCML assay - % of dead cells before the ADCML assay 
x 100 
                                                   % of infected cells 
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 Enrichment of infected cells with antibody-induced internalization of viral cell 
surface proteins by magnetic cell sorting. PRV-infected monocytes (13 h p.i.) were 
incubated for 1 h at 37°C with 0.9 mg/ml of FITC-labeled PRV-specific antibodies 
(without genistein). Cells were washed with phosphate buffered saline (PBS), 
supernatant was removed completely and the cells were resuspended in 90 µl of 
buffer, consisting of PBS at pH 7.2 supplemented with 0.5% bovine serum albumin 
and 2 mM EDTA. After washing, 10 µl of MACS (magnetic antibodies cell 
separation) anti-FITC Microbeads® (Miltenyi Biotec, Bergisch Gladbach, Germany) 
were added and cells were incubated for 30 min at 4°C. Cells were washed, 
resuspended in 500 µl buffer and sorted with the MiniMACS (Miltenyi Biotec), 
according to the manufacturer’s instructions. The flow-through fraction, enriched in 
cells with complete internalization, was collected, washed in RPMI-1640® and used in 
the ADCML assay. 
 
Definition of the viral protein distribution. The distribution of viral 
glycoproteins was scored as described before (Favoreel et al., 1999; Van de Walle et 
al., 2001): (i) “no internalization”, when the fluorescence label exhibited a 
homogeneous or aggregated cell surface cover without internalized vesicles; (ii) 
“partial internalization”, when the labeled viral glycoproteins formed randomly 
distributed aggregates on the cellular surface and some were localized in internalized 
vesicles; (iii) “complete internalization”, when all visible viral glycoproteins were 
located in vesicles inside the cell, without any remaining on the plasma membrane. 
Quantitative results were obtained by examining the fluorescence distribution on at 
least 200 cells, by exciting with an Osram HBO 50-W bulb using a I3 filter and 
observing with a Leica DM IL fluorescence microscope (Leica, Germany). All assays 
were run independently at least three times. 
 
Indirect immunofluorescence staining of viral cell surface proteins. PRV-
infected monocytes (13 h p.i.) were centrifuged for 10 min at 500xg, washed and 
fixed for 10 min in 1% paraformaldehyde. The cells were washed and incubated for 1 
h at 37°C with 0.9 mg/ml of porcine PRV-specific antibodies (originating from 
different hyperimmune sera as described in the text), followed by 1/300 FITC-labeled 
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rabbit α-swine antibodies (Nordic Immunological Laboratories, Tilburg, The 
Netherlands) for 1 h at 37°C. Finally, the cells were washed thoroughly and analyzed 
by flow cytometry. 
 
PRV gE-gI IgG binding assay. PRV gE-gI IgG binding was assessed on PRV-
infected swine kidney (SK)-cells. Therefore, seven days old confluent monolayers of 
SK-cells were trypsinized, inoculated with PRV Ka or PRV Ka gE-gI null mutant at a 
m.o.i. of 10 and further incubated in 25 cm2 culture flasks for suspension culture 
(Sarstedt, Nümbrecht, Germany) on a tilting platform at 37°C in SK-medium, based 
on MEM® (Gibco BRL) and supplemented with 5% FBS, 0.3 mg/ml glutamine, 100 
U/ml penicillin, 0.1 mg/ml streptomycin and 0.1 mg/ml kanamycin. At 13 h p.i., cells 
were centrifuged for 10 min at 400xg, washed and resuspended in SK-medium. Cells 
were incubated for 1h at 37°C with 0.4 mg/ml of biotinylated PRV-negative porcine 
IgG antibodies (in the presence of 50 µg/ml genistein), essentially as described before 
(Favoreel et al., 1997). To investigate the effect of different PRV-specific 
hyperimmune sera on the efficiency of gE-gI IgG binding, SK-cells (13 h p.i.) were 
first incubated with biotinylated PRV-negative IgG antibodies, as described above, 
followed by incubation for 1h at 37°C with 0.9 mg/ml IgG antibodies (in the presence 
of 50 µg/ml genistein) derived from hyperimmune sera of pigs inoculated with either 
PRV Kawild-type or PRV KagE-gI null, followed by streptavidin-FITC (in the presence of 
50 µg/ml genistein) for 1h at 37°C and flow cytometric analysis. 
 
Flow cytometric analysis. The intensity of fluorescence of the cells was analyzed 
with a Becton-Dickinson (San Jose, California) FACScalibur equipped with a 15-mW 
air-cooled argon ion laser and interfaced to a Macintosh Quadra 650 computer (Apple 
Computer, Inc., Cupertino, California) using BD Cellquest software. Acquisition rates 
were maintained at 100-200 cells/s. At least 5000 cells were analyzed for each sample 
and forward-scattered light versus side-scattered light dot plots were used to identify 
monocyte populations. Statistical analysis was performed with SPSS (SPSS Inc., 
Chicago, Illinois, USA). 
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Results 
 
 Effect of antibody and complement concentration on ADCML of PRV-
infected monocytes. To optimize the ADCML assay, PRV-infected (Ka, Be, 89V87 
or NIA3) porcine blood monocytes (13 h p.i.) were incubated with different 
concentrations (0-1.8 mg/ml) of PRV-specific antibodies or different concentrations 
(0 - 10%) of porcine complement. Genistein (50 µg/ml) was used to avoid 
internalization and had no effect on cell viability, as assessed by the use of propidium 
iodide (PI) and flow cytometric analysis. ADCML was shown to be specific, since (i) 
incubating mock-infected cells with 0.9 mg/ml PRV-specific IgG and subsequently 
with 5% porcine complement resulted in background levels of lysis (3.8 ± 2.5% dead 
cells) and (ii) incubating PRV Ka-infected cells with 0.9 mg/ml IgG antibodies 
derived from a PRV-negative pig and subsequently with 5% porcine complement also 
resulted in background levels of lysis (0.9 ± 1.6% dead cells). 
Fig. 1.A&B shows that ADCML of PRV-infected monocytes increases with 
increasing concentrations of antibodies and complement. A steady-state level of cell 
lysis was observed when using at least 0.9 mg/ml of antibodies and 5% of porcine 
complement. These concentrations were therefore used in all further experiments. A 
low percentage (2.1% - 9.7%) of dead cells was observed when adding 5% of porcine 
complement without the addition of antibodies. To further investigate if this 
percentage could be attributed to the activation of the alternative complement 
pathway, experiments with the chelators EGTA and EDTA were performed. The Ca2+ 
and Mg2+-chelator EDTA blocks the activation of both the classical and the 
alternative pathway and was used to examine if the observed cell death during 
ADCML is indeed complement-mediated (Joseph et al., 1975; Friedman et al., 2000). 
The Ca2+-chelator EGTA only blocks the activation of the classical pathway and was 
used to determine if the low percentage of cell lysis observed when no PRV-specific 
antibodies were added in the ADCML assay, is due to activation of the alternative 
complement pathway (Joseph et al., 1975; Friedman et al., 2000). PRV Ka-infected 
cells were incubated with 10mM EDTA or 10mM EGTA (in combination with 1mM 
Mg2+) 15 min before and during complement incubation. Adding 10mM EDTA 
(inhibitor of both classical and alternative pathway) during the ADCML assay 
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reduced the percentage of dead cells from 49.0% ± 3.6 to 1.3% ± 1.5 indicating that 
the observed lysis during ADCML is indeed complement-mediated. Adding 10mM 
EGTA (inhibitor of the activation of the classical pathway), in combination with 1 
mM Mg2+, resulted in a reduction of the percentage of lysed cells to 9.0% ± 1.0. This 
percentage is comparable to the percentage of cell lysis we observe when only 
complement and no antibodies are added during the ADCML assay (7.3% ± 0.6). 
Hence, we can conclude that the low percentage of dead cells when adding porcine 
complement without the addition of antibodies is most probably due to activation of 
the antibody-independent alternative complement pathway. 
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FIG. 1. (A)&(B). Effect of different concentrations of antibodies and porcine complement on 
ADCML of PRV-infected monocytes. Monocytes, at 13 h p.i. with Kaplan (×), 89V87 (∆), Becker (◊) 
or NIA3 (), were incubated for 1 h at 37°C with different concentrations of PRV-specific antibodies 
followed by 5% of porcine complement for 1 h at 37°C (A) or 0.9 mg/ml PRV- specific antibodies for 
1 h at 37°C followed by different concentrations of porcine complement for 1 h at 37°C (B). 
Afterwards, PI was added for 5 min and percentage of dead PRV-infected monocytes was analyzed by 
flow cytometry. The data are means ± standard deviations of triplicate assays. 
 
Further, we tested whether the use of different virus strains and IgG purified from 
different hyperimmune sera, resulted in different ADCML efficiencies. The use of 
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comparable concentrations of IgG antibodies derived from different porcine 
hyperimmune sera had no significant effect on the efficiency of ADCML nor did the 
use of three different PRV wild type strains result in significantly different 
susceptibilities of the infected monocytes toward ADCML (Fig. 2.). There was no 
increase in ADCML efficiency when incubating the cells with porcine complement 
for 2 or 3 h compared to 1 h (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 2. Effect of antibodies derived from different hyperimmune sera on ADCML efficiency of 
PRV-infected monocytes. Monocytes, at 13 h p.i. with Kaplan, 89V87, Becker or NIA3, were 
incubated for 1 h at 37°C with antibodies derived from hyperimmune sera against 89V87 (black bars), 
NIA3 (grey bars) or Kaplan (white bars). Afterwards, cells were incubated with 5% of porcine 
complement for 1 h at 37°C. Finally, PI was added for 5 min and percentage of dead PRV-infected 
monocytes was analyzed by flow cytometry. The data are means ± standard deviations of triplicate 
assays. 
 
 Effect of antibody-induced internalization of viral cell surface glycoproteins 
on ADCML of PRV-infected monocytes. Addition of PRV-specific polyclonal 
antibodies to PRV-infected monocytes induces internalization of the majority of 
plasma membrane-anchored viral glycoproteins (Favoreel et al., 1999). In order to 
investigate whether this process may interfere with ADCML of PRV-infected 
monocytes, PRV 89V87-infected monocytes (13 h p.i.) were incubated for 1 h at 
37°C with 0.9 mg/ml FITC-labeled antibodies in the presence or absence of 50µg/ml 
genistein and subsequently used in the ADCML assay. Genistein is a tyrosine kinase 
inhibitor which blocks the internalization process (Favoreel et al., 1999). The 
percentage of cells lysed by ADCML when internalization could occur (39.0% ± 2.0) 
was lower than the percentage of lysis when no internalization could occur (46.0% ± 
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3.5). Using a PRV strain with a point mutation in the tyrosine residue in the 
cytoplasmic tail of gB that is critical for efficient antibody-induced internalization 
(Favoreel et al., 2002) resulted in a similar increase in ADCML of PRV-infected 
monocytes (50.7 ± 1.6% cell lysis versus 41.4 ± 3.4% when using the wild-type 
virus). Although these data together indicate that antibody-induced internalization is 
beneficial for the virus to avoid ADCML of infected cells, the differences in ADCML 
are relatively small. This can possibly be attributed to the fact that (in the absence of 
genistein and using a wild-type virus) only 36% of the cells had undergone complete 
internalization. To test this hypothesis, the population of infected cells with complete 
internalization was enriched by magnetic cell sorting (cfr. Materials and Methods). 
This enrichment had no effect on the viability of the cells (as assessed by using PI and 
flow cytometric analysis) and resulted in an increase of cells with internalized viral 
glycoproteins in the flow through fraction from 36.0 ± 6.2% to 74.3 ± 2.1% (Fig. 
3.A). Of the latter population of cells, only 21% ± 6.6 were lysed by ADCML (Fig. 3. 
B), which is significantly less than the 46% ± 3.5 that were lysed by ADCML when 
no internalization could occur (p< 0.005, two way ANOVA) (Fig. 3.B).  
Taking the results of the experiments with and without genistein and with and without 
magnetic cell sorting together, we calculated that approximately 47% of the cells with 
no or partial internalization are lysed by complement, whereas only about 12% of the 
cells with complete internalization are lysed by complement. The reasoning behind 
this calculation can be found as an addendum at the end of the Results section, page 
45. 
 
 Effect of gE-gI on ADCML of PRV-infected monocytes. HSV gE-gI possesses 
Fc receptor activity, which has been shown to be important for immune evasion of the 
virus in vivo (Nagashunmugam et al., 1998). Fc receptor activity has been 
demonstrated for PRV gE-gI as well, but its effect on immune evasion had not been 
investigated thus far (Favoreel et al., 1997). To examine the role of PRV gE-gI in 
ADCML evasion in vitro, PRVwild type- and PRVgE-gI null-infected monocytes were used 
in the ADCML assay. First, an indirect immunofluorescence assay (cfr. Materials and 
Methods) was used to ensure that cells infected with the gE-gI mutants (13 h p.i.) did 
not bind lower amounts of PRV-specific antibodies, compared to cells infected with 
the wild type strains (Fig. 4. IA). Second, cells infected with the wild type strains or 
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gE-gI null strains (13 h p.i.) were subjected to the ADCML assay, using the same 
antibodies. 
 
 A 
         % of PRV-infected cells with …… internalization 
                                                                  no                  partial              complete 
absence of genistein:  
  before magnetic cell sorting            48.0 ± 5.2          16.0 ± 1.5          36.0 ± 6.2 
                                        
  after magnetic cell sorting                
       flow through fraction                 15.0 ± 1.0          10.7 ± 1.2          74.3 ± 2.1 
       retained fraction                         82.4 ± 2.5            9.3 ± 1.2            8.3 ± 2.1 
presence of genistein:                     93.4 ± 1.2           3.0 ± 0.0             3.6 ± 1.1 
 
 B 
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FIG. 3. Effect of antibody-induced internalization of viral cell surface proteins on ADCML of PRV-
infected monocytes. PRV-infected monocytes (13 h p.i.) were incubated with FITC-labeled PRV-
specific antibodies for 1 h at 37°C in the presence or absence of genistein (internalization inhibitor). 
Afterwards, cells with internalized viral proteins were enriched by magnetic cell sorting. (A) 
Percentage of cells with no, partial, or complete internalization in the absence of genistein (before and 
after enrichment) or in the presence of genistein. The data are means ± standard deviations of triplicate 
assays. (B) Representative flow cytometric contour plots showing the percentage of dead (PI-positive) 
infected (FITC-positive) monocytes after ADCML of monocytes without (+ genistein) (1) or with 
internalized viral protein-antibody complexes (- genistein, after enrichment by magnetic cell sorting) 
(2). Percentages given are means ± standard deviations of triplicate assays. 
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Fig. 4. IB shows that cells infected with the wild type strains were only slightly, but 
significantly, less susceptible (p< 0.01) to ADCML compared to cells infected with 
the gE-gI null mutants. 
A possible explanation for the rather small difference in ADCML susceptibility 
between PRVwild type- and PRVgE-gI null-infected monocytes could be that gE-gI-specific 
antibodies that are present in the hyperimmune serum used in the ADCML assay, 
interfere with the PRV gE-gI Fc receptor activity. Therefore, the same ADCML 
experiments were repeated using antibodies derived from a hyperimmune serum of a 
pig infected with the KagE-gI null mutant and therefore does not contain gE-gI specific 
antibodies. Fig. 4. IIB shows that this resulted in a much more prominent difference in 
ADCML susceptibility between PRVwild type- and PRVgE-gI null-infected monocytes 
(p<0.001). 
To ensure that the observed difference in ADCML susceptibility of wild type- or gE-
gI null-infected cells, using the antibodies derived from gE-gI-negative hyperimmune 
serum, were not due to differences in the quantity of antibodies bound to the wild 
type- or gE-gI null-infected cells, an indirect immunofluorescence assay using the 
same antibodies was performed (Fig. 4. IIA). From the results of the ADCML assay, 
using wild type and gE-gI-negative hyperimmune sera and PRVwild type - and PRVgE-gI 
null -infected monocytes, it can be concluded (i) that the PRV gE-gI IgG binding, like 
HSV gE-gI IgG binding, protects infected cells from efficient ADCML in vitro and 
(ii) that there are indications that gE-gI specific antibodies can interfere with the PRV 
gE-gI Fc receptor activity. 
To further investigate whether gE-gI-specific antibodies can interfere with PRV 
gE-gI Fc receptor activity, we performed a displacement assay on PRV Ka-infected 
swine kidney (SK)-cells. SK-cells, in contrast to monocytes, do not express natural Fc 
receptors on their cell surface and are therefore better suited to study the PRV gE-gI 
Fc receptor activity. The displacement assay consisted of preincubation of PRV-
infected SK-cells with PRV-negative IgG, followed by incubation of the cells with 
PRV-specific IgG derived from hyperimmune sera of pigs inoculated with wild type 
PRV or gE-gI null PRV. If there are antibodies present among the PRV-specific 
antibodies that are directed against epitopes on gE that are important for Fc receptor 
activity, it is to be expected that they will be able to displace the PRV-negative IgG 
which were previously bound with their Fc side, since the affinity of IgG antibodies to 
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their antigen is typically higher than that of the Fc sides of antibodies to the Fc 
receptor (Fauger et al., 1998; Friget et al., 1998). 
II. PRV-specific antibodies containing 
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FIG. 4. Effect of gE-gI deletion on ADCML of PRV-infected monocytes using polyclonal PRV-
specific antibodies containing gE-gI-specific antibodies (I) or containing no gE-gI-specific antibodies 
(II). (A) Fluorescence intensity of monocytes, 13 h p.i. with PRV wild type strains (grey shaded) or 
with the gE-gI null mutants (⎯) and stained using 0.9 mg/ml porcine PRV-specific antibodies 
containing gE-gI-specific antibodies (I) or containing no gE-gI-specific antibodies (II) for 1h at 37°C, 
followed by incubation for 1h at 37°C with FITC-labeled rabbit α-swine antibodies. Mock-infected 
monocytes were used as a negative control (dotted plots). Fluorescence intensity was analyzed by flow 
cytometry. (B) Effect of deletion of gE-gI on ADCML of PRV-infected monocytes when using PRV-
specific antibodies containing gE-gI-specific antibodies (I) or containing no gE-gI-specific antibodies 
(II). Monocytes, at 13 h p.i. with the wild type strains (grey bars) or the gE-gI null mutants (white bars) 
were used in the ADCML assay. Afterwards, PI was added for 5 min and percentage of dead PRV-
infected monocytes was analyzed by flow cytometry. The data are means ± standard deviations of 
triplicate assays. 
 
 
Fig. 5. A, shows that wild type PRV-infected SK-cells exhibit IgG binding capacity, 
whereas gE-gI null-infected SK-cells do not, as has been shown before (Favoreel et 
al., 1997). This was determined using a FACS assay as described in the Methods 
section. Fig. 5. B shows the results of the displacement assay. Here, PRVwild type-
infected cells were incubated with 0.4 mg/ml biotinylated PRV-negative IgG and 
subsequently with 0.9 mg IgG/ml derived from either wild type or gE-gI-negative 
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hyperimmune sera, followed by incubation with streptavidin-FITC and flow 
cytometric analysis of the fluorescence intensity. Antibodies, derived from pigs 
inoculated with wild type PRV were able to efficiently displace the biotinylated PRV-
negative IgG, whereas antibodies derived from gE-gI null-infected pigs were not, 
supporting our hypothesis that gE-gI-specific antibodies can at least partially interfere 
with PRV gE-gI Fc receptor activity. 
 
 A 
 
 
 
 
 
 
 
B  
 
 
 
 
 
 
 
FIG. 5. (A). PRV gE-gI Fc receptor activity. Flow cytometric histogram showing fluorescence 
intensity of SK-cells, 13 h p.i. with PRV Kawild type or with KagE-gI null , incubated for 1 h at 37°C with 0.4 
mg/ml biotinylated PRV-negative IgG, followed by incubation for 1 h at 37°C with streptavidin-FITC. 
PRV Kawild type shows gE-gI Fc receptor activity (dotted plot), whereas PRV KagE-gI null does not (grey 
shaded). As a negative control, PRV Kawild type –infected SK-cells were incubated with streptavidin-
FITC only (dash/dotted line). (B). Displacement assay. The dotted plot and grey shaded plot represent 
the fluorescence intensity of the SK-cells, treated as described in (A). PRV Kawild type –infected cells 
were incubated for 1h at 37°C with 0.4 mg/ml of biotinylated porcine PRV-negative IgG, followed by 
incubation for 1 h at 37°C with 0.9 mg/ml of PRV-specific IgG antibodies derived from hyperimmune 
sera of pigs infected with either wild type PRV or gE-gI null PRV. Finally, SK-cells were incubated for 
1 h at 37°C with streptavidin-FITC. Bound PRV-negative IgG were efficiently displaced by antibodies 
derived from hyperimmune serum of a pig infected with wild type PRV (solid line) but not when using 
antibodies derived from hyperimmune serum of a pig infected with gE-gI null PRV (dotted line).
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ADDENDUM: Calculation of ADCML susceptibility for cells with and without internalization 
 
We calculated the susceptibility towards cells with complete internalization (12%) and cells without 
internalization (47%) as follows: 
We based the calculations on the percentage of flow cytometrically determined complement-mediated 
lysis of two mixed populations: one population with a predominant number of cells without complete 
internalization (in the presence of genistein) and one population with a predominant number of cells 
with complete internalization (absence of genistein, enrichment of cells with complete internalization 
by magnetic cell sorting). These calculations were done as follows: 
 
Sensitivity of cells without complete internalization towards complement-mediated lysis = x 
Sensitivity of cells with complete internalization towards complement-mediated lysis = y 
 
Equation 1: 
In the presence of genistein: 96% of the cells do not have complete internalization, 4% of the cells do 
have complete internalization. Of this total population of cells, 46% is lysed by complement 
(Fig.3a&b). 
Hence: 96x + 4y = 46 
 
Equation 2: 
In the absence of genistein, after enrichement of cells with complete internalization: 26% of the cells 
do not have complete internalization, 74% do have complete internalization. Of this total population of 
cells, 21% is lysed by complement (Fig.3a&b). 
Hence: 26x + 74y=21 
 
To solve the equations: 
Equation 1: 
96x + 4y = 46 
 
 y = 46 – 96x 
  4 
 
 
Introduce this in equation 2: 
 
26x + 74(46 – 96x) = 21 
         4 
 
resulting in x = 0.47, and introducing this in equation 1 (or 2) gives y = 0.12 
 
Hence, the sensitivity of cells without complete internalization (x) is 0.47, so 47% of these cells are 
lysed by complement. 
The sensitivity of cells with complete internalization (y) is 0.12, so only 12% of these cells are lysed by 
complement.  
 
To check the reliability of these percentages, we compared them to the flow cytometrically determined 
percentages of complement-mediated lysis of a third population of cells (no genistein, no enrichment 
by magnetic cell sorting). Here we had 64% of cells without complete internalization, 36% of cells 
with complete internalization, and this resulted in 39% of the total population of cells that were lysed 
by complement (Fig.3a and page 39). 
The equation would be: 
 
64x + 36y  
 
Introducing the calculated values for x and y (x=0.47, y=0.12) in the equation gives an estimated 
percentage of lysis of 34.4%, which is, although somewhat underestimated, fairly close to the actual 
percentage of lysis (39.0% ± 2.0%)(page 39). Hence, we concluded that the calculated percentages of 
sensitivity (12% and 47%) are fairly good estimates for the actual sensitivities of cells with or without 
complete internalization towards antibody-dependent complement-mediated lysis. 
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Discussion 
 
 PRV-infected blood monocytes are known to be able to transport PRV in well-
vaccinated pigs (Wittmann et al., 1980; Nauwynck & Pensaert, 1992). These infected 
monocytes express viral glycoproteins on their plasma membrane and should 
therefore be susceptible to antibody-dependent complement-mediated lysis 
(ADCML). Recently, a mechanism has been postulated of how PRV-infected 
monocytes potentially may avoid ADCML: the antibody-induced internalization of 
the majority of viral plasma membrane proteins (Favoreel et al., 1999). The aim of the 
current study was therefore to evaluate the importance of this mechanism in the 
ADCML evasion of PRV-infected monocytes in vitro. Further, a second potential 
ADCML evasion strategy has been described for several alphaherpesviruses, 
including PRV: gE-gI Fc receptor activity. For HSV, the prototypical 
alphaherpesvirus, this gE-gI IgG binding has been shown to interfere with efficient 
antibody-dependent lysis in vitro and in vivo (Johnson et al., 1988; Frank & 
Friedman, 1989; Nagashunmugam et al., 1998). Here, we also investigated the effect 
of the PRV gE-gI Fc receptor activity on the efficiency of ADCML of PRV-infected 
monocytes in vitro. A third potential mechanism of complement evasion, gC 
complement binding, has also been described for several alphaherpesviruses, 
including HSV and PRV (Friedman et al., 1984; Huemer et al., 1993). For HSV, it 
has already been shown that this gC complement binding is important for evasion of 
the antibody-independent, alternative complement activation pathway, rather than for 
the antibody-dependent classical pathway (ADCML) (Friedman et al., 1984; 
Friedman et al.; 1996; Lubinski et al., 1999; Friedman et al., 2000). Therefore, this 
mechanism was not considered in the current study. 
 An in vitro ADCML assay was set up, using PRV-infected porcine blood 
monocytes, porcine PRV-specific antibodies, and porcine complement, to simulate the 
in vivo situation. During the set up of this ADCML assay, we observed that a low 
percentage (up to 10% ± 2) of PRV-infected monocytes was lysed, when porcine 
complement was added to PRV-infected monocytes without prior addition of 
antibodies. This was not seen when using mock-infected cells and the low percentage 
of lysed cells was confirmed to be caused by activation of the alternative complement 
pathway, which does not require the presence of antibodies (reviewed by Pangburn & 
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Müller-Eberhard, 1984). Our results therefore suggest that although complement-
mediated lysis of PRV-infected monocytes via the alternative pathway indeed does 
occur, it seems to be of rather minor importance. Efficient antibody-independent 
complement-mediated lysis of PRV-infected cells may perhaps be disturbed by 
binding of viral glycoprotein C to complement factor C3b (Huemer et al., 1993). 
Activation of the alternative complement pathway by PRV-infected cells has already 
been described before (Kimman et al., 1992). The percentage of infected cells lysed 
by the alternative complement activation in this study was approximately 20%, which 
is higher than the percentage observed in our study. The differences in cell type 
(swine kidney cells) and complement source (rabbit complement) can probably 
account for these differences. 
 Antibody-induced internalization of plasma membrane-bound viral glycoproteins 
in PRV-infected monocytes leaves the infected monocyte with only few viral protein-
antibody complexes on its surface (Favoreel et al., 1999). Since ADCML of infected 
cells principally depends on the density of antigen-antibody complexes on the cell 
surface (reviewed by Sissons & Oldstone, 1980), our hypothesis was that this 
internalization process may interfere with efficient ADCML. To investigate this, 
PRV-infected monocytes were incubated with PRV-specific antibodies in the absence 
or presence of genistein (a tyrosine kinase inhibitor that blocks the internalization 
(Favoreel et al., 1999)), prior to incubation with complement. From these 
experiments, it could be concluded that cells with internalized viral glycoproteins are 
significantly less susceptible toward ADCML than cells that did not undergo 
internalization (p< 0.005): 47% of the cells without internalization of viral cell surface 
proteins were lysed by ADCML, compared to only 12% of the cells that had 
undergone internalization of viral cell surface glycoproteins. Since allowing antibody-
induced internalization of antigen-antibody complexes to proceed protects PRV-
infected monocytes from efficient ADCML in vitro, and since the internalization 
process in PRV-infected monocytes is fast and efficient, starting within minutes after 
antibody addition (Favoreel et al., 1999), it is tempting to speculate that this process 
may be significant for the survival of infected monocytes in vaccinated animals. 
Further research will clarify whether the short time-span between antibody binding 
and internalization is short enough to allow a significant percentage of infected 
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monocytes to successfully avoid lysis by antibody-dependent components of the 
immune system. 
 For HSV, varicella-zoster virus (VZV) and PRV, the gE-gI complex has been 
demonstrated to display Fc receptor activity (Johnson et al., 1988; Litwin et al., 1992; 
Favoreel et al., 1997). The expression of the gE-gI complex results in a species 
specific high affinity binding of IgG and it has been suggested that this Fc receptor 
activity may cause ‘antibody bipolar bridging’ resulting in disarmed bound antibodies 
which are unable to activate the classical complement pathway (Frank & Friedman, 
1989). For HSV, gE-gI IgG binding has been shown to be important for immune 
evasion of the virus in vivo (Nagashunmugam et al., 1998). In the current report, we 
show that, as expected, porcine blood monocytes infected with gE-gI-deleted PRV 
mutants are more susceptible to ADCML, compared to wild type-infected cells. This 
difference in percentage of lysed infected cells was significant (p< 0.01), but 
surprisingly low. However, the difference in ADCML between wild type and gE-gI 
null-infected monocytes became much more prominent when the ADCML assay was 
performed using antibodies derived from a hyperimmune serum of a pig infected with 
the KagE-gI null mutant. Additionally, we showed that antibodies derived from a 
hyperimmune serum of a pig, infected with wild type PRV, but not from a pig 
infected with the PRV gE-gI null mutant can at least partially interfere with efficient 
PRV gE-gI IgG binding. Taken all these findings together indicates that the PRV gE-
gI Fc receptor activity (i) aids in protecting PRV-infected monocytes from efficient 
ADCML in vitro and (ii) that gE-gI-specific antibodies can at least partially interfere 
with efficient IgG binding by PRV gE-gI. 
 During all ADCML assays we performed, even when blocking internalization and 
using gE-gI null virus to avoid Fc binding of the antibodies, ADCML of infected cells 
never reached 100%. This may suggest that, besides the two mechanisms studied in 
this report, PRV may have other tools at its disposal to avoid ADCML of infected 
cells. Moreover, since a significant difference (p< 0.05) in the percentage of lysed 
infected cells was always observed when using either PRV strain Kaplan or Becker 
(Be-infected monocytes were always 1.5-fold less susceptible toward ADCML than 
Ka-infected monocytes), these other possible evasion mechanisms of PRV could be 
more effective for certain PRV strains than for others. One such mechanism could be 
PRV gC complement binding (Huemer et al., 1993). The binding of gC to the C3 
factor of the complement cascade was first described for HSV (Friedman et al., 1984) 
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and has been shown to be important for immune evasion of HSV in vivo (Lubinski et 
al., 1999). Although HSV gC has been shown to interfere only with the antibody-
independent and not the antibody-dependent (ADCML) pathway of complement 
activation (Fries et al., 1985; Friedman et al., 1996), a possible role for this 
glycoprotein in protecting PRV-infected cells from ADCML cannot at present be 
ruled out and may be worth investigating in further detail. Several other mechanisms 
of ADCML evasion of infected cells have been described for other viruses and 
include the expression of viral proteins that mimic the function of cellular inhibitors 
of complement activation (Mold et al., 1988; Albrecht & Fleckenstein, 1992; Isaacs et 
al., 1992; Russo et al., 1996; Spiller et al., 1996; Saifuddin et al., 1997; Kapadia et 
al., 2000). Further research will be necessary to elucidate whether PRV makes use of 
such or other mechanisms to avoid ADCML of infected cells. 
 Furthermore, even when using a non-mutated virus and allowing antibody-induced 
internalization to proceed, a substantial number of PRV-infected cells (39.0 ± 2.0%) 
were lysed by ADCML. This most likely can be attributed to the fact that none of the 
complement evasion mechanisms is absolute. Antibody-induced internalization, 
which removes antigen-antibody complexes from the cell surface, only occurs 
completely in 36% of PRV-infected monocytes, leaving the other 64% unprotected. 
Also, the gE-gI Fc receptor activity may be partially inhibited to perform its function 
by the presence of gE-specific antibodies in serum (see Fig. 4). As discussed above, 
gC complement binding has been shown to be predominantly important for evading 
antibody-independent complement activation. These three arguments together 
possibly explain why a significant percentage of PRV-infected monocytes is sensitive 
towards ADCML. However, immune evasion strategies of PRV still allow a 
significant fraction of PRV-infected monocytes to avoid ADCML in vitro. This 
indicates that, although not perfect, PRV complement evasion strategies may still 
provide PRV-infected cells with an important tool to extend their life span and time to 
transmit virus throughout the body. 
 In conclusion, this report shows that antibody-induced internalization of PRV 
plasma membrane proteins, together with PRV gE-gI Fc receptor activity, are of 
significant importance in protecting PRV-infected monocytes from efficient ADCML 
in vitro. 
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Summary 
 
 Pseudorabies virus (PRV) may still cause abortion, even in the presence of a 
vaccination-induced immunity and blood monocytes have been shown to be essential 
to transport the virus throughout the body of these immune animals. It has been 
demonstrated recently that addition of anti-PRV polyclonal antibodies to PRV-
infected monocytes induces internalization of plasma membrane-anchored viral 
proteins and this may interfere with antibody-dependent cell lysis. In the present 
study, it was shown that actin, microtubules, clathrin and dynein, the major cellular 
components involved in physiological endocytosis, are used by PRV to generate the 
antibody-induced internalization of viral glycoproteins. In a first assay, porcine 
monocytes, inoculated with PRV for 13 hours, were treated with different 
concentrations of chemical inhibitors like colchicine, cytochalasin D, latrunculin B 
and amantadine-HCl, which inhibit polymerization of microtubules, actin/clathrin, 
actin and clathrin respectively, before the addition of PRV-specific antibodies. This 
resulted in a significant reduction of internalization compared to the non-treated 
control. In a second assay, double labeling experiments of viral proteins on the one 
hand and cellular components on the other hand were performed during the 
internalization process. A clear co-localization of actin, microtubules, clathrin and 
dynein with the viral proteins was observed at different stages during the 
internalization process. All these results indicate that cellular components are 
involved in the virological internalization process. 
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Introduction 
 
 Pseudorabies virus (PRV) is a member of the Alphaherpesvirinae, which causes 
Aujeszky’s disease in its natural host, the pig. The clinical signs of the disease depend 
on the age of the pig and are characterised by nervous signs in newborn pigs, 
respiratory disorders in fattening pigs and reproductive failure in sows. Abortion may 
be an important consequence of PRV infection in susceptible pregnant sows (Pensaert 
& Kluge, 1989). In the presence of vaccination immunity, PRV inoculation can still 
result in infection of the respiratory tract, involving mononuclear cells in draining 
lymph nodes. These cells may enter the bloodstream, resulting in a restricted viraemia 
(Wittmann et al., 1980). The restricted replication in immune animals generally does 
not cause problems. However, abortion may occur as a result of cell-mediated 
transplacental spread and intrafetal replication. It has been shown that blood 
monocytes are essential to transport the virus in vaccination-immune pigs (Nauwynck 
& Pensaert, 1992; Nauwynck & Pensaert, 1995a). However, little is known on the 
exact mechanism how these PRV-infected monocytes survive in the blood without 
being eliminated by antibody-dependent cell lysis or cytotoxic T-lymphocytes. 
 Recently, it was demonstrated by Favoreel et al. (1999) that addition of PRV-
specific antibodies to PRV-infected monocytes resulted in an aggregation of the 
membrane-bound viral proteins, followed by the internalization of these antigen-
antibody complexes. This fast and efficient antibody-induced internalization process 
is mediated by the viral proteins gB and gD and may interfere with antibody-
dependent cell lysis (Favoreel et al., 1999). 
 Antibody-induced internalization of viral cell surface proteins resembles the well-
studied bivalent ligand-induced endocytosis of cellular receptors (Favoreel et al., 
2000). It is known that binding of such a ligand to its receptor induces aggregation of 
the receptors. This results in a conformational change by which adaptor proteins (AP) 
can bind to certain highly conserved amino acid sequences in the cytoplasmic tail of 
the receptor. These AP will then bind to clathrin molecules, the driving force behind 
membrane invagination, with formation of clathrin-coated pits, which are finally 
pinched off into the cytoplasm as clathrin-coated vesicles (Goldstein et al., 1985; 
Hirst & Robinson, 1998). It is assumed that actin plays an important role during this 
stage of endocytosis (reviewed by Qualmann et al., 2000). Clathrin-coated vesicles 
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will then deliver the receptor-ligand complexes to early endosomes, with the receptors 
directed back to the plasma membrane via a recycling pathway and the ligand proteins 
sorted into a lysosomal pathway (Ghosh et al., 1994). The transport of the lysosomes 
to the centre of the cell is performed by the motor protein dynein, which mediates 
vesicle or organelle transport and moves along microtubules (reviewed by Goodson et 
al., 1997; Hamm-Alvarez, 1998). 
 The main purpose of the current study was to investigate whether several 
components of the cellular cytoskeleton (clathrin, actin, dynein and microtubules), 
known to play a role in the process of bivalent ligand-induced endocytosis of cellular 
receptors, are being used in PRV-infected monocytes to generate the antibody-
induced internalization of viral cell surface proteins. 
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Materials and Methods 
 
 Virus strains. PRV strains 89V87 and Kaplan (Ka) and PRV (Ka) deletion 
mutants gB-, gC-, gD-, gE-, gH- and gM- were used. All strains have been described 
earlier (Dijkstra et al., 1996, Kaplan & Vater, 1959, Klupp et al., 1992, Mettenleiter et 
al., 1987, 1988; Nauwynck & Pensaert, 1992; Rauh & Mettenleiter, 1991). Strains 
carrying deletions in the genes encoding essential glycoproteins were grown on 
complementing cell lines. 
 
 Isolation of porcine blood monocytes. Pigs from a PRV-negative farm were used 
as blood donors. Blood was collected from the vena jugularis on heparin (15 U/ml) 
(Leo, Zaventem, Belgium). Blood mononuclear cells were separated on Ficoll Paque 
(Pharmacia Biotech AB, Uppsala, Sweden) following the manufacturer’s instructions. 
Mononuclear cells were then resuspended in medium A, based on RPMI-1640 (Gibco 
BRL, Life Technologies Inc., Gaithersburg, MD) supplemented with 10% fetal calf 
serum (FCS), 0.3 mg/ml glutamine, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 0.1 
mg/ml kanamycin, 1 mM sodium pyruvate, 1% non-essential amino acids 100x 
(Gibco BRL) and 10 U/ml heparin. Afterwards, cells were seeded on a 4-well 
chambered coverglass (Nunc A/S, Roskilde, Denmark) at a concentration of 2.5x106 
cells/ml and cultivated at 37°C with 5% CO2. After 48 h, non-adherent cells, mainly 
consisting of lymphocytes, were removed by washing the chambered coverglass three 
times with RPMI-1640. 
 
 Inoculation of blood monocytes. The adherent cells, consisting of ≥70% of 
monocytes (as assessed by flow cytometric analysis after incubation with 74.22.15 
(Pescovitz et al., 1984)), were inoculated with different PRV strains at a m.o.i. of 20 
in 0.5 ml medium A without heparin. Monocytes were incubated for 13 h at 37°C 
with 5% CO2. 
 
 Incubation of PRV-infected monocytes with porcine anti-PRV polyclonal 
antibodies. Monocytes, 13 h after inoculation with PRV, were washed three times 
with RPMI-1640 and incubated for 1 h at 37°C with FITC-conjugated PRV-specific 
polyclonal antibodies (0.33 mg/ml) (as described by Favoreel et al., 1999). These 
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FITC-labeled, protein A-purified IgG antibodies were, as described earlier 
(Nauwynck & Pensaert, 1995b), derived from a PRV (89V87)-inoculated pig 
originating from a PRV-negative farm and had a titer of 512, as determined with a 
serum neutralization (SN) test (Andries et al., 1978). At different time points (0, 2, 5, 
10, 30 and 60 min) post antibody addition (p.Ab.a), cells were fixed with 0.4% 
formaldehyde (except where indicated otherwise). Finally, the cells were washed 
thoroughly, mounted in a glycerin-phosphate buffered saline solution (PBS) (0.9:0.1, 
vol/vol) with 2.5% 1,4-diazabicyclo(2.2.2)octane (DABCO; Janssen Chimica, Beerse, 
Belgium), excited with an Osram HBO 50-W bulb using a I3 filter, and observed with 
a Leica DM IL inverted fluorescence microscope (Leica, Germany). 
 
 Definition of the viral glycoprotein distribution. The viral cell surface protein 
distribution was scored as a ‘rim’ when the fluorescence label exhibited a 
homogeneous cell surface cover. The cells were scored as ‘patched’ when the labeled 
viral proteins formed randomly distributed aggregates on the cellular surface. The 
viral proteins were considered ‘internalized’ when all visible viral proteins were 
located in vesicles inside the cell, without any remaining on the plasma membrane. 
Quantitative results were obtained by examining the fluorescence distribution on at 
least 200 cells. All assays were run independently at least three times. 
 
 Chemical inhibitors of the different cellular components. To determine the 
involvement of the cellular components during the observed process of antibody-
induced internalization, different concentrations of colchicine (Sigma-Aldrich Chemie 
GmbH, Steinheim, Germany; inhibitor of tubulin polymerization; 0 µM-500 µM), 
cytochalasin D (Sigma-Aldrich Chemie GmbH, Steinheim, Germany; inhibitor of G-
actin polymerization to F-actin and inhibitor of budding of clathrin-coated vesicles; 0 
µM-100 µM), latrunculin B (ICN Biochemicals Inc., Ohio; actin-disrupting agent; 0 
µM-50 µM) and amantadine-HCl (Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany; inhibitor of clathrin-coated-pit invagination at the plasma membrane; 0 
µm-500 µM) were added 30 min before and during antibody incubation. For each 
concentration of the chemical inhibitors, the viability of the monocytes was analyzed 
by flow cytometry after the addition of 10 µg propidium iodide (Molecular Probes, 
Eugene, Oregon). Only concentrations with no significant effect on cell viability were 
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used. Statistical analysis was performed with SPSS (SPSS Inc., Chicago, Illinois, 
USA). 
 
 Double immunofluorescence labeling of viral proteins with microtubules or 
actin. After incubation with FITC-conjugated PRV-specific antibodies, as described 
above, the cells were washed in a cytoskeleton-stabilizing buffer (CSB), containing 
10 mM Pipes buffer, 150 mM NaCl, 5 mM EGTA, 5 mM MgCl and 5 mM glucose 
and afterwards fixed for 10 min at 37°C with a 3% solution of paraformaldehyde in 
CSB. After washing in CSB, cells were permeabilized for 2 min in a 0.1% solution of 
Triton-X 100 in CSB and then washed again in CSB. 
Microtubules were stained by incubation of cells for 1 h at 37°C with mouse anti-α-
tubulin IgG1 antibodies 1:20 in CSB (Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany). Afterwards, cells were washed in washing buffer (WB), containing 200 
mM Tris, 1.45 M NaCl, 20 mM EGTA and 20 mM MgCl and subsequently incubated 
for 1 h at 37°C with goat-anti-mouse IgG-Texas Red 1:40 in CSB (Molecular Probes, 
Eugene, Oregon) and washed twice in WB. 
To stain actin, cells were incubated for 1 h at 37°C with 200 nM phalloidin-Texas 
Red (Molecular Probes, Eugene, Oregon) in CSB and afterwards washed twice in 
WB. 
 
 Double immunofluorescence labeling of viral proteins with clathrin or dynein. 
After incubation with FITC-conjugated PRV-specific antibodies, as described above, 
the cells were washed with Tris-buffered saline (containing 20 mM Tris-HCl and 150 
mM NaCl) + 4.5% sucrose (w/v) + 2% heat-inactivated goat serum (TBS-SG), fixed 
in a 3% solution of paraformaldehyde and permeabilized with methanol 100% as 
described by Racoosin & Swanson (1994). 
Clathrin was stained by incubation of cells for 1 h at 37°C with mouse anti-clathrin 
IgM antibodies (ICN Biomedicals Inc., Ohio) 1:100 in PBS, supplemented with 0.3% 
gelatine, and dynein by incubation with mouse anti-dynein IgM antibodies (Sigma-
Aldrich Chemie GmbH, Steinheim, Germany) 1:100 in PBS, supplemented with 0.3% 
gelatine. Afterwards, cells were washed in TBS-SG and incubated for 1 h at 37°C 
with rat-anti-mouse IgM-biotin (Serotec Ltd, Oxford, UK) 1:250 in PBS, 
supplemented with 0.3% gelatine. After washing, cells were incubated for 1 h at 37°C 
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with streptavidin-Texas Red 1:100 in PBS, supplemented with 0.3% gelatine, 
(Molecular Probes, Eugene, Oregon) and washed twice in TBS-SG. 
 
 Confocal Laser Scanning Microscopy. Fluorescent double stained samples were 
examined on a Bio-Rad Radiance 2000 confocal laser scanning system (Bio-Rad 
House, Hertfordshire, UK), linked to a Nikon Diaphot 300 microscope (Nikon 
Corporation, Tokyo, Japan) and interfaced to an AST Premmia SE 4/66d computer 
(AST Computer, Irvine, California). Krypton/Argon laser light was used to excite 
FITC (488 nm line) and Texas Red (568 nm line) fluorochromes using a K1- and a 
K2-emission filter respectively. Extended focus images were obtained with Bio-Rad 
COMOS Software. Images were printed on a Kodak XLS 8600 PS printer (Eastman 
Kodak Company, Rochester, New York). 
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Results 
 
 Kinetics of antibody-induced internalization of PRV-infected monocytes in 
adhesion versus suspension and the importance of viral proteins gB and gD. In 
the study of Favoreel et al. (1999), monocytes in suspension were used to investigate 
the kinetics of the antibody-induced redistribution and internalization of viral cell 
surface proteins, expressed on PRV-infected monocytes. To obtain better confocal 
images, monocytes in adhesion were used in this study. Identical experiments as 
described by Favoreel et al. (1999) were performed first, to evaluate whether 
monocytes in adhesion behave like monocytes in suspension. The evolution of 
redistribution of the viral glycoproteins after addition of PRV-specific antibodies did 
not differ between PRV-infected monocytes in adhesion and monocytes in suspension 
(Fig. 1A). Shortly after antibody addition, viral proteins became aggregated in patches 
and then rapidly internalized. The only visible difference between monocytes in 
adhesion and monocytes in suspension was that the internalization process was more 
efficient when monocytes were in adhesion. After 1 h of incubation with PRV-
specific IgG, the percentage of cells that showed internalized viral cell surface 
proteins was 85% in adhesion, which is higher than the value previously obtained by 
Favoreel et al. (1999) with monocytes in suspension (65%). 
In the study of Favoreel et al. (1999) it has been shown, by the use of PRV (Ka) and 
isogenic deletion mutants, that the viral proteins gB and gD are very important for the 
viral protein internalization process in suspension. Similar experiments with PRV 
(Ka) and the gB and gD deletion mutant strains were performed with monocytes in 
adhesion. From Fig. 1B it can be concluded that viral proteins gB and gD are also of 
significant importance in the internalization process for monocytes in adhesion 
(P<0.001, one way anova). As an extra control, experiments using the PRV (Ka) 
deletion mutants gC, gE, gH and gM were performed and none of these mutants had 
an impaired ability to induce internalization, which is also consistent with previously 
described results with monocytes in suspension (Favoreel et al., 1999) (data not 
shown). Therefore, in all further experiments adherent monocytes were used. 
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FIG. 1. (A). Antibody-induced redistribution of viral glycoproteins expressed on the plasma 
membrane of PRV-infected monocytes in adhesion. PRV-infected monocytes were incubated at 37°C 
with FITC-labeled PRV-specific antibodies and fixed at different time points during this incubation. 
Distribution of viral glycoproteins was observed by fluorescence microscopy and scored as described 
in Materials and Methods. Curves indicate percentages of PRV-positive cells with rims (◊), patches (
) 
and internalized viral cell surface proteins (∆). The data are means ± standard deviations of triplicate 
assays.  
   (B). Viral glycoprotein internalization is mediated by viral proteins gB and gD. Monocytes 
in adhesion were infected with PRV (Ka) and gB and gD deletion mutant strains. PRV-infected 
monocytes were incubated at 37°C with FITC-labeled PRV-specific antibodies and fixed at different 
time points during this incubation. Curves indicate percentages of monocytes with internalized viral 
cell surface proteins when infected with PRV (Ka) (◊), gB deletion mutant (
) and gD deletion mutant 
(∆) strains. The data are means ± standard deviations of triplicate assays. 
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 Influence of chemical cellular inhibitors on antibody-induced internalization 
of viral cell surface proteins. During different steps of the well-studied process of 
ligand-induced endocytosis of cellular receptors, microtubules, actin, clathrin and 
dynein are of critical importance (Goldstein et al., 1985; Hirst & Robinson, 1998; 
Merrifield et al., 1999). Experiments with different chemical inhibitors were 
performed to investigate whether these components of the cellular cytoskeleton are of 
importance in the process of internalization of viral cell surface proteins. The 
concentrations of colchicine, cytochalasin D and amantadine-HCl are similar as those 
used in several other studies (Bourguignon & Bourguignon, 1984; Cooper, 1987; 
Everitt & Rodriguez, 1999; Favoreel et al., 1997). For latrunculin B, an actin- 
disrupting agent, a concentration of 50 µM was used, based on the effect of different 
concentrations of the agent on the monocyte actin filaments (determined via 
phalloidin-Texas Red staining) and on cell viability (determined via propidium iodide 
staining). None of the reagents caused significant decreases in the expression of viral 
glycoproteins on the plasma membrane, nor did they affect patching of viral cell 
surface proteins after the addition of antibodies, as analyzed by fluorescence 
microscopy (data not shown). All the different concentrations of the chemical 
inhibitors which were used in the experiments, caused no significant decrease in cell 
viability, as analyzed by flow cytometry after incubation with propidium iodide. As 
shown in Fig. 2, all the inhibitors reduced the antibody-induced internalization of viral 
glycoproteins in PRV-infected monocytes in a concentration-dependent manner. 
Addition of 500 µM colchicine resulted in a significant reduction of internalization of 
60.0 ± 4.5% (P<0.001, one way anova) when compared to the non-treated monocytes 
(relative internalization level of 100%), indicating the importance of microtubules 
during the antibody-induced internalization of viral glycoproteins.  Addition of 30 µM 
cytochalasin D, 50 µM latrunculin B and 500 µM of amantadine-HCl resulted in a 
significant reduction of internalization of 79.0 ± 3.5%, 56.0 ± 1.0% and 59.0 ± 4.4% 
respectively (P<0.001, one way anova) compared to non-treated cells.  These results 
suggest that actin polymerization, clathrin-coated pit formation and vesicle budding 
and tubulin polymerization are all involved in the process of antibody-induced 
internalization of viral glycoproteins. 
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FIG. 2. PRV-infected monocytes (13 h post inoculation) were incubated for 30 min at 37°C with 
different concentrations of colchicine, an inhibitor of tubulin polymerization (A), cytochalasin D, an 
inhibitor of G-actin polymerization and clathrin-coated vesicle budding (B), latrunculin B, an inhibitor 
of actin polymerization (C) and amantadine-HCl, an inhibitor of clathrin-coated pit formation (D). 
Afterwards, FITC-labeled porcine PRV polyclonal antibodies were added for 1 h at 37°C. The data are 
means ± standard deviations of triplicate assays. 
 
 Visualization of the cellular components microtubules, actin, clathrin and 
dynein during the different stages of antibody-induced internalization of viral 
glycoproteins. To further elucidate the role of the different cellular components in the 
observed process, microtubules, actin, clathrin and dynein were visualized by 
fluorescence labeling in PRV-infected monocytes at different time points after 
addition of porcine PRV-specific antibodies. 
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Microtubules. Monocytes were inoculated with 89V87 for 13 h and incubated with 
FITC-labeled PRV polyclonal antibodies. After fixation at different time points post 
antibody addition (p.Ab.a), mouse anti-α-tubulin was added, followed by goat-anti-
mouse IgG-Texas Red. The organization of the microtubules in the cell at the 
different stages during antibody incubation was analyzed by confocal microscopy and 
scored as an ‘intact network’ if a clear network with a clear microtubule organizing 
center (MTOC) was visible and as a ‘disorganized network’ if only short microtubules 
and only a vague MTOC were visible. Fig. 3 shows six different configurations of 
viral glycoproteins and microtubules, observed by confocal microscopy at different 
time points p.Ab.a. At 0 min p.Ab.a (13 h post inoculation), 96 ± 2.6% of the cells 
had an intact network with microtubules organized as perinuclear fibers originating 
from the MTOC. Of the cells in rim and patch, 92 ± 2.6% and 94 ± 2.1% had a 
disorganized network at 2 and 5 min p.Ab.a respectively. The disorganization of the 
microtubules was accompanied by a rounding of the cells. Over 99% of the cells with 
internalized viral proteins showed an intact microtubule network and an intact cell 
morphology again from 10 up to 60 min p.Ab.a. At these time points (10 up to 60 min 
p.Ab.a), 94 ± 2.1% and 92 ± 2.4% respectively of the cells that remained in rim and 
patch had still a disorganized network. 
It can be concluded from these results that a depolymerization of the microtubules 
occurs shortly after antibody binding to the infected cells and that a reorganization of 
the microtubule network seems to be important for the subsequent internalization of 
the viral glycoproteins to take place. 
 
Actin. No visible change in the organization of the actin filaments was observed on 
the different redistribution stages of the viral glycoproteins during PRV-specific 
antibody incubation. A cortex of actin fibers, lying just beneath the plasma membrane 
was observed in over 95% of the cells at all time points. 
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FIG. 3. Double immunofluorescence labeling of viral glycoproteins (FITC) with microtubules 
(Texas red) at different time points during antibody-induced internalization, observed by confocal 
microscopy. The images are middle sections of each cell. Arrow indicates the position of the nucleus. 
Bar, 5 µm. 
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Clathrin and dynein. With a double immunofluorescence labeling, viral 
glycoproteins (FITC-labeled) and clathrin or dynein (Texas Red-labeled) were stained 
to see if and when a co-localization could be observed. First, a positive control with 
10 µg of BODIPY FL-LDL (Molecular Probes, Eugene, Oregon) was enclosed, 
because endocytosis of low-density lipoprotein (LDL) is known to be clathrin- and 
dynein-dependent (Kibbey et al., 1998; Ichikawa et al., 2000). A co-localization 
between LDL and clathrin respectively dynein could be observed, indicating that the 
technique used for the double immunofluorescence labeling experiments was 
performed in a proper way (data not shown). 
Fig. 4A. shows the viral glycoproteins (FITC) with clathrin (Texas Red) at different 
time points p.Ab.a. An accumulation of clathrin was seen in the regions were the viral 
glycoproteins were located at 2 and 5 min p.Ab.a. A clear co-localization of vesicles 
which contain the viral protein-antibody complexes, with clathrin was seen, from 10 
till 30 min p.Ab.a. From 30 min p.Ab.a, clathrin started to recycle back to the plasma 
membrane and the vesicles were further transported towards the nucleus. At 60 min 
p.Ab.a, a co-localization of the viral glycoproteins with clathrin was no longer 
observed. 
70  Chapter 3 
 
 
A 2 min 
p.Ab.a 
 
5 min 
p.Ab.a 
10 min 
p.Ab.a 
30 min 
p.Ab.a 
60 min 
p.Ab.a 
 
 
 
1 
 
 
 2 
 
 
 
 3 
 
 
 
B 60 min 
p.Ab.a 
30 min 
p.Ab.a 
10 min 
p.Ab.a 
5 min 
p.Ab.a 
 
 
 
1 
 
 
 
 
2 
 
 
 3 
 
 
FIG. 4. Double immunofluorescence labeling of viral glycoproteins (FITC) with clathrin (Texas 
red) (A) and dynein (Texas red) (B) at different time points during antibody-induced internalization, 
observed by confocal microscopy. Lane 1 shows viral proteins, lane 2 shows clathrin (A) and dynein 
(B) and lane 3 shows images, obtained by merging (1) and (2). The images are middle sections of each 
cell.  Arrow indicates the position of the nucleus. Bar, 5 µm. 
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Discussion 
 
PRV-infected porcine blood monocytes have been shown to be capable of 
transporting the virus to different internal organs in pigs with specific antibodies in 
the blood circulation (Wittmann et al., 1980; Nauwynck & Pensaert, 1992; Nauwynck 
& Pensaert, 1995a). Since viral proteins become expressed on the plasma membrane 
of PRV-infected monocytes, one would expect that antibody-dependent cell lysis will 
eliminate these cells. However, some cells avoid such destruction. One possible 
explanation for the inefficient antibody-dependent lysis of PRV-infected monocytes 
has been described recently: the fast and efficient antibody-induced internalization of 
viral cell surface proteins (Favoreel et al., 1999). 
The data presented here show that this antibody-induced internalization process shows 
strong similarities to the bivalent ligand-induced endocytosis of cellular receptors 
(Goldstein et al., 1985). In order to generate the antibody-viral antigen internalization 
process, the PRV-infected monocyte mobilizes different cellular components such as 
clathrin, actin, dynein, and microtubules as shown by the use of different chemical 
inhibitors and by co-localization studies between the different cellular components 
and the viral proteins. 
The first step after the addition of PRV-specific antibodies to PRV-infected 
monocytes is the aggregation of the viral plasma membrane glycoproteins.  This 
aggregation (patching) is followed by an invagination of the plasma membrane and 
the formation of vesicles, containing the viral protein-antibody complexes. The 
importance of clathrin during these early steps was shown by inhibition of clathrin-
coated-pit invagination at the plasma membrane using amantadine-HCl and inhibition 
of clathrin-coated vesicle budding using cytochalasin D which resulted in a strong 
decrease in internalization, as well as by immunofluorescence double staining. A clear 
co-localization of vesicles which contain the viral glycoprotein-antibody complexes 
and clathrin was seen from 5 till 30 min p.Ab.a. From that time point on, clathrin 
recycled back to the plasma membrane and the vesicles were further transported 
towards the nucleus. A very similar role for clathrin has been shown during the 
spontaneous endocytosis of certain herpes viral glycoproteins, such as varicella-zoster 
virus gE (Olson & Grose, 1997) and human cytomegalovirus virus gB (Tugizov et al., 
1999). Spontaneous endocytosis of PRV gB and gE has also been described and is 
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likely to be clathrin-dependent as well (Tirabassi & Enquist, 1998). Despite these 
similarities, it is, in the current context, important to clearly discriminate spontaneous 
gB and gE endocytosis and the antibody-induced internalization of the major viral cell 
surface proteins. PRV gB and gE endocytosis are spontaneous processes (antibody-
independent), which affect gB and gE alone and which occur during early stages of 
infection (< 6 h post infection) (Tirabassi & Enquist, 1998). Antibody-induced 
internalization of PRV proteins, on the other hand, is antibody-dependent, results in 
internalization of all major viral cell surface proteins, and can be induced from 7 up to 
17 h post infection (Favoreel et al., 1999).  
Actin filaments have also been shown to be of major importance during the first 
stages of the receptor-mediated endocytosis process, but a clear role for actin in 
endocytic processes has not been established (reviewed by Qualmann et al., 2000). 
Two major hypotheses have been described. The first hypothesis proposes an active 
role of actin during the initial stages of the endocytosis process, by which actin 
modulates vesicle budding and mediates vesicle transport or fusion (Lamaze et al., 
1997; Merrifield et al., 1999). The second hypothesis suggests a more passive role for 
actin filaments, by which actin provides the integrity of the cell, necessary for the 
endocytosis process to take place (Gaidarov et al., 1999). Since a significant reduction 
in endocytosis was observed with both the inhibitors cytochalasin D and latrunculin 
B, but no change in distribution of actin filaments was observed during the different 
stages of the internalization process by fluorescence labeling, our results tend to 
favour the second hypothesis. 
During bivalent ligand-induced endocytosis of cellular receptors, the clathrin-coated 
pits are pinched off into the cell as clathrin-coated vesicles, followed by shedding of 
the clathrin coat and fusion of the endocytic vesicles with early endosomes. Further 
transport of these vesicles towards the nucleus is mediated by dynein, a microtubule 
motor protein that moves along microtubules (Goodson et al., 1997; Hamm-Alvarez, 
1998). In the present study, involvement of dynein in the transport of the vesicles 
containing the viral protein-antibody complexes was demonstrated by a clear co-
localization of the internalized viral proteins with dynein from 5 till 60 min p.Ab.a.  
In order to have an indication whether the microtubules function as ‘highways’ during 
this transport of the vesicles towards the cell nucleus, experiments with a chemical 
inhibitor of microtubule polymerization (colchicine) and double immunofluorescence 
labeling of microtubules with the viral proteins were performed. Addition of 
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colchicine resulted in a significant decrease in internalization, which suggests the 
involvement of microtubules during the process of antibody-induced internalization of 
viral glycoproteins. A remarkable observation was made when microtubules and viral 
glycoproteins were analyzed by double immunofluorescence staining. At 0 min 
p.Ab.a, the cells had an intact network and normal cell morphology, indicating that an 
infection with PRV had no influence on the organization of the microtubule network. 
This observation is consistent with earlier experiments performed at our laboratory, 
which revealed that the microtubule network remains intact from 0 until 16 hours 
after infection with 89V87 (data not shown). During the stages of rim and patch (2 
and 5 min p.Ab.a respectively), the microtubule network became disorganized which 
was accompanied by a loss of cell shape. It has already been described that a 
disorganization of the microtubule network affects the cell shape of certain cell types, 
including macrophages (Rodinov et al., 1993; Rosania & Swanson, 1996). During the 
subsequent stages of internalization (10, 30 and 60 min p.Ab.a), the microtubule 
network appeared to be intact again, accompanied by a convalescent normal cell 
shape and transport of the vesicles towards the nucleus. It has been shown that certain 
membrane proteins are prevented from patching and subsequent endocytosis because 
they are linked to microtubules. These integral membrane proteins are immobilized at 
specialized microdomains on the cell surface, which are linked to the microtubules via 
the spectrin-ankyrin network, a member of the membrane-associated cell cortex 
(Drenckhahn et al., 1993). Furthermore, it has been suggested that the size of bivalent 
antigen-induced aggregates (patches) of cellular plasma membrane proteins needs to 
exceed a ‘minimal patch size’ before subsequent endocytosis can occur (Bourguignon 
& Bourguignon, 1984). Indications for the existence of a similar minimal patch size 
for antibody-induced internalization of PRV cell surface proteins to occur have been 
described (Favoreel et al., 1999). It could be hypothesized that some or all of the viral 
proteins inserted in the plasma membrane are (in)directly linked with and 
immobilized by components of the cellular cytoskeleton, such as microtubules. Such 
an association has already been described for the Us9 glycoprotein of the human 
cytomegalovirus, a betaherpesvirus (Maidji et al., 1998). If future research shows that 
a similar cytoskeleton-association exists for PRV glycoproteins as well, 
disorganization of the microtubule network would be necessary for proper patching 
and subsequent internalization to occur. 
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The underlying physiological mechanism explaining the microtubule disorganization 
remains to be studied.  One possible explanation could be that antibody-induced 
aggregation of viral cell surface proteins induces a Ca2+ influx in the monocytes. 
Such a Ca2+ influx has already been described upon aggregation of cellular receptors 
by bivalent ligands and antibodies (Bourguignon & Bourguignon, 1984; Dyer & 
Benjamins, 1990). Since high concentrations in Ca2+ are known to destabilize the 
microtubule network, such a Ca2+ influx could cause the observed microtubule 
disorganization (Soto et al., 1996).  
It is generally accepted that microtubules are being used by cells for efficient 
transport of proteins and lipids to various sites within the cell (Cole & Lippincott-
Schwartz, 1995). Therefore it is reasonable to suggest that the microtubule network 
needs to be intact again before transport of the internalized viral glycoproteins 
towards the center of the cell can take place. This is consistent with the results of the 
present study where it was shown that the microtubules regained their structure at 
approximately 10 min p.Ab.a, during the later stages of the internalization process. 
The low percentage of cells in rim and patch that remained in these configurations 
during these later stages p.Ab.a still had a disorganized microtubule network, 
supporting the idea that an intact network is necessary for later stages in the 
internalization process to occur. 
In conclusion, the current study provides strong indications that actin, microtubules, 
clathrin and dynein, important components during physiological endocytosis, are 
being mobilized by PRV-infected monocytes to generate the antibody-induced 
internalization of viral glycoproteins, a potential immune evasion mechanism of PRV. 
Furthermore, the present findings establish an interesting in vitro model for 
(biochemical) investigations on the possible interactions between certain viral 
glycoproteins, expressed on the plasma membrane of a PRV-infected cell, and 
different components of the cellular cytoskeleton.  The model can also be used to 
study viral and cellular endocytosis processes in general, since the antibody-induced 
internalization of viral glycoproteins in PRV-infected monocytes is easily 
reproducible and is a fast, very efficient and coordinated process. 
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Summary 
 
 Although rare, pseudorabies virus (PRV) may cause abortion in the presence of a 
vaccination-induced immunity and blood monocytes have been shown to be essential 
to transport the virus throughout the body of these immune animals. It has been 
demonstrated that addition of PRV-specific polyclonal antibodies to PRV-infected 
monocytes induces internalization of plasma membrane-anchored viral proteins 
(immune-masked monocytes), a process that interferes with antibody-dependent cell 
lysis in vitro. In the present study, we examined the long-term fate of these 
productively infected immune-masked monocytes with regard to viability of the cells 
and expression of viral antigens. In a first assay, the viability of PRV-infected 
monocytes in the presence or absence of PRV-specific antibodies was evaluated until 
194 h post inoculation (p.i.). It was shown that in the continuous presence of PRV-
specific antibodies, approximately 30% of the PRV-infected monocytes were still 
viable at 194 h p.i., compared to 0% in the absence of PRV-specific antibodies. In a 
second assay, the expression of viral glycoproteins was investigated in the immune-
masked monocytes, in the continuous presence of PRV-specific antibodies until 194 h 
p.i. This assay showed that approximately 75% of the surviving immune-masked 
PRV-infected monocytes did no longer show visually detectable expression of viral 
proteins from 120 h p.i. onward. Addition of the reactivating agent dexamethasone 
was able to induce a re-expression of viral proteins. In conclusion, it can be stated that 
internalization of viral cell surface proteins in PRV-infected monocytes may not only 
delay destruction of the cells by the immunity, but may also lead to a quiescent 
infection and an expanded life span of the cells, giving a possible explanation for how 
these cells may act as carriers of PRV in the blood of vaccinated animals. 
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Introduction 
 
 The alphaherpesvirus pseudorabies virus (PRV) causes Aujeszky’s disease in its 
natural host, the pig. The disease is characterized by nervous signs in newborn pigs, 
respiratory disorders in fattening pigs and reproductive failure in sows (Wittmann et 
al., 1980). Abortion can be an important consequence of PRV infection in susceptible 
pregnant sows (Pensaert & Kluge, 1989). Even in the presence of a vaccination-
induced immunity, PRV inoculation may result in infection of the respiratory tract, 
involving mononuclear cells in draining lymph nodes. These cells can enter the 
bloodstream, resulting in a restricted viraemia (Wittmann et al., 1980), that generally 
does not cause problems. However, rarely, abortion in immune animals can occur as a 
result of transplacental spread and intrafetal replication. Infected porcine blood 
monocytes are essential to transport the virus in vaccination-immune pigs to enable 
the virus to reach the pregnant uterus (Nauwynck & Pensaert, 1992; Nauwynck & 
Pensaert, 1995a). Different components of the immunity, including the antibody-
dependent immune effectors, should be able to lyse PRV-infected monocytes in the 
blood stream of vaccinated animals. Indeed, PRV-infected monocytes express viral 
proteins in their plasma membrane (Favoreel et al., 1999) and binding of antibodies to 
these antigens should induce antibody-dependent lysis of these cells (Sisson & 
Oldstone, 1980). One of the mechanisms that may aid PRV in masking infected blood 
monocytes from antibody-dependent cell lysis consists of the antibody-induced 
internalization of antigen-antibody complexes (Favoreel et al., 1999). During this 
process, binding of PRV-specific antibodies to viral proteins on the cell surface of 
PRV-infected monocytes results in internalization of the antigen-antibody complexes 
(immune-masked monocytes). This internalization process is fast and efficient, 
mediated by viral proteins gB and gD, and reduces the sensitivity of PRV-infected 
monocytes towards antibody-dependent complement-mediated cell lysis in vitro (Van 
de Walle et al., 2001; 2003a). Such immune-masked monocytes have already been 
shown to be capable of transmitting virus to vascular endothelial cells through 
adhesion and fusion processes in the presence of neutralizing antibodies in vitro, as a 
possible first step for PRV to reach internal organs (Van de Walle et al., 2003b). 
To date, antibody-induced internalization of viral cell surface proteins has only been 
studied in vitro over relatively short periods post antibody addition (≤ 2 h) and post 
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inoculation (≤ 17 h). However, the circulation of PRV-infected monocytes in vivo 
occurs in the continuous presence of PRV-specific antibodies. Therefore, the aim of 
the current study was to investigate the effect of the continuous presence of porcine 
PRV-specific antibodies on PRV-infected monocytes over an extended period of time, 
examining both the viability of the infected cells as well as the expression level of 
viral proteins in the infected cells. 
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Materials and Methods 
 
 Virus strains. PRV strain 89V87 was used in all experiments (Nauwynck & 
Pensaert, 1992). 
 
 Isolation of porcine blood monocytes. Pigs from a PRV-negative farm were used 
as blood donors. Blood was collected from the vena jugularis on heparin (15 U/ml) 
(Leo, Zaventem, Belgium). Blood mononuclear cells were separated on Ficoll Paque 
(Pharmacia Biotech AB, Uppsala, Sweden) following the manufacturer’s instructions. 
Mononuclear cells were then resuspended in medium A, based on RPMI-1640 (Gibco 
BRL, Life Technologies Inc., Gaithersburg, MD) supplemented with 10% fetal calf 
serum (FCS), 0.3 mg/ml glutamine, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 0.1 
mg/ml kanamycin, 1 mM sodium pyruvate, 1% non-essential amino acids 100x 
(Gibco BRL) and 10 U/ml heparin. Afterwards, cells were seeded on 4-well 
multidishes (Nunc A/S, Roskilde, Denmark) at a concentration of 2.5x106 cells/ml 
and cultivated at 37°C with 5% CO2. After 48h, non-adhering lymphocytes were 
removed by washing the 4-well multidish three times with RPMI-1640. 
 
 Inoculation of blood monocytes. The adherent cells, consisting of ≥70% of 
monocytes (as assessed by flow cytometric analysis using the monoclonal antibody 
74.22.15 (Pescovitz et al., 1984)), were inoculated 3 times with a time interval of 24 h 
with the PRV strain 89V87 at a m.o.i. of 10 in 0.5 ml medium A without heparin. 
Mock-infected monocytes were used as a control. 
 
 Incubation of PRV-infected monocytes with porcine antibodies. Monocytes, 
were always at 1 h post inoculation (p.i.) or mock-infected, washed three times with 
RPMI-1640 and incubated with porcine PRV-specific polyclonal antibodies (0.4 mg 
of IgG/ml). These protein A-purified IgG antibodies were, as described earlier 
(Nauwynck & Pensaert, 1995b), derived from a PRV (89V87)-inoculated pig 
originating from a PRV-negative farm and had a titer of 512, as determined with a 
serum neutralization (SN) test (Andries et al., 1978). As a control, protein A-purified 
PRV-negative porcine serum was used, at the same concentration (0.4 mg of IgG/ml). 
This serum was derived from a PRV-negative pig and had a titer < 2 with the SN test. 
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At different time points (0, 24, 48, 72, 96, 120 and 194 h) p.i., monocytes were 
incubated for 30 min on ice with 100 µg/ml of ethidium mono-azide bromide (EMA) 
(Molecular Probes, Eugene, Oregon, USA) which specifically stains dead cells. Cells 
were washed twice with RPMI-1640 and cell smears were made by centrifuging for 4 
min at 700 rpm, followed by fixation for 20 min at –20°C with acetone 100%. 
 
 Direct immunofluorescence staining of cell smears. Cell smears were washed 
twice with phosphate buffered saline (PBS) and viral antigens were visualized by 
incubating cell smears for 1 h at 37°C with FITC-labeled porcine polyclonal IgG 
antibodies (Favoreel et al., 1999), dilution 1:100 in PBS. After washing twice in PBS, 
nuclei were stained by incubating cell smears at room temperature for 10 min with 
Hoechst 33342 (Molecular Probes, Eugene, Oregon, USA) which stains nuclei, 
dilution 1:100 in PBS. Finally, cell smears were washed thoroughly with PBS, 
mounted with a glycerin-phosphate buffered saline solution (PBS) (0.9:0.1, vol/vol) 
with 2.5% 1,4-diazabicyclo (2.2.2) octane (DABCO; Janssen Chimica, Beerse, 
Belgium), excited with an Osram HBO 50-W bulb using an I3, a TR and a D filter, 
and observed with a Leica DM RBE microscope (Leica GmbH, Wetzlar, Germany). 
Quantitative results were obtained by examining the EMA (dead cells), Hoechst (all 
cells) and FITC intensity (viral antigen-positive cells). Images were obtained by using 
a Sony color video camera (model DXC-9100P), linked to a Macintosh computer. 
Statistical analysis were performed with SPSS (SPSS Inc., Chicago, Illinois,USA). 
 
 Treatment of PRV-infected monocytes with dexamethasone. At 144 h p.i., 
PRV-infected monocytes incubated with PRV-specific polyclonal antibodies were 
washed three times with PRMI-1640 and subsequently incubated with 3 µM 
dexamethasone 98% (Sigma-Aldrich Chemie GmbH, Steinheim, Germany), 
supplemented with 0.4 mg/ml PRV-specific polyclonal antibodies. At two and four 
days after the addition of dexamethasone, (at 192 and 240 h p.i. respectively), cells 
were incubated with EMA, cell smears were made and direct immunofluorescence 
stainings were performed as described above. 
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Results 
 
 Efficiency of PRV inoculation of monocytes in the continuous presence or 
absence of PRV-specific antibodies. Figure 1. shows that the repeated PRV 
inoculation as described in the Materials and methods section resulted in the 
expression of viral antigens in all monocytes at 96 h p.i., both in the presence and in 
the absence of PRV-specific antibodies, as determined by immunofluorescence 
staining with FITC-labeled PRV-specific antibodies. Hence, all monocytes became 
productively infected irrespective of the presence of PRV-specific antibodies in the 
medium. 
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 FIG. 1. Efficiency of PRV inoculation. Monocytes (n= 104) were inoculated three times with PRV 
at a time interval of 24 h, and, each time, at 1 h p.i., supplemented with either 0.4 mg/ml PRV-specific 
polyclonal IgG antibodies () or 0.4 mg/ml  PRV-negative IgG antibodies (∆). Mock-infected 
monocytes, incubated with either PRV-specific (◊) or PRV-negative (o) IgG antibodies were used as 
controls. At different time points p.i., expression of viral  antigens was determined by fixation of the 
cells for 20 min at –20°C in acetone 100%, followed by incubation for 1 h at 37°C with FITC-labeled 
PRV-specific porcine polyclonal antibodies. Data represent means ± standard deviations of triplicate 
assays. 
 
 Long term survival of monocytes in the continuous presence or absence of 
PRV-specific antibodies. To evaluate whether and how long PRV-infected 
monocytes survive in the continuous presence of antibodies, monocytes were 
inoculated 3 times with the PRV strain 89V87 and always at 1 h p.i. resuspended in 
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medium supplemented with 0.4 mg/ml of porcine PRV-specific polyclonal IgG 
antibodies or, as a control, 0.4 mg/ml PRV-negative porcine IgG. Mock-infected 
monocytes, incubated with either PRV-specific or PRV-negative IgG antibodies were 
used as controls. Fig. 2 shows that the viability of PRV-infected monocytes, both in 
the presence or absence of PRV-specific antibodies, decreased dramatically until 72 h 
p.i. The percentage of viable cells at different time points post inoculation in the 
presence of PRV-negative IgG antibodies was comparable with the percentage of 
viable cells at the corresponding time points in the absence of antibodies (data not 
shown). However, from 120 h p.i. onwards, all PRV-infected monocytes incubated 
with PRV-negative IgG antibodies were lysed, whereas approximately 30% of the 
PRV-infected monocytes incubated with PRV-specific polyclonal IgG antibodies 
remained viable (box). These results indicate that in the continuous presence of PRV-
specific antibodies, some PRV-infected monocytes remain viable for unusual long 
periods of time. 
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 FIG. 2. Long term survival of PRV-infected monocytes. Monocytes (n= 104), at 1 h post inoculation 
with PRV, were incubated with 0.4 mg/ml of either PRV-specific polyclonal IgG antibodies () or 
PRV-negative IgG antibodies (∆). Mock-infected monocytes, incubated with either PRV-specific (◊) or 
PRV-negative (o) IgG antibodies were used as controls. At different time points p.i., viability was 
determined by incubating the cells for 30 min on ice with ethidium mono-azide bromide (EMA) to 
stain dead cells and, after fixation in acetone 100%, all cells were stained by incubating for 10 min at 
room temperature with Hoechst. Data represent means ± standard deviations of triplicate assays. 
 
 Expression of viral proteins in the long term surviving PRV-infected 
monocytes. In this part of the study, the expression of viral antigens was examined in 
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the subpopulation of PRV-infected monocytes that survived for unusual long times in 
the presence of PRV-specific antibodies (Fig. 2, box). Fig. 3A shows that the majority 
of these surviving PRV-infected cells gradually stopped producing viral antigens. All 
of the surviving monocytes were positive for viral antigens at 72h p.i., whereas, by 
194 h p.i., only 25% of the surviving cells showed visually detectable viral antigen 
expression. 
Fig. 3.B shows monocytes, at 194h p.i. with PRV, in the continuous presence of PRV-
specific polyclonal IgG antibodies. Of the three PRV-infected monocytes (all three 
nuclei are stained with Hoechst), two cells are no longer viable, as determined by 
EMA (indicated by arrows), and show viral glycoprotein expression (visualized by 
incubation with FITC-labeled PRV-specific antibodies). The third, surviving PRV-
infected cell, shows no or very little visually detectable viral protein expression. The 
results from these experiments demonstrate that in the continuous presence of PRV-
specific antibodies, the majority of surviving PRV-infected monocytes stop 
expressing visually detectable viral antigens. 
 
 Effect of dexamethasone addition. The observation that, in the continuous 
presence of PRV-specific antibodies, approximately 75% of the surviving PRV-
infected monocytes do no longer express visually detectable viral antigens from 120 h 
p.i. onwards could imply that antibody binding to the viral antigens on the cell surface 
of PRV-infected monocytes may abort the infection and direct the cells in a quiescent 
infected state. To investigate whether this stage of quiescence possibly resembles 
latency, dexamethasone, a glucocorticoid known to induce herpesvirus reactivation 
from latency (Schoembaum et al., 1990; Donofrio & van Santen, 2001), was added to 
the cells. Therefore, monocytes at 144h p.i. with PRV and in the continuous presence 
of 0.4 mg/ml PRV-specific polyclonal IgG antibodies, were washed and 3 µM 
dexamethasone was added, supplemented with 0.4 mg/ml PRV-specific polyclonal 
IgG antibodies.  
 
 
 
 
 
 
25
30 
35 
40 
ur
vi
vi
ng
 
A
88  Chapter 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 FIG. 3. (A). Expression of viral glycoproteins in the long term surviving PRV-infected monocytes. 
Monocytes (n= 104), at 1 h post inoculation with PRV, were incubated with 0.4 mg/ml of PRV-specific 
polyclonal IgG antibodies. From 72 h p.i. onwards, expression of viral proteins in surviving PRV-
infected monocytes was determined at different time points as described in Materials and Methods. The 
square represents the total number (x 104) of surviving monocytes. The number of surviving monocytes 
with visually detectable viral antigen expression (o) gradually decreases whereas the number of 
surviving monocytes without visually detectable viral antigen expression (∆) increases over time. Data 
represent means ± standard deviations of triplicate assays.  
    (B). Immunofluorescence staining of monocytes at 194 h p.i. with PRV, in the continuous 
presence of PRV-specific antibodies. Arrows indicate dead cells with abundant viral protein 
expression, arrowheads indicates living cells with low viral protein expression. Bar 3 µm. 
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The concentration of dexamethasone used had no effect on cell viability, as assessed 
by flow cytometric analysis using 10 µg propidium iodide (Molecular Probes, 
Eugene, Oregon, USA) which specifically stains dead cells (data not shown). 
 
addition of 
dexamethasone 
at t=144 h p.i. 
Number (x 104) of surviving monocytes 
with viral antigen expression at 
... 
post inoculation 
t=144 t=192 t=240 
7.0 ± 2.3 
7.0 ± 2.3 
6.0 ± 1.2 
13.0 ± 1.5* 
5.0 ± 1.7 
14.0 ± 0.6* 
no 
yes 
 
 
 
 
 
 
 
 
 Table 1. Effect of dexamethasone on the number of surviving PRV-infected monocytes with viral 
antigen expression. Monocytes, at 144 h post inoculation with PRV and in the continuous presence of 
0.4 mg/ml of PRV-specific polyclonal IgG antibodies, were washed and incubated with 3 µΜ 
dexamethasone 98%, supplemented with 0.4 mg/ml PRV-specific polyclonal antibodies. At 192 h and 
240 h p.i., expression of viral glycoproteins in surviving PRV-infected monocytes was determined. 
Data represent means ± standard deviations of triplicate assays. Asterisks indicate significant 
differences (p < 0.01, one way anova). 
 
At two (192 h p.i.) and four (240 h p.i.) days after the dexamethasone addition, PRV-
infected monocytes were analyzed for the number of surviving cells that were viral 
antigen-positive (the total number of surviving cells remained relatively constant, data 
not shown). The results of these experiments are presented in Table 1. When no 
dexamethasone was added to monocytes in the presence of PRV-specific antibodies, 
the number of surviving cells with viral antigen expression did not alter significantly 
(control). However, after the addition of dexamethasone, supplemented with PRV-
specific antibodies, the number of surviving viral antigen-positive monocytes started 
to significantly increase from 7.0 ± 2.3 x 104 to 13.0 ± 1.5 x 104 at two days and 14.0 
± 0.6 x 104 at four days after the dexamethasone addition (p < 0.01, one way anova).
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Discussion 
 
 The main purpose of this study was to investigate in vitro the fate of PRV-infected 
monocytes with antibody-induced internalization of the plasma membrane-anchored 
viral proteins (immune-masked monocytes) for extended periods of time in the 
continuous presence of PRV-specific antibodies. Therefore, both the viability of these 
PRV-infected immune-masked monocytes and the expression of viral proteins was 
examined until 194 h p.i. in the continuous presence of PRV-specific or PRV-negative 
antibodies. 
 It was shown that, although a productive PRV infection normally leads to cell lysis 
starting at 48-72 h (Wang et al., 1988; present results), in the continuous presence of 
PRV-specific antibodies approximately 30% of the productively infected monocytes 
remained viable for an unusual long period of time (up to 194 h after inoculation with 
PRV, end of the experiment). Although carried out in an in vitro model, these results 
may indicate that immune-masked PRV-infected monocytes in vivo (continuously 
surrounded by PRV-specific antibodies in the blood of vaccinated animals) may have 
a prolonged life time, giving these cells more chance to spread throughout the body of 
vaccination-immune pigs. 
 Analyzing the expression of viral proteins in the immune-masked PRV-infected 
monocytes (cultivated in the continuous presence of PRV-specific antibodies) that 
survived a PRV-infection for unusual long periods of time, led to a somewhat 
surprising observation. The number of surviving monocytes with visually detectable 
antigen expression, being 3.0x105 at 96 h p.i., significantly decreased from that time 
point onward to approximately 0.5x105 at 194 h p.i.. This result implies that the 
continuous presence of PRV-specific antibodies leads to a quiescent viral infection in 
a subpopulation of PRV-infected monocytes. Suppression of intracellular virus 
replication upon binding of specific antibodies to infected cells has already been 
reported for herpes simplex virus type 1 (HSV-1) and Sindbis virus. Binding of HSV-
specific antibodies, especially anti-gB and anti-gE antibodies, to HSV-1-infected 
neuronal cells results in a quiescent intracellular expression of viral proteins (Oakes & 
Lausch, 1984; Sanna et al., 1999). Moreover, for Sindbis virus it was demonstrated 
that suppression of intracellular virus expression upon antibody binding resulted in a 
prolonged cell survival (Chanas et al., 1982). The fact that mainly gB- and gE-
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specific antibodies are capable of suppressing intracellular HSV-1 replication is 
remarkable since we showed earlier that PRV gB and gE can activate intracellular 
signal transduction pathways upon antibody binding (Favoreel et al., 1997; 2002). 
Further research will be necessary to clarify if antibody-induced activation of 
intracellular signal transduction pathways may lead to a quiescent PRV infection. 
 Moreover, our observation that a significant fraction of the PRV-infected cells 
without visually detectable viral expression can be stimulated to resume viral antigen 
expression upon addition of the reactivating agent dexamethasone, suggests the 
intriguing possibility that the antibody-induced quiescent state of PRV-infection may 
resemble or lead to a latent PRV infection. Latency is defined as a status in which 
viral DNA persists, but infectious virus is not produced, and is a well-known 
characteristic of herpesviruses, including PRV (Beran et al., 1980). For PRV it is 
known that the virus mainly establishes latency in neurons of the trigeminal ganglion 
(Wittmann et al., 1983; Cheung, 1995). However, latency in non neuronal sites, 
including tonsils and blood mononuclear cells, has also been suggested for PRV 
(Wittmann & Rziha, 1989). Our observation that the antibody-induced quiescent PRV 
infection in monocytes may possibly resemble latency may aid in clarifying this issue. 
However, it is crucial to point out that our dexamethasone data may be indicative, but 
not more than that. Dexamethasone is a member of the glucocorticoid family which 
have numerous effects on the cell. It is generally accepted that most, if not all, of the 
effects of glucocorticoids are mediated via the glucocorticoid receptor, which will 
undergo a conformational change upon ligand binding which in turn ultimately leads 
to activation of the transcription of a variety of responsive genes (Newton, 2000). 
Hence, although some of the responses induced by dexamethasone may induce 
herpesvirus reactivation, several other responses may possibly give alternative 
explanations for our observations. Further experimentation, consisting of in situ 
hybridisation using RNA probes detecting on the one hand gB-mRNA (as a tool to 
detect productively infected cells) and on the other hand LAT-RNA (to detect 
latently-infected cells) are a first necessity to investigate whether the PRV quiescent 
infection in monocytes resembles a latent infection. 
 Taken all the results from this study together, it can be concluded that 
internalization of viral cell surface proteins in PRV-infected monocytes may not only 
delay destruction of the cells by the immunity, but may also lead to a quiescent 
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infection and an expanded life span of the cells, giving these cells the opportunity to 
reach internal organs via the blood of vaccinated animals. 
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Summary 
 
 Pseudorabies virus (PRV) may cause abortion, even in the presence of a 
vaccination-induced immunity. Blood monocytes are essential to transport the virus in 
these immune animals, including transport to the pregnant uterus. Infected monocytes 
express viral proteins on their cell surface. Specific antibodies recognize these 
proteins and should activate antibody-dependent cell lysis. Previous work showed that 
addition of PRV-specific polyclonal antibodies to PRV-infected monocytes induced 
internalization of viral cell surface proteins, protecting the cells from efficient 
antibody-dependent cell lysis in vitro (immune-masked monocytes). As a first step to 
reach the pregnant uterus, PRV has to cross the endothelial cell barrier of the maternal 
blood vessels. The current aim was to investigate in vitro whether immune-masked 
PRV-infected monocytes can transmit PRV in the presence of virus-neutralizing 
antibodies via adhesion and fusion of these monocytes with endothelial cells. Porcine 
blood monocytes, infected with a LacZ-carrying PRV strain, were incubated with 
PRV-specific antibodies to induce internalization. Then, cells were co-cultivated with 
endothelial cells for different periods of time. Only PRV-infected monocytes with 
internalized viral cell surface proteins efficiently adhered to endothelial cells. LacZ 
transmission to endothelial cells, as a measure for monocyte-endothelial cell fusion, 
could be detected after co-cultivation from 30 min onwards. Viral transmission was 
confirmed by the appearance of plaques. Adhesion of immune-masked PRV-infected 
monocytes to endothelial cells was mediated by the cellular adhesion molecules 
wCD11R3 and CD18 and subsequent fusion was mediated by the virus. In conclusion, 
immune-masked PRV-infected monocytes can adhere and subsequently transmit virus 
to endothelial cells in the presence of virus-neutralizing antibodies. 
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Introduction 
 
 Pseudorabies virus (PRV) is a member of the Alphaherpesvirinae and causes 
Aujeszky’s disease in its natural host, the pig. Clinical signs depend mostly on the 
virulence of the virus strain and the age of the affected pig (Kluge et al., 1992). 
Infection with a virulent strain is characterized by nervous signs in newborn pigs, 
respiratory disorders in fattening pigs and reproductive failure in sows (Wittmann et 
al., 1980). In the presence of a vaccination-induced immunity, PRV still can replicate, 
resulting in a restricted viraemia (Wittmann et al., 1980). In general, such a viraemia 
does not cause problems; however, abortion may still occur as a result of cell-
mediated transplacental spread and intrafetal replication (Nauwynck & Pensaert, 
1992). Porcine blood monocytes have been shown to be essential to transport the virus 
to the pregnant uterus in vaccination-immune pigs (Nauwynck & Pensaert, 1992; 
Nauwynck & Pensaert, 1995a). Exactly how these infected monocytes survive in the 
blood in the presence of an activated immunity and subsequently transmit the virus to 
endothelial cells of the placental blood vessels, as a first step to reach the fetuses, is 
still poorly understood. 
 PRV-infected monocytes express viral envelope proteins in their plasma membrane 
(Favoreel et al., 1999). Antibodies bind to these viral glycoproteins which should 
induce antibody-dependent lysis of the infected cells (Sissons & Oldstone, 1980). 
Apparently, this does not happen efficiently in PRV-infected monocytes. Earlier, it 
has been shown that addition of PRV-specific antibodies to PRV-infected monocytes 
results in aggregation of the membrane-bound viral glycoproteins, followed by the 
internalization of these glycoprotein-antibody aggregates. This antibody-dependent 
internalization is fast and efficient, is mediated by the viral proteins gB and gD 
(Favoreel et al., 1999,2002; Van de Walle et al., 2001) and protects infected 
monocytes from efficient antibody-dependent cell lysis in vitro (Van de Walle et al., 
2003). This mechanism may help to explain how infected monocytes survive in the 
blood of vaccinated animals. How these infected monocytes with internalized viral 
cell surface proteins (immune-masked monocytes) are then able to transmit PRV to 
the fetuses in the presence of neutralizing antibodies remains unclear. As a first step 
to reach the fetuses, PRV has to cross the endothelial cell barrier of the maternal 
blood vessels. A likely scenario how this happens is that PRV-infected monocytes 
98  Chapter 5 
adhere to the endothelial cells and, subsequently, PRV crosses the endothelial barrier 
in the presence of virus-neutralizing antibodies. At least two hypotheses as to how the 
latter occurs can be put forward: on the one hand, immune-masked PRV-infected 
monocytes may cross the endothelial cell barrier by means of diapedesis; on the other 
hand, immune-masked PRV-infected monocytes may fuse with the vascular 
endothelial cells, thereby transmitting virus to these cells. In both cases, transmission 
of virus to endothelial cells is the very first step required for PRV to reach the fetuses. 
Although the subsequent steps are still to be unraveled, it has been shown before that 
all these steps can occur through direct cell-to-cell spread of the virus. Indeed, 
monocytes infected with a gDnull mutant, which can only spread through direct cell-to-
cell transport (Rauh & Mettenleiter, 1991; Peeters et al., 1992a), still can induce 
abortion in vaccinated sows (Nauwynck, 1997). 
 Diapedesis of leukocytes at sites of inflammation is a well-known process 
(reviewed by Muller & Randolph, 1999) and in general requires the action of 
chemokines (Baggiolini, 1998). The hypothesis of diapedesis as a means of PRV 
transmission through the endothelial barrier can certainly not be ruled out as a 
possible means of PRV transmission to fetal tissues and may be worth investigating in 
more detail. However, in the case of PRV-induced abortion, there are no indications 
of inflammation or local production of chemokines at the placental site or other 
triggers that could induce diapedesis of PRV-infected monocytes. Therefore, the aim 
of the current study was to evaluate the second hypothesis, comprising the adhesion 
and subsequent fusion of immune-masked PRV-infected monocytes with endothelial 
cells. In this context, it is noteworthy that contact between infected macrophages or 
neutrophils and endothelial cells has been suggested to be implicated in the 
dissemination of human cytomegalovirus (HCMV) from and to endothelial cells 
(Waldman et al., 1995; Grundy et al., 1998). Spread of HCMV to the embryo or fetus 
is well documented and is probably mediated by infected trophoblasts, macrophages 
and endothelial cells (Fisher et al., 2000). 
 Alphaherpesviruses are well-known for their cell-to-cell spread and the roles of 
different viral glycoproteins in PRV cell-to-cell spread have been extensively studied 
by the use of PRV deletion mutants. Viral glycoproteins gB and gH/gL have been 
shown to be essential for cell-to-cell spread, whereas gE and gD are modulatory 
(Klupp et al., 1997; Peeters et al., 1992a; Peeters et al., 1992b; Rauh & Mettenleiter, 
1991; Zsak et al., 1992). Recently, it was suggested that the betaherpesvirus HCMV 
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spreads from infected endothelial cells to leukocytes via microfusion events (Gerna et 
al., 2000). 
 The aim of the present study was to investigate in vitro if immune-masked PRV-
infected monocytes can transmit PRV to endothelial cells via adhesion and fusion in 
the presence of virus-neutralizing antibodies and if so, what the underlying 
mechanism is. 
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Materials and Methods 
 
 Virus strains. The PRV Kaplan mutants ∆gG, ∆gD, ∆gB and ∆gH were used. All 
these strains carry the ß-galactosidase gene (LacZ) as described earlier (Mettenleiter 
& Rauh, 1990; Rauh & Mettenleiter, 1991; Rauh et al., 1991; Babic et al., 1996). 
 
 Antibodies. Unlabeled and FITC-labeled protein A-purified polyclonal IgG 
antibodies were used, derived from PRV (89V87) inoculated pigs, originating from a 
PRV-negative farm (Nauwynck et al., 1995b). Unlabeled anti-PRV IgG antibodies 
with a titer of 512, as determined by a serum neutralization test (Andries et al., 1978), 
were used in the culture medium to inhibit virus transmission via extracellular 
medium. The FITC-labeled anti-PRV IgG antibodies were used to induce 
internalization of viral cell surface proteins in PRV-infected monocytes, at a 
concentration of 0.33 mg/ml (Favoreel et al., 1999). To visualize the cellular adhesion 
molecules CD15, CD11a, wCD11R3 and CD18 on porcine monocytes, monoclonal 
antibodies DU-HL60-3 (Sigma; Whyte & Binns, 1994), BL1H8, 2F4/11 and BA3H2 
(Alvarez et al., 2000; Dominguez et al., 2001) respectively, were used. 
 
 Isolation of porcine arterial endothelial cells. Endothelial cells were isolated as 
described previously by Nauwynck and Pensaert (1995b), with some modifications. 
Briefly, endothelial cells were obtained from the aorta of 5 to 6 week old piglets by 
flushing several times with 2.5 mg/ml trypsin (Sigma Chemical Company, St. Louis, 
Missouri, USA) at 37°C. The collected cell fractions were centrifuged for 10min at 
260xg and resuspended in endothelial growth medium, based on Dulbecco’s MEM® 
(Gibco BRL, Life Technologies Inc., Paisley, Scotland) and supplemented with 10% 
fetal bovine serum (FBS), 0.6 mg/ml glutamine, 100 U/ml penicillin, 0.1 mg/ml 
streptomycin, 0.1 mg/ml kanamycin, 1 mM sodium pyruvate and 1% non-essential 
amino acids 100x (Gibco BRL). Cells were seeded on Corning cell culture flasks 
(Costar Corporation, Cambridge, USA). Purity of endothelial cells was analysed by 
fluorescence staining with 1,1’-dioctadecyl-1-3,3,3’,3’-tetramethylindocarbocyanine-
perchlorate-acetylated low density lipoprotein (DiI-Ac-LDL) (Biomedical 
Technologies Inc., Stoughton, USA) (Voyta et al., 1984) and was always ≥ 90%. 
Cells from the first to third passages were harvested by trypsinization, seeded on 4-
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well multidish (Nunc A/S, Roskilde, Denmark) in endothelial growth medium and 
used upon confluency. 
 
 Isolation of porcine blood monocytes. PRV-negative pigs were used as blood 
donors. Blood was collected from the vena jugularis on heparin (15U/ml) (Leo, 
Zaventem, Belgium). Blood mononuclear cells were separated on Ficoll Paque® 
(Amersham Pharmacia Biotech AB, Uppsala, Sweden) following the manufacturer’s 
instructions. Mononuclear cells were then resuspended in medium (A), based on 
RPMI-1640® (Gibco BRL, Life Technologies Inc., Paisley, Scotland) and 
supplemented with 10% FBS, 0.3 mg/ml glutamine, 100 U/ml penicillin, 0.1 mg/ml 
streptomycin, 0.1 mg/ml kanamycin, 1 mM sodium pyruvate, 1% non-essential amino 
acids 100x (Gibco BRL) and 10 U/ml heparin. Afterwards, cells were seeded on 58 
mm petri dishes with cell culture coating (Nunc A/S, Roskilde, Denmark) at a 
concentration of 2x106 cells/ml and cultivated at 37°C with 5% CO2. After 48 h, non-
adhering lymphocytes were removed by washing the petri dishes three times with 
RPMI-1640. 
 
 Inoculation of blood monocytes. After the removal of lymphocytes, adherent 
cells, consisting of ≥ 70% of monocytes, as assessed by flow cytometric analysis after 
indirect immunofluorescence staining with the monocyte marker 74.22.15 (Pescovitz 
et al.), were inoculated with the different PRV strains at a multiplicity of infection 
(m.o.i.) of 20 in 0.5 ml medium (A) without heparin. Cells were further incubated at 
37°C with 5% CO2. For all strains used and for all experiments, between 80 and 90% 
of the monocytes were infected. 
 
 Incubation of PRV-infected monocytes with porcine anti-PRV polyclonal 
antibodies (pAbs). At 13 h post inoculation (p.i.) with PRV, monocytes were 
centrifuged for 10min at 500xg, washed and resuspended in medium (A). Cells were 
incubated for 1 h at 37°C with FITC-labeled PRV pAbs (as described by Favoreel et 
al., 1999). Cells were washed two times with RPMI-1640® and then used in the 
adhesion/fusion assay. As a negative control, 50 µg/ml of genistein (Sigma Chemical 
Company, St. Louis, Missouri, USA) was added 45 min before and also during 
antibody incubation. Genistein inhibits tyrosine kinase activity and therefore 
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antibody-induced internalization of viral proteins (Favoreel et al., 1999). This 
concentration of genistein had no effect on cell viability as determined earlier 
(Favoreel et al., 1999) and had also no effect on adhesion or fusion processes (data 
not shown). 
 
 Definition of the viral protein distribution. The viral protein distribution was 
scored as ‘no internalization’ when the fluorescence label exhibited a homogeneous or 
patched cell surface cover. The viral glycoproteins were considered ‘internalized’ 
when viral proteins were located in vesicles inside the cell. 
 
 Adhesion/fusion assay. After incubation with FITC-labeled PRV pAbs in the 
presence or absence of genistein (as described above), PRV-infected monocytes were 
washed, counted and resuspended in endothelial growth medium, supplemented with 
PRV-neutralizing IgG antibodies and 50 µg/ml genistein. To each well of endothelial 
cells, approximately 1.5x105 monocytes were added, followed by centrifugation for 2 
min at 44xg. At different time points of co-cultivation (0, 30, 60 and 120 min), wells 
were washed two times thoroughly with endothelial growth medium and fixed for 10 
min with 2% formaldehyde and 0.2% glutaraldehyde (Merck & Co., Inc., West 
Chester, USA). The 4-well multidishes, consisting of monocytes and endothelial cells, 
were then stained for ß-galactosidase activity with X-gal, following the 
manufacturer’s instructions (Invitrogen LTD., Paisley, Scotland). After 2 hours, cells 
were mounted in a glycerin-phosphate buffered saline solution (PBS) (0.9:0.1, 
vol/vol) with 2.5% 1,4-diazabicyclo(2.2.2)octane (DABCO; Janssen Chimica, Beerse, 
Belgium). Quantitative results were obtained by examining the X-gal signal (showing 
adhesion/fusion) by light microscopy and the fluorescence distribution (showing 
internalization/no internalization) by fluorescence microscopy. Cells were excited 
with an Osram HBO 50-W bulb using a I3 filter and observed with a Leitz DM RBE 
microscope (Wild Leitz GmbH, Heidelberg, Germany). Images were obtained by 
using a Sony color video camera (model DXC-9100P), linked to a Macintosh 
computer. 
 The percentage of adhesion of monocytes to endothelial cells was calculated as 
follows: (number of adhered monocytes at time point x / number of monocytes added 
per well) × 100. To determine the percentage of monocytes fused with endothelial 
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cells, the following formula was used: (number of LacZ positive endothelial cells at 
time point x / number of adhered monocytes at time point x) × 100. All assays were 
run independently at least three times. 
 Some wells were, instead of fixed, further cultivated at 37°C with 5% CO2 in the 
presence of virus-neutralizing antibodies and controlled for plaque formation at 30 h 
of co-cultivation. 
 
 Indirect immunofluorescence staining of cellular adhesion proteins on the cell 
surface of PRV-infected monocytes before and after antibody-induced 
internalization of viral cell surface proteins. Monocytes (isolated as described 
above) were seeded on 4-well chambered coverglasses (Nunc A/S, Roskilde, 
Denmark) at a concentration of 2.5x106 cells/ml and inoculated with PRV. 
Monocytes, at 13 h p.i. with PRV, were incubated with 0.33 mg/ml FITC-labeled 
PRV pAbs and fixed for 10 min with 3% formaldehyde at different time points (0 
min, before internalization; 60 min, after internalization). Cells were washed two 
times with RPMI-1640® and incubated for 1 h at 37°C with α-CD15 (dilution 1:50), 
α-CD11a (dilution 1:10), α-wCD11R3 (dilution 1:30) or α-CD18 (dilution 1:30). 
Cells were washed again two times with RPMI-1640® and subsequently incubated for 
1 h at 37°C with goat anti-mouse-Texas Red (dilution 1:50) (Molecular Probes, 
Eugene, Oregon). Finally, cells were washed thoroughly, mounted in a glycerin-PBS 
solution and analyzed by confocal microscopy. 
 
 Adhesion-blocking assay. Experiments were performed as described for the 
adhesion/fusion assay, with some modifications. After incubation for 1 h at 37°C with 
FITC-labeled PRV pAbs in the absence of genistein (to allow internalization of viral 
cell surface proteins), PRV-infected monocytes were washed and subsequently 
incubated for 30 min at 37°C with medium A, supplemented with the monoclonal 
antibodies α-CD11a, α-wCD11R3 and/or α-CD18 (dilution 1:10). After washing and 
counting, monocytes were added to wells of endothelial cell, fixed at 0, 30 and 60 min 
of cocultivation, and stained for ß-galactosidase activity with X-gal (as described 
above). As a control, no antibodies were supplemented to medium A. 
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 Confocal Laser Scanning Microscopy. Double stained samples of viral proteins 
and cellular adhesion molecules were examined with a Leica TCS SP2 laser scanning 
spectral confocal system (Leica Microsystems GmbH, Wetzlar, Germany) and linked 
to a DM IRB inverted microscope (Leica Microsystems). Argon and HeNe laser lights 
were used to excite FITC (488 nm line) and Texas red (543 nm line) fluorochromes. 
Extended focus images were obtained with Leica confocal software. 
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Results 
 
 Internalization of viral cell surface proteins in PRV-infected monocytes 
(immune-masked monocytes). To examine the possible adhesion and fusion of 
immune-masked PRV-infected monocytes with endothelial cells, porcine monocytes 
were inoculated with a PRV strain carrying the β-galactosidase fusion gene LacZ. 
Transmission of the enzyme β-galactosidase (which can be visualized easily by 
adding the substrate X-gal) from the PRV-infected monocyte to endothelial cells in 
the presence of PRV-neutralizing antibodies was used as a measure of fusion. A PRV 
strain carrying the LacZ gene inserted in the gG locus (Kaplan ∆gG) was chosen, 
since this mutant has been shown to exhibit wild type growth properties (Mettenleiter 
& Rauh, 1990). Moreover, this mutant has also been shown to have no effect on the 
efficiency of antibody-induced internalization of viral glycoproteins in PRV-infected 
monocytes (Favoreel et al., 1999). 
 
 Adhesion of immune-masked PRV-infected monocyte to endothelial cells. PRV 
Kaplan ∆gG-infected monocytes, at 13 h p.i., were incubated for 1 h at 37°C with 
FITC-labeled PRV pAbs as described in the Material and Methods section. This 
antibody incubation resulted in 63.5% ± 2.5 of monocytes with internalized viral cell 
surface proteins (immune-masked monocytes) and 36.5% ± 1.2 of cells without 
internalized viral cell surface proteins (for images of cells without internalized viral 
cell surface proteins see Fig. 3.A; for images of cells with internalized viral cell 
surface proteins see Fig. 3.B). The mixture of monocytes with and without 
internalized viral cell surface proteins were then added to a monolayer of endothelial 
cells at 37°C in the presence of virus-neutralizing antibodies and adhesion kinetics of 
both types of monocytes (with and without internalized viral glycoproteins) were 
determined. Fig. 1.A shows (i) that adhesion of monocytes to endothelial cells reaches 
its plateau at 60 min of co-cultivation and (ii) that the immune-masked PRV-infected 
monocytes (with internalized viral cell surface proteins) adhere much more efficiently 
to the endothelial cells than PRV-infected monocytes without internalization. To 
confirm the latter, experiments were repeated in the presence of genistein, a reagent 
known to inhibit antibody-induced internalization (Favoreel et al., 1999). Adding 
genistein before and during antibody addition (as described in Materials and Methods) 
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resulted in a population of 94.3% ± 1.5 of PRV-infected monocytes without 
internalization. Adhesion efficiency of these monocytes to endothelial cells was low 
(Fig.1.A). 
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 FIG. 1. (A). Kinetics of adhesion of PRV-infected monocytes with endothelial cells in the presence 
of virus neutralizing antibodies. Monocytes were harvested at 13 h p.i. and incubated for 1 h at 37°C 
with FITC labeled PRV-specific antibodies and added to endothelial cells. Graphs represent kinetics 
for monocytes with internalized viral cell surface proteins (=immune-masked monocyte) (◊) or without 
internalized viral cell surface proteins (), or treated with genistein (O). The data are means ± standard 
deviations of triplicate assays. 
    (B). Percentage of internalization (at 1 h post antibody addition) and adhesion (at 60 min of 
cocultivation) of monocytes, inoculated for 13 h with the PRV Kaplan ∆gG reference strain, ∆gB 
mutant or ∆gD mutant. Data represent means ± standard deviations of triplicate assays. Asterisks 
indicate significant differences (p < 0.01). 
 
 
 
 It was reported previously that monocytes infected with the PRV Kaplan mutants 
∆gB and ∆gD have reduced antibody-induced internalization efficiencies (Favoreel et 
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al., 1999; Van de Walle et al., 2001). Monocytes inoculated with these strains for 13 h 
and incubated with PRV pAbs for 1 h, showed reduced adhesion efficiencies 
compared to the reference strain (Fig. 1.B). Reduction in adhesion efficiency of the 
∆gB and ∆gD mutants compared to the wild type virus corresponded fairly close to 
their reduction in internalization efficiency, suggesting further that, in the presence of 
neutralizing antibodies, internalization of viral cell surface proteins correlates directly 
with an increase in adhesion efficiency of infected monocytes to endothelial cells. 
Taken together, these results show that efficient internalization of antigen-antibody 
complexes from the cell surface of infected monocytes is essential to allow efficient 
adhesion of PRV-infected monocytes to endothelial cells in the presence of virus-
neutralizing PRV pAbs. 
 
 Fusion of the immune-masked PRV-infected monocytes with endothelial cells. 
Fig. 2.A shows that, following adhesion, immune-masked PRV-infected monocytes 
fused with underlying endothelial cells in the presence of neutralizing antibodies. This 
was demonstrated by β-galactosidase transmission from the cytoplasm of the infected 
monocyte to the underlying endothelial cells (Fig. 2.A). Fig. 2.B shows that fusion of 
the immune-masked PRV-infected monocytes started from 30 min of co-cultivation, 
reaching a level of 38.0% ± 2.5 of fused immune-masked monocytes at 120 min of 
co-cultivation (end of the experiment). The presence of β-galactosidase in the 
endothelial cells was caused by fusion between infected monocytes and endothelial 
cells and not by infection of the endothelial cells by cell-free virus, as endothelial 
cells, infected with cell-free LacZ-carrying ∆gG PRV (in the absence of neutralizing 
antibodies), only became β-galactosidase positive from 3 h p.i. onwards (data not 
shown). 
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 FIG. 2. (A). Double labeling of viral cell surface proteins (FITC) (a) and β-galactosidase activity 
(X-gal) (b) of PRV-infected monocytes (arrow), at 30 min (lane 1) and 120 min (lane 2) of 
cocultivation. Lane 1 shows a PRV-infected monocyte with internalized viral cell surface proteins 
(arrow), adhered to the underlying endothelial cells. Lane 2 shows a PRV-infected monocyte with 
internalized viral cell surface proteins (arrow) fused with the underlying endothelial cells (endothelial 
cells stain positive for β-galactosidase activity, arrowhead). Bar 15µm. (B). Kinetics of fusion of PRV-
infected monocytes with internalized viral cell surface proteins (= immune-masked monocytes) with 
underlying endothelial cells. Data represent means ± standard deviations of triplicate assays. 
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 Viral transmission from the immune-masked monocyte to endothelial cells, in the 
presence of virus-neutralizing antibodies, was confirmed by the appearance of plaques 
at 30 h of co-cultivation (Fig. 2.C). the number of plaques was similar to the number 
to be expected based on the percentage of fused monocytes. 
 C 
 
 
 
 
 
 
 
 FIG. 2. (C) Fluorescence microscopy images of plaques in a monolayer of endothelial cells at 30 h 
of cocultivation with PRV-infected monocytes in the presence of virus-neutralizing antibodies, fixed in 
100% methanol and stained for viral antigens using FITC-labeled PRV-specific antibodies. Bar 0.5mm. 
 
 Adhesion is mediated by cellular adhesion molecules. Antibody-induced 
internalization of PRV-infected monocytes results in infected monocytes with no or 
only very few viral protein-antibody complexes on their surface (Favoreel et al., 
1999). This implies that viral protein(s) most likely are not responsible for the 
adhesion to endothelial cells and that the adhesion occurs via another (cellular) 
mechanism. Cellular adhesion processes of monocytes to endothelial cells are well 
studied. They are mediated by different adhesion molecules on the cell surface of the 
monocytes such as Sialyl Lewisx (also designated CD15), the β1- and β2-integrins 
(Tedder et al., 1995; Stewart et al., 1995; Bullido et al., 1996). However, it has been 
shown before that internalization of viral cell surface proteins in PRV-infected 
monocytes, induced by PRV-specific antibodies, results in co-internalization of 
several, uncharacterized, cellular proteins (Favoreel et al., 1999). Therefore, we first 
investigated if and which adhesion molecules are still present on the plasma 
membrane of PRV-infected monocytes after the antibody-induced internalization 
process.
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 FIG. 3. (A) & (B). Double immunofluorescence labeling of viral cell surface proteins (FITC) with 
different cellular adhesion molecules (CD15, CD11a, wCD11R3 and CD18) (Texas red) before (A) and 
after (B) antibody-induced internalization of viral cell surface proteins. Monocytes, at 13h p.i. with 
PRV, were incubated for 1 h at 37°C with FITC-labeled PRV-specific antibodies. At time points 0 min 
(A) and 60 min (B) post antibody addition, cells were fixed for 10min with 3% formaldehyde. 
Afterwards, cells were incubated for 1h at 37°C with monoclonal antibodies against different cellular 
adhesion molecules, followed by incubation for 1 h at 37°C with goat anti-mouse Texas red. Lane 1 
shows the viral cell surface proteins, lane 2 shows the cellular adhesion molecules, and lane 3 shows 
images obtained by merging (1) and (2). The images are middle sections of each cell. Arrow indicates 
the position of the nucleus. Bar 5 µm. 
 
Double immunofluorescence staining of CD15 and some β2-integrins, known to be 
present on porcine monocytes on the one hand and viral cell surface proteins on the 
other hand, demonstrated that the adhesion molecules CD15, CD11a, wCD11R3 and 
CD18 were present on the plasma membrane of PRV-infected monocytes before the 
antibody-induced internalization process (Fig. 3.A). After antibody-induced 
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internalization of viral cell surface proteins on the infected monocytes, however, only 
the adhesion molecules wCD11R3 and CD18 were still visually present on the plasma 
membrane (Fig. 3.B). Hence, wCD11R3 and CD18 may possibly play a role during 
adhesion of the immune-masked monocytes to endothelial cells. To examine this, an 
adhesion blocking assay was performed using monoclonal antibodies directed against 
these adhesion molecules. Fig. 3.C shows that pre-incubating immune-masked PRV-
infected monocytes with α-wCD11R3, α-CD18 or α-wCD11R3 + α-CD18, all 
resulted in a significant decrease of the percentage of PRV-infected monocytes 
adhered to endothelial cells (p< 0.005, one way anova), compared to non-treated cells. 
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 FIG. 3. (C). Adhesion blocking assay. Kinetics of adhesion of immune-masked PRV-infected 
monocytes, pre-incubated with a mixture of α-wCD11R3 and α-CD18 (), with α-wCD11R3 (∆), 
with α-CD18 (Σ) or with α-CD11a (O), to endothelial cells. As a control, non-treated PRV-infected 
monocytes (◊) were used. Data represent means ± standard deviations of triplicate assays. 
 
Pre-incubating the immune-masked PRV-infected monocytes with α-CD11a, an 
adhesion molecule no longer present on the plasma membrane of PRV-infected 
monocytes after antibody-induced internalization, resulted in adhesion efficiencies 
comparable to non-treated cells (Fig. 3.C). Hence, wCD11R3 and CD18 are important 
during adhesion of the immune-masked PRV-infected monocytes to endothelial cells. 
 
 
 Fusion is viral mediated. To investigate if fusion of immune-masked PRV-
infected monocytes with endothelial cells is mediated by viral proteins, we inoculated 
monocytes with the PRV mutant ∆gH. This PRV mutant (i) carries the ß-
galactosidase fusion gene (LacZ) (Babic et al., 1996), (ii) is known to be essential for 
virus-cell fusion and cell-to-cell spread of PRV (Peeters et al., 1992b) and (iii) is not 
112  Chapter 5 
important for the antibody-induced internalization process (Favoreel et al., 1999; Van 
de Walle et al., 2001). Since PRV ∆gH has no effect on efficient antibody-induced 
internalization, using PRV ∆gH had no effect on the percentage of adhesion of PRV-
infected monocytes to endothelial cells compared to the ∆gG reference strain (Fig. 
4.A). Fig. 4.B shows that ∆gH-infected immune-masked monocytes are unable to fuse 
with endothelial cells (p< 0.01, one way ANOVA). This implies that fusion is viral-
mediated, probably by a mechanism similar to virus-cell fusion. 
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 FIG. 4. (A). Percentage of internalization of viral cell surface proteins (at 1 h post antibody 
addition) and adhesion (at 60 min of cocultivation with endothelial cells) of monocytes, inoculated for 
13 h with the PRV Kaplan ∆gG reference strain or ∆gH mutant. Data represent means ± standard 
deviations of triplicate assays. (B). Kinetics of fusion of immune-masked monocytes, infected with the 
PRV Kaplan ∆gG reference strain (◊) or ∆gH mutant () with endothelial cells. Data represent means 
± standard deviations of triplicate assays. 
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Discussion 
 
 Pseudorabies virus (PRV)-infected porcine blood monocytes have been shown to 
transport the virus to different internal organs of vaccinated pigs, in the presence of 
PRV-neutralizing antibodies (Wittmann et al., 1980; Nauwynck & Pensaert, 1992, 
1995a). However, infected monocytes express viral proteins in their plasma 
membrane (Favoreel et al., 1999) and binding of PRV-specific antibodies to these 
viral proteins should therefore induce antibody-dependent lysis of the infected cells. 
Recently, a mechanism has been postulated how PRV-infected monocytes potentially 
may avoid efficient antibody-dependent lysis: binding of PRV-specific antibodies to 
the viral cell surface proteins has been shown to activate a signal to the cell, mediated 
by viral proteins gB and gD, followed by rapid internalization of the majority of 
antigen-antibody complexes present on the cell surface (Favoreel et al., 1999, 2002). 
This mechanism protects PRV-infected monocytes with internalized viral cell surface 
proteins (immune-masked monocytes) from efficient complement-mediated lysis in 
vitro (Van de Walle et al., 2003). 
 In order for PRV to be able to reach the pregnant uterus in vaccinated animals, 
these immune-masked PRV-infected blood monocytes should be capable of 
transmitting the virus, in the presence of neutralizing antibodies, to the endothelial 
cells of the placental blood vessel walls. Here, we showed in an in vitro assay that in 
the presence of virus-neutralizing antibodies, immune-masked monocytes can 
efficiently adhere to the endothelial cells, followed by transmission of virus through 
fusion of the monocyte with the endothelial cells. 
 PRV-infected monocytes with internalized viral cell surface proteins (immune-
masked monocytes) adhered much more efficiently to endothelial cells than PRV-
infected monocytes without internalization. These results indicate that, in the presence 
of virus-neutralizing antibodies, antibody-induced internalization of viral cell surface 
proteins is important for efficient adhesion of PRV-infected monocytes to endothelial 
cells. Why are PRV-infected cells without internalized viral cell surface proteins 
unable to adhere efficiently to the endothelial monolayer? PRV-infected monocytes 
without internalized viral cell surface proteins, in contrast to immune-masked 
monocytes, are covered by PRV-specific antibodies, which possibly may result in 
(sterically) hindered access of the adhesion molecules on the monocytes (cellular as 
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well as viral such as gC and gD) to adhesion receptors on the underlying endothelial 
cells. This is consistent with earlier results showing that PRV-infected cells, covered 
with PRV-neutralizing antibodies, are unable to adhere to non-infected cells 
(Hanssens et al., 1993). 
 Since monocytes with internalized viral cell surface proteins possess only very 
few, if any, viral proteins on their plasma membrane (Favoreel et al., 1999), adhesion 
of immune-masked monocytes to endothelial cells is most likely mediated by cellular, 
and not viral, adhesion molecules on the cell surface. Physiological adhesion requires 
the interaction of integrins, such as CD11a/CD18 (also designated LFA-1) and 
CD11b/CD18 (also designated MAC-1) on monocytes with the Ig superfamily 
(ICAM-1, ICAM-2 and VCAM-1) on endothelial cells (Stewart et al., 1995; Bullido 
et al., 1996). However, it has been shown before that during internalization of viral 
cell surface proteins induced by PRV-specific antibodies, at least certain, unidentified, 
cellular proteins undergo co-internalization with the cell surface proteins (Favoreel et 
al., 1999). Determining if and which cellular adhesion molecules remain on the 
plasma membrane of the immune-masked PRV-infected monocytes was therefore 
essential as a first step to examine the process of adhesion of the immune-masked 
monocytes to endothelial cells. Double immunofluorescence stainings before and after 
the antibody-induced internalization of viral cell surface proteins showed that 
significant amounts of the adhesion molecules wCD11R3 and CD18 remained on the 
plasma membrane after antibody-induced internalization, whereas CD15 and CD11a 
were no longer visually present on the cell surface, suggesting that the adhesion 
molecules wCD11R3 and CD18, but not CD15 and CD11a, may be involved in the 
adhesion of the immune-masked monocytes to endothelial cells. WCD11R3 and 
CD18 were confirmed to be involved in the adhesion process, since pre-incubation of 
the immune-masked PRV-infected monocytes with monoclonal antibodies against 
these adhesion molecules, but not against CD11a, significantly reduced adhesion. 
Similarly, the CD18 molecule has been shown to be involved in the adhesion of 
peripheral blood leukocytes to HCMV-infected endothelial cells (Span et al., 1991). 
The reduction of adhesion of the immune-masked PRV-infected monocytes after pre-
incubation with monoclonal antibodies against wCD11R3 and CD18 was, although 
significant, only approximately 65%, which may imply the involvement of other 
adhesion molecules. Besides CD11a and wCD11R3, there exist two other CD11 
molecules ,wCD11R1 and wCD11R2, which may be involved during adhesion 
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(Dominguez et al., 2001). Further, for human monocytes it has been described that 
adhesion to endothelial cells can also occur via the β1-integrin VLA-4, although to a 
much lesser extent than via the β2-integrins CD11/CD18 (Meerschaert & Furie, 
1994). The expression of VLA-4 has also been described for porcine leukocytes, 
although its role in adhesion to porcine endothelial cells has, to our knowledge, not 
yet been investigated (Whyte & Binns, 1994). A possible hypothesis for the very 
efficient adhesion via cellular adhesion molecules could be that PRV induces an 
upregulation of certain adhesion molecules upon infection, as has already been 
described for many viruses, including herpesviruses. For example, for herpes simplex 
virus type 1, it has been shown that virus-infected blood monocytes adhere much 
more efficiently to human endothelial cells compared to non-infected monocytes, due 
to the production of certain cytokines, leading to an upregulation of cellular adhesion 
molecules on endothelial cells (Larcher et al., 2001). Further, HMCV has been shown 
to induce an upregulation of adhesion molecules in infected endothelial cells resulting 
in an increased adhesion of the endothelial cells to peripheral blood leukocytes 
(Shahgasempour et al., 1997). Based on the present study, no indications were found 
for a similar upregulation of adhesion molecules in PRV-infected monocytes. 
However, the potential of such a putative upregulation to increase the chances of PRV 
to cross the barrier of endothelial cells may make it worth investigating in more detail. 
 Following adhesion, immune-masked monocytes fuse with endothelial cells. The 
rate of fusion was lower than the rate of adhesion, possibly suggesting that upon 
adhesion, expression/transport of viral proteins (e.g. gB, gH/gL) to the cell surface 
was necessary to induce fusion. Indeed, fusion was shown to be virus mediated, since 
inoculating monocytes with a LacZ-carrying ∆gH mutant abolished the fusion 
capacity of the immune-masked monocytes (without affecting internalization and 
adhesion efficiencies). Fusion was shown to result in virus transmission to endothelial 
cells by the appearance of plaques. Only about 50% of the adhered monocytes fused 
with the endothelial cells, even after 240 min of co-cultivation of monocytes with 
endothelial cells (data not shown), indicating that a significant fraction of immune-
masked monocytes are incapable of fusing with endothelial cells. The reason for this 
inability to fuse is speculative but one explanation could be that, upon adhesion to the 
endothelial cells, not all monocytes are triggered efficiently to resume expression of 
viral proteins on the cell surface. 
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 Adhered leukocytes, either during immune cell-to-cell contact or during contact 
with epithelial/endothelial cells, are generally polarized (Sanchez-Madrid & del Pozo, 
1999; Bromley et al., 2001). Such polarization may support efficient virus spread, 
since it may result in predominant transport of viral cell surface proteins (implicated 
in cell fusion) or even virions, to the contact area between both cells. Such 
unidirectional deposition virions at the contact site between infected leukocytes and 
contact cells has already been described for human immunodeficiency virus (Pearce-
Pratt et al., 1994; Fais et al., 1995) and may be worth investigating during the 
interaction of immune-masked PRV-infected monocytes with endothelial cells. 
 In conclusion it can be stated that immune-masked PRV-infected monocytes 
efficiently adhere to and subsequently fuse with endothelial cells in the presence of 
virus-neutralizing antibodies in vitro. The adhesion process is mediated by cellular 
adhesion molecules wCD11R3 and CD18 and subsequent fusion is mediated by the 
virus. This adhesion and fusion process gives a potential explanation as to how PRV-
infected monocytes transmit virus to vascular endothelial cells in vaccinated animals, 
as a first step to reach internal organs such as the pregnant uterus. 
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 Despite the presence of an immunity, induced by inactivated vaccines, a cell-
associated viraemia of pseudorabies virus (PRV) can still occur, enabling the virus to 
reach internal organs and occasionally, to cause abortion (Wittmann et al., 1980; de 
Mûelenaere & Pensaert, 1989). Porcine blood monocytes are essential to transport the 
virus throughout the body of these vaccinated animals, in the presence of virus-
specific antibodies (Nauwynck & Pensaert, 1992). This virus transport in the presence 
of virus-specific antibodies indicates that some PRV-infected monocytes are able to 
survive in the blood long enough to transmit the virus to internal organs, including the 
pregnant uterus. This implies that recognition and destruction of the virus-infected 
cells by antibody-dependent cell lysis occurs inefficiently. One of the mechanisms 
that may aid PRV in masking infected blood monocytes from the antibody-dependent 
cell lysis consists of the antibody-induced internalization of antigen-antibody 
complexes that are present on the cell surface of infected monocytes (Favoreel et al., 
1999). Using in vitro models, it was the goal of this thesis to gain further insight in 
how this process of antibody-induced internalization may help PRV-infected 
monocytes to reach fetal tissues in the presence of antibody-dependent components of 
the immune system. The overall hypothetical model illustrating how PRV may reach 
internal organs in vaccinated animals, based on the in vitro findings in this thesis, is 
presented in the scheme at the end of the General Discussion. 
 We demonstrated in vitro that PRV-infected monocytes with internalized viral cell 
surface proteins are indeed significantly less susceptible towards antibody-dependent 
complement-mediated lysis (ADCML) than infected cells without internalization. In 
vivo, PRV-specific antibodies and complement are simultaneously present in the 
blood of immune animals whereas in our in vitro model, PRV-infected monocytes 
were first incubated with PRV-specific antibodies for 1h (to allow internalization) and 
only afterwards incubated with porcine complement. Nevertheless, the process of 
antibody-induced internalization of viral cell surface proteins in PRV-infected 
monocytes occurs very rapidly, starting within 5 min post antibody addition (Favoreel 
et al., 1999), whereas complement needs approximately 10 min to become activated 
by antibodies (Sissons et al., 1979). Thus, based on our in vitro findings, it is to be 
expected that the process of antibody-induced internalization may be fast enough to 
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allow PRV-infected monocytes to escape efficient elimination by complement-
mediated cell lysis. 
 Besides ADCML, antibody-dependent cell-mediated cytotoxicity (ADCC) is also a 
major component of the antibody-dependent immune system. The interaction between 
antibodies and Fc receptors on cytotoxic effector cells, such as 
monocytes/macrophages, polymorphonuclear leukocytes, T-cells and natural killer 
(NK) cells, induces a signal transduction cascade in the effector cells which ultimately 
leads to destruction of the infected cell (Sissons & Oldstone, 1980). The kinetics of 
ADCC activation are similar to those of ADCML, but efficient ADCC can already be 
achieved by a 10-fold lower concentration of antibodies bound to the infected cell 
(Perrin et al., 1977). Hence, ADCML evasion of PRV-infected monocytes by 
internalization of the majority of antigen-antibody complexes may not automatically 
imply efficient ADCC evasion. 
 Another potential mechanism to escape antibody-dependent components of the 
immune system has also been described for PRV and for the other alphaherpesviruses 
herpes simplex virus (HSV) and varicella zoster virus (VZV). This mechanism 
implies Fc receptor activity of the viral glycoprotein complex gE-gI (Johnson et al., 
1988; Litwin et al., 1992; Favoreel et al., 1997). In the current thesis, we showed that 
PRV gE-gI indeed renders PRV-infected monocytes less susceptible towards 
ADCML, although with surprisingly low efficiency. A possible explanation for this 
low efficiency could be that gE-gI specific antibodies interfere with efficient gE-gI Fc 
receptor activity by binding to the Fc binding domain in the gE-gI complex. In 
support of this hypothesis, we found that (i) performing the ADCML assay using a 
PRV-positive pig serum without gE-gI specific antibodies resulted in a much more 
pronounced protective effect of gE-gI towards ADCML and (ii) based on flow 
cytometric experiments we showed that gE-gI positive, but not gE-gI negative pig 
serum, can block gE-gI Fc receptor activity. It would be interesting to further 
investigate whether, similarly, gE-gI specific antibodies may be able to inhibit Fc 
receptor activity of HSV and VZV. Also, the possibility that the gE-gI Fc receptor 
activity may be inhibited through the presence of gE-gI specific antibodies may have 
consequences regarding vaccination. For PRV, although the currently applied PRV 
vaccines are certainly efficient and helped in eradicating PRV in several countries, 
most of the PRV vaccines are based on a gE-deleted mutant. Such a “marker” vaccine 
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makes it easy to distinguish infected animals (presence of gE-specific antibodies) 
from vaccinated animals (absence of gE-specific antibodies) (Van Oirschot et al., 
1986). Since a gE-negative vaccine fails to elicit a gE-specific antibody response, it 
can be hypothesized that the PRV gE-gI Fc receptor will not be blocked, which may 
allow gE-gI-mediated immune-evasion during a subsequent PRV wild type infection. 
Still, the currently used gE-marker vaccines are successful in eradicating PRV, which 
may indicate that gE-gI-mediated immune evasion in vivo will most likely be of 
minor importance for PRV. 
 Since antibody-induced internalization may aid PRV-infected monocytes in 
masking the cells from efficient immune-mediated destruction (immune-masked 
monocytes), it is crucial to fully understand the mechanism of this process in order to 
possibly find methods to interfere with the process. From earlier studies, it is known 
that the viral proteins gB and gD, present on the cell surface of infected cells, are 
indispensable for the initiation of the internalization process and only one single 
tyrosine residue in the cytoplasmic tail of gB is crucial for correct functioning of gB 
during the internalization process (Favoreel et al., 1999; 2002). To date, it remained 
unclear if the subsequent steps of internalization are mediated by viral components or 
rather are directed by the cellular endocytosis machinery. Using different chemical 
inhibitors and confocal studies, we were able to demonstrate that, after virus-mediated 
initiation of the process, the subsequent steps of internalization most likely are all 
physiological and occur via the same route as the well-studied bivalent-ligand induced 
endocytosis of cellular receptors. Like for the cellular endocytosis process, we 
showed that during internalization of the antigen-antibody complexes, (i) the 
cytoskeleton component actin provides the integrity of the cell, necessary for 
internalization to occur, and clathrin molecules are involved most likely by formation 
of clathrin-coated pits/vesicles and (ii) microtubules and dynein are necessary for 
transport of the vesicles towards the perinuclear area of the cell. It is our current 
thinking that, upon crosslinking induced by the addition of virus-specific antibodies, 
specific tyrosine-based amino acid motifs in the cytoplasmic tails of viral proteins gB 
& gD interact with adaptor protein 2 which then link the viral proteins to clathrin-
molecules as a first step in the formation of clathrin-coated vesicles. One of the most 
intriguing questions regarding the mechanism of the internalization process is why the 
majority of viral cell surface proteins are internalized and not solely the two viral 
proteins that initiate the process (gB and gD). An attractive hypothesis may be that 
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viral cell surface proteins are not randomly located in the plasma membrane, but 
grouped in specialized microdomains in the plasma membrane such as the 
cholesterol- and sphingolipid-rich lipid rafts (Brown and London, 2000). For several 
viruses such as human immunodeficiency virus (HIV) and influenza virus, association 
of viral cell surface proteins with such rafts has already been demonstrated (Scheiffele 
et al., 1999; Ono & Freed, 2001). Preliminary data suggest that for PRV, at least some 
plasma membrane-anchored glycoproteins may be associated with or become 
associated with these microdomains upon antibody crosslinking (H. Favoreel, 
personal remark). If this would be the case, internalization initiated by gB and gD 
may result in internalization of the entire microdomain, containing the majority of 
viral cell surface proteins. Another interesting question is why internalization of viral 
cell surface proteins does not occur in all PRV-infected monocytes. This observation 
may perhaps be explained by individually differences in the inherent endocytosis 
capacity among the heterogeneous population of monocytes. Another explanation 
may be that different PRV strains have different capacities to induce internalization. 
Indeed, performing the internalization experiments with different laboratory strains 
and field strains of PRV resulted in significant differences in the internalization 
efficiency (ranging from 30% up to 80% of internalization), indicating that the 
efficiency of internalization is most likely virus-dependent. Since viral proteins gB 
and/or gD are indispensable for the efficient initiation of internalization, it may be 
interesting to examine whether the internalization capacity of certain PRV strains may 
be explained by differences in the gB & gD DNA and amino acid sequences. 
 In order to be able to transmit virus to internal organs, the immune-masked PRV-
infected monocytes do not only have to evade recognition by the immune system, 
they also have to survive a productive PRV infection long enough to reach these 
organs. In the current thesis, we observed that a subpopulation of the immune-masked 
PRV-infected monocytes (but not the non-masked monocytes) survived a PRV 
infection for remarkable long periods, up to 8 days post inoculation (end of the 
experiment). Moreover, we found that the majority of these surviving PRV-infected 
cells did no longer show visually detectable expression of viral proteins, although 
these cells were productively infected at early stages post inoculation. The most 
obvious explanation for these observations is that the presence of PRV-specific 
antibodies leads to a quiescent virus infection in a subpopulation of PRV-infected 
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monocytes. Suppression of intracellular virus replication upon binding of specific 
antibodies to infected cells has already been reported for other viruses such as HSV 
and Sindbis virus (Chanas et al., 1982; Oakes & Lausch, 1984). Binding of antibodies 
can apparently trigger a signal that leads to a quiescent infection. Interesting in this 
context is the finding that anti-gB and anti-gE antibodies are most efficient in 
inducing a quiescent HSV infection (Oakes & Lausch, 1984). Findings at our and 
other laboratories have indicated that binding of anti-gB and anti-gE antibodies to 
PRV- and HSV-infected cells can activate cellular tyrosine-phosphorylation 
dependent signal transduction pathways (Favoreel et al., 1997; 2002; Rizvi & 
Raghavan, 2003). The combination of these results suggests that antibody-induced 
activation of intracellular signal transduction pathways may ultimately lead to a 
quiescent infection. An explanation for the way how activated signal transduction 
pathways may suppress an ongoing virus infection can perhaps be found when 
comparing these findings with the knowledge on cytokine-mediated control of virus 
infections. Binding of several cytokines (e.g. interferons) to infected cells also 
activates tyrosine-phosphorylation dependent signal transduction pathways which 
then suppress the infection via multiple ways (Guidotti & Chisari, 2000). Such 
pathways induce the expression of 2’5’-oligoadenylate synthetases which mediate 
antiviral activities by induction of a cellular RNAse that degrades viral transcripts, 
Mx proteins which may bind viral ribonucleoprotein complexes and protein kinase R 
which may inhibit viral protein synthesis initiation (Guidotti & Chisari, 2000). An 
attractive hypothesis may therefore be that signal transduction pathways, activated by 
binding of antibodies to infected cells, may induce similar inhibitory effects on virus 
replication. 
 Another interesting in vitro finding in our study was that addition of the 
reactivating agent dexamethasone stimulated a significant fraction of the quiescent 
PRV-infected cells to resume viral antigen expression. Glucocorticoids, like 
dexamethasone, have important anti-inflammatory effects but can also reactivate 
herpesviruses from latency (Schoembaum et al., 1990; Newton, 2000). Whether, 
based on this observation, it may be hypothesized that this quiescent PRV infection 
may resemble or lead to a latent PRV infection will depend on further and more 
extensive experimentations, including in situ hybridization to detect latency-
associated transcripts. Whereas latency in monocytes/macrophages is a well-known 
feature of the betaherpesviruses human cytomegalovirus (HCMV) and human 
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herpesvirus 6 (HHV-6) (Kondo et al., 1991; Sinclair & Sissons, 1996), latency of 
PRV in blood mononuclear cells is still a matter of debate (Mettenleiter, 1994). 
 Immune-masked PRV-infected monocytes have to cross the barrier of endothelial 
cells of maternal blood vessels in order to reach fetal tissues. Adhesion of the 
immune-masked monocytes to endothelial cells, in the presence of virus-neutralizing 
antibodies, is a first necessity. We demonstrated that efficient adhesion of immune-
masked PRV-infected monocytes to endothelial cells occurs in vitro and is mediated 
by the cellular adhesion molecules wCD11R3 and CD18, and possibly other adhesion 
molecules such as wCD11R1, wCD11R2 and VLA-4. Following adhesion, we 
observed a rapid fusion of the adhering infected cells with the underlying endothelial 
cells, resulting in virus transmission to endothelial cells. The fusion process we 
observed between immune-masked monocytes and endothelial cells was virus-
mediated since the presence of viral glycoprotein gH was indispensable for fusion to 
occur. Since PRV gH is known to be essential for the well-studied virus-cell fusion 
process (Peeters et al., 1992b), we suggest that the fusion of immune-masked 
monocytes with endothelial cells occurs in a similar way. Transmission of virus to 
endothelial cells via similar (micro)fusion events has already been described for other 
viruses like HCMV and HIV (Dianzani et al., 1996; Gerna et al., 2000). For the 
betaherpesvirus HCMV, virus is transferred from polymorphonuclear leukocytes to 
endothelial cells, and vice versa, via microfusion events which are documented by 
discontinuation of some areas of the membranes of the adhering cells (Gerna et al., 
2000). Thus, based on the results of our in vitro study, we demonstrated that adhesion 
and subsequent fusion of immune-masked monocytes with endothelial cells may 
provide a means of PRV transmission to endothelial cells. However, other possible 
routes for PRV to cross the endothelial barrier may not be ruled out at present, with 
diapedesis of immune-masked PRV-infected monocytes as the most important 
possible alternative explanation. 
 Although cell fusion events may explain transfer of PRV from immune-masked 
monocytes to endothelial cells, it does not explain how PRV subsequently spreads 
through the different layers of the maternal (and fetal) placenta in order to reach fetal 
tissues. Further spread of PRV will most likely involve direct cell-to-cell spread, a 
well-known general feature of herpesviruses. Direct cell-to-cell spread allows the 
virus to spread from an infected cell to adjacent cells, without entering the (immune-
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surveilled) extracellular milieu. This mechanism of direct cell-to-cell spread involves 
processes which are closely related to the process of virus entry in the cell. For PRV, 
the difference between these two processes is that gD is essential for virus entry, 
while it is redundant for cell-to-cell spread (Peeters et al., 1992a). Since abortion in 
vaccinated sows can still occur upon inoculation of the arteria uterina with 
monocytes infected with a PRVgD null mutant (Nauwynck, 1997), it is safe to assume 
that PRV uses direct cell-to-cell spread to reach the fetal tissues. 
 In conclusion, the in vitro work of this thesis provides strong indications that the 
process of antibody-induced internalization of viral cell surface proteins on PRV-
infected monocytes may be important for PRV to reach internal organs in the 
presence of an immunity, induced by inactivated vaccines. Moreover, this knowledge 
may be of importance for further research on the intriguing interactions between 
blood leukocytes and other herpesviruses like HCMV, EHV-1 and VZV, which are 
also known to circulate and cause disease in immune hosts (Galil et al., 2002; Revello 
& Gerna, 2002; van der Meulen et al., 2003). 
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Summary 
 
 Pseudorabies virus (PRV) can still replicate in the respiratory tract of the pig in the 
presence of a vaccination-induced immunity resulting in a restricted viraemia. 
Moreover, although rare, abortion may be an important consequence of this limited 
replication in immune animals. Porcine blood monocytes have been shown to be 
essential to transport the virus throughout the body, including the pregnant uterus, of 
vaccination-immune pigs. Recently, a potential immune evasion strategy has been 
proposed how PRV-infected porcine blood monocytes may be able to avoid 
recognition by the immune system. This process consists of aggregation and 
subsequent virus-mediated internalization of the majority of antigen-antibody 
complexes from the cell surface of PRV-infected monocytes. 
 The aim of the current thesis was to investigate in vitro whether this process may 
lower the susceptibility of the cells towards antibody-dependent cell lysis, what the 
underlying mechanism of the process is, and how these PRV-infected monocytes with 
internalized antigen-antibody complexes may transmit virus to internal organs. 
 
 In Chapter 1, a brief introduction is given on PRV, with emphasis on pathogenesis 
of PRV (both in naive and immune pigs) on the one hand and the known PRV 
immune evasion strategies on the other hand. 
 
 In Chapter 2, it was first evaluated whether the process of virus-mediated 
internalization of antigen-antibody complexes from the cell surface of PRV-infected 
monocytes indeed has an effect on the efficiency of antibody-dependent cell lysis. 
Therefore, an in vitro model was set up to examine the susceptibility of PRV-infected 
monocytes towards antibody-dependent complement-mediated lysis (ADCML). PRV-
infected monocytes, at 13 h p.i., were incubated for 1 h at 37°C with 0.9 mg/ml FITC-
labeled porcine polyclonal PRV-specific antibodies in the presence or absence of 
50µg/ml genistein, a tyrosine kinase inhibitor which blocks internalization. In some 
experiments, the population of infected monocytes with complete internalization were 
enriched by magnetic cell sorting. Afterwards, cells were incubated with a 5% 
dilution of porcine complement and finally incubated for 5 min with propidium iodide 
(PI), which specifically stains dead cells. Fluorescence intensity of the cells was 
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analyzed by flow cytometry. Approximately 47% of the cells without internalized 
antigen-antibody complexes was lysed by complement whereas this was only 12% for 
the cells with internalized complexes, indicating that the internalization process aids 
in protecting PRV-infected monocytes from antibody-dependent cell lysis. Further, it 
was studied whether another potential immune evasion mechanism described for 
several alphaherpesviruses, including PRV, also reduces the susceptibility of PRV-
infected monocytes towards antibody-dependent complement-mediated lysis in vitro. 
This immune evasion mechanism consists of the Fc receptor activity of the viral gE-gI 
complex. This Fc receptor activity may possibly interfere with efficient antibody-
dependent cell lysis by ‘disarming’ the antibodies by binding their Fc region, which 
normally activates the antibody-dependent immune effectors. Using wild type PRV 
strains and gE-gI null strains in the ADCML assay, we demonstrated that gE-gI Fc-
receptor activity interferes, although at very low efficiency, with efficient ADCML of 
PRV-infected monocytes. We hypothesized that this low efficiency was due to the 
fact that some of the polyclonal antibodies in our ADCML assay may have been 
directed against epitopes on gE and/or gI, important for its Fc receptor function. Such 
binding can thereby interfere with efficient Fc binding of gE-gI. To support this 
hypothesis, we repeated the same experiments using porcine PRV-specific antibodies 
derived from a pig infected with a gE-gI null mutant (and therefore contains no gE-gI-
specific antibodies). This resulted in a much more pronounced protective effect of the 
gE-gI Fc receptor towards ADCML-mediated lysis of PRV-infected monocytes. 
Further, using flow cytometry, we showed that PRV-specific polyclonal antibodies 
derived from hyperimmune serum from a wild type virus-inoculated pig (but not from 
a gE-gI null virus-inoculated pig) were able to block the gE-gI Fc receptor activity. 
Hence, gE-gI specific-antibodies present in PRV-positive pig serum may be able to 
inhibit gE-gI Fc receptor functioning. Another interesting observation was that 
monocytes inoculated with the PRV strain Becker were always 1.5-fold less 
susceptible towards ADCML than cells inoculated with the PRV strain Kaplan. This 
was not due to differences in efficiency of internalization of antigen-antibody 
complexes or gE-gI Fc receptor activity between both strains. Combined with the fact 
that, even when blocking both antigen-antibody internalization and gE-gI Fc receptor 
activity, lysis of 100% of PRV-infected monocytes was never achieved, these data 
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suggest that PRV may have developed additional ADCML evasion mechanisms 
which could be more effective for certain PRV strains than for others. 
 
 In Chapter 3, the underlying mechanism of the antibody-induced internalization of 
viral cell surface proteins in PRV-infected monocytes was studied in more detail. Up 
till now, only the initiation of this process had been unraveled and was shown to be 
mediated by the viral proteins gB and gD, expressed on the cell surface of PRV-
infected monocytes. Further research was necessary to clarify whether the subsequent 
steps of the internalization process were also mediated by the virus or merely 
involved the cellular endocytosis machinery. The cellular components, known to play 
a role during physiological endocytosis processes, have already been extensively 
studied. The cellular cytoskeleton component actin is important during the first stages 
of endocytosis, together with clathrin which mediates membrane invagination and 
vesicle formation. For further transport of vesicles towards the center of the cell, 
microtubules and the motor protein dynein are indispensable. In this chapter, the 
involvement of cellular cytoskeleton components during different steps of the 
internalization of PRV cell surface proteins was investigated via two ways. On the 
one hand, PRV-infected monocytes were treated with different concentrations of 
chemical inhibitors for 45 min before and also during the addition of PRV-specific 
antibodies. The chemical inhibitors used were colchicine, cytochalasin D, latrunculin 
B and amantadine-HCl, known to inhibit polymerization of microtubules, 
actin/clathrin, actin and clathrin respectively. Addition of each chemical inhibitor 
resulted in a significant reduction of cells with internalized viral proteins compared to 
non-treated controls. On the other hand, to further elucidate the role of the different 
cellular components during internalization, double labeling experiments of viral 
proteins and cellular components were performed during the different redistribution 
stages of the internalization process. A clear co-localization was observed between the 
viral glycoproteins and clathrin during the early stages of the internalization process. 
No change in the distribution of actin could be observed, implying a more passive role 
for actin. A clear co-localization between the viral glycoproteins and dynein was 
observed during the later stages internalization and the internalized vesicles were in 
close contact with microtubules. Hence, these data demonstrate that upon the viral-
induced initiation of the internalization process, all further steps involve cellular 
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components, in a similar way as observed during physiological receptor-mediated 
endocytosis processes. 
 
 Besides the sensitivity towards recognition by the immune system another factor 
determining the chance of an PRV-infected monocyte to reach internal organs, is the 
time the monocyte may survive the infection. Indeed, a productive PRV infection 
results rapidly in cell death, which would obscure the chances of the virus to reach 
internal organs. Therefore, in Chapter 4, in vitro studies were performed to investigate 
the long-term fate of the PRV-infected monocytes with internalized viral proteins 
(immune-masked monocytes) with regard to viability and expression of viral antigens. 
In a first assay, the viability of PRV-infected monocytes in the presence or absence of 
PRV-specific antibodies was evaluated until 194 h p.i. In the continuous presence of 
PRV-specific antibodies, approximately 30% of the PRV-infected monocytes were 
still viable at 194 h p.i., compared to 0% in the absence of PRV-specific antibodies. 
These results demonstrate that in the presence of PRV-specific antibodies, some PRV-
infected monocytes survive for unusual long periods of time. In a second assay, the 
expression of viral glycoproteins was investigated in the population of immune-
masked monocytes which survived a PRV infection for unusual periods of time (in 
the continuous presence of PRV-specific antibodies). Although all PRV-infected 
monocytes showed viral protein expression at 96 h p.i., approximately 75% of the 
surviving immune-masked PRV-infected monocytes did no longer show visually 
detectable expression of viral proteins from 120 h p.i. onwards, in the continuous 
presence of PRV-specific antibodies. This implies that a subpopulation of PRV-
infected cells developed a quiescent infection status. Addition of dexamethasone (an 
agent known to reactivate herpesviruses from latency) was able to induce a re-
expression of viral proteins. The results of this study demonstrated that antibody-
induced internalization of viral proteins leads to an expanded life span of the cells and 
suppression of viral protein expression in a subpopulation of the PRV-infected 
monocytes, which may help explaining how PRV-infected monocytes can act as 
carriers of the virus to internal organs in the blood of vaccinated animals. 
 
 In Chapter 5, it was shown in vitro that the immune-masked PRV-infected 
monocytes are able to transmit PRV to endothelial cells of blood vessels in the 
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presence of virus-neutralizing antibodies by means of adhesion and fusion processes. 
To this end, porcine blood monocytes were inoculated with a LacZ-carrying PRV 
strain and at 13 h p.i. incubated with FITC-labeled PRV-specific antibodies to induce 
internalization of the viral cell surface proteins. Afterwards, these cells were 
cocultivated with monolayers of cultured porcine endothelial cells in the presence of 
virus-neutralizing antibodies. At different time points, monolayers of endothelial cells 
were fixed and stained with X-gal to visualize LacZ expression. It was demonstrated 
that the adhesion of monocytes to endothelial cells reached its plateau at 60 min of 
cocultivation and that PRV-infected monocytes with internalized viral cell surface 
proteins (immune-masked) adhere much more efficiently to endothelial cells than 
PRV-infected monocytes without internalization (50% adhesion versus 4% adhesion 
respectively). When evaluating the LacZ transmission from the cytoplasm of the 
infected monocyte to the underlying endothelial cells, as a measure for 
monocyte/endothelial cell fusion, it was found that fusion started from 30 min of 
cocultivation and reached a level of 38.0% ± 2.5 of fused immune-masked monocytes 
at 120 min of cocultivation. Virus transmission during the fusion process was 
confirmed by the appearance of plaques. Performing double immunofluorescence 
stainings for some of the most important adhesion molecules expressed on monocytes 
on the one hand and viral cell surface proteins on the other hand, in combination with 
an adhesion blocking assay, demonstrated that the adhesion of immune-masked 
monocytes to endothelial cells was mediated by the cellular adhesion molecules 
wCD11R3 and CD18. Using a LacZ-carrying PRV strain deleted in the gene encoding 
the viral protein gH, essential for virus-cell fusion and cell-to-cell spread, resulted in 
immune-masked PRV-infected monocytes that were unable to fuse with endothelial 
cells. This indicates that fusion is virus-mediated, probably by a mechanism similar to 
virus-cell fusion. The adhesion and fusion processes described here may possibly 
explain how PRV crosses the endothelial cell barrier of placental blood vessels in 
vaccinated animals, as a first step to reach the pregnant uterus. 
 
 As a general conclusion, based on the current in vitro findings, it can be stated that 
the process of antibody-induced internalization of viral cell surface proteins in PRV-
infected monocytes is likely to be an important mechanism used by PRV to circulate 
in the blood of vaccinated animals. The process, initiated by the virus and completed 
by the cellular endocytosis machinery, may enable PRV to evade the antibody-
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dependent components of the immune system. Further, it allows PRV-infected 
monocytes to survive the infection for unusual long periods of time in the presence of 
PRV-specific antibodies, most likely by inducing an abortive infection. Finally, the 
internalization process allows PRV-infected monocytes to efficiently adhere and 
transmit virus to endothelial cells in the presence of neutralizing antibodies and this 
may be an important first step for the virus to reach internal organs in vaccinated 
animals.
138  Chapter 7 
Samenvatting 
 
 Het Aujeszky virus (AV), ook wel pseudorabies virus genoemd, kan vermeerderen 
in het ademhalingsstelsel van varkens, geïmmuniseerd met geïnactiveerde vaccins, 
wat kan resulteren in een beperkte viremie. Als gevolg van deze beperkte viremie kan 
AV-geïnduceerde abortus, weliswaar zeldzaam, nog voorkomen bij immune zeugen 
(gevaccineerd met een geïnactiveerd vaccin). Geïnfecteerde bloed monocyten zijn 
essentieel voor het transport van het virus naar de drachtige baarmoeder in deze 
vaccinatie-immune dieren. Een mogelijk mechanisme dat zou kunnen verklaren hoe 
AV-geïnfecteerde monocyten ontsnappen aan efficiënte herkenning en eliminatie door 
het immuunsysteem werd recentelijk naar voren gebracht. Dit proces bestaat erin dat 
na binding van antistoffen op de virale antigenen die aanwezig zijn op de 
plasmamembraan van de geïnfecteerde monocyt, deze antigeen-antistofcomplexen 
aggregeren en snel door de cel opgenomen worden (internalisatie). De internalisatie 
van de antigeen-antistofcomplexen wordt geïnduceerd door twee virale eiwitten op de 
plasmamembraan, namelijk gB en gD. 
 Het doel van deze thesis was om in vitro na te gaan of (i) dit internalisatieproces de 
gevoeligheid van AV-geïnfecteerde monocyten tegen antistof-afhankelijke cellyse 
inderdaad kan verminderen, (ii) wat het onderliggend mechanisme is van het 
internalisatieproces en (iii) op welke manier AV-geïnfecteerde monocyten met 
geïnternaliseerde antigeen-antistofcomplexen virus kunnen overdragen naar 
endotheelcellen van de bloedvatwand. 
 
 In Hoofdstuk 1 werd een korte inleiding gegeven over AV, met de nadruk op de 
pathogenese in zowel naïeve als immune varkens. Daarnaast werden de immuno-
evasie mechanismen die reeds bekend zijn voor AV uitgebreid besproken. 
 
 In Hoofdstuk 2 werd eerst en vooral onderzocht of het proces van virus-
gemedieerde internalisatie van antigeen-antistofcomplexen op de celmembraan van 
AV-geïnfecteerde monocyten inderdaad een effect heeft op de doeltreffendheid van 
antistof-afhankelijke cellyse. Een in vitro model werd geconstrueerd om de 
gevoeligheid van AV-geïnfecteerde monocyten tegen antistof-afhankelijke 
complement-gemedieerde cellyse (AACGL) na te gaan. AV-geïnfecteerde 
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monocyten, op 13 uren na inoculatie, werden geïncubeerd met 0,9 mg/ml FITC-
gemerkte polyklonale AV-specifieke varkensantistoffen gedurende 1 uur bij 37°C in 
de aan- of afwezigheid van 50µg/ml genisteïne, een specifieke inhibitor van het 
internalisatieproces. In bepaalde experimenten werd de populatie van geïnfecteerde 
monocyten met geïnternaliseerde antigeen-antistofcomplexen aangerijkt door middel 
van magnetische celsortering. Nadien werden de cellen geïncubeerd gedurende 1 uur 
met een 5% verdunning van varkenscomplement en tenslotte geïncubeerd gedurende 
5 minuten met het fluorescerende propidiumjodide dat specifiek DNA van dode cellen 
merkt. De fluorescentie-intensiteit van de cellen werd nagegaan aan de hand van 
flowcytometrie. Ongeveer 47% van de cellen zonder internalisatie werden gelyseerd 
door complement in tegenstelling tot slechts 12% van de cellen met geïnternaliseerde 
antigeen-antistofcomplexen. Dit resultaat toont aan dat het internalisatieproces van 
antigeen-antistofcomplexen kan helpen bij de bescherming van AV-geïnfecteerde 
monocyten tegen antistof-afhankelijke cellyse in vivo. Daarnaast werd onderzocht of 
een ander immuno-evasie mechanisme, reeds beschreven voor verschillende 
alfaherpesvirussen waaronder AV, ook in staat is de gevoeligheid van AV-
geïnfecteerde monocyten te verminderen tegen AACGL. Dit immuno-evasie 
mechanisme bestaat uit de Fc-receptoractiviteit van het virale eiwitcomplex gE-gI dat 
aanwezig is op de plasmamembraan van geïnfecteerde cellen. Deze Fc-
receptoractiviteit kan interfereren met doeltreffende antistof-afhankelijke cellyse. 
Door binding van gE-gI met de Fc-regio van antistoffen, kan deze Fc-regio de 
antistof-afhankelijke immuuncomponenten niet langer activeren. AACGL 
experimenten met AV wild type stammen en AV mutanten die de genen missen die 
coderen voor het gE-gI eiwitcomplex toonden aan dat monocyten geïnfecteerd met 
wild type AV iets minder gevoelig waren voor AACGL dan monocyten geïnfecteerd 
met de gE-gI-negatieve AV stam. Met andere woorden, de gE-gI Fc-receptoractiviteit 
beschermt de AV-geïnfecteerde monocyten enigszins tegen AACGL, maar op een 
weinig efficiënte manier. Een mogelijke hypothese voor dit weinig efficiënt effect van 
de gE-gI Fc-receptor is dat sommige antistoffen in het AV-specifiek polyklonaal 
serum dat gebruikt wordt tijdens de AACGL experimenten, mogelijk gericht zijn 
tegen de epitopen op gE-gI die belangrijk zijn voor de Fc-receptoractiviteit. Daardoor 
kunnen deze IgG-bindende epitopen op gE-gI bedekt zijn met antistoffen waardoor ze 
hun Fc-receptoractiviteit niet kunnen uitvoeren. Om deze hypothese te ondersteunen 
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werden dezelfde AACGL experimenten herhaald, maar nu met AV-specifieke 
varkensantistoffen die afkomstig waren van een varken dat geïnfecteerd was met een 
AV gE-gI-negatieve mutant (en dat bijgevolg geen gE-gI-specifieke antistoffen heeft). 
Dit resulteerde in een duidelijk meer uitgesproken beschermend effect van de gE-gI 
Fc-receptor tegen AACGL van AV-geïnfecteerde monocyten. Bovendien konden we 
aantonen, aan de hand van flowcytometrie, dat AV-specifieke polyklonale antistoffen 
afkomstig van een varken geïnoculeerd met wild type AV virus (maar niet van een 
varken geïnoculeerd met een AV gE-gI-negatieve mutant) in staat waren de gE-gI Fc-
receptoractiviteit te blokkeren. Samengevat kunnen we stellen dat gE-gI-specifieke 
antistoffen aanwezig in AV-positief varkensserum waarschijnlijk in staat zijn de gE-
gI Fc-receptorfunctie te inhiberen. Een andere interessante observatie was dat 
monocyten geïnoculeerd met de AV stam Becker altijd 1,5 maal minder gevoelig 
waren tegen AAGCL dan wanneer cellen geïnoculeerd waren met de AV stam 
Kaplan. Dit was niet te wijten aan verschillen in de onderzochte immuno-evasie 
mechanismen (de internalisatie van antigeen-antistofcomplexen en de gE-gI Fc-
receptoractiviteit) tussen beide stammen. Gecombineerd met het feit dat in onze 
experimenten AACGL nooit in staat was alle AV-geïnfecteerde monocyten te lyseren, 
zelfs indien zowel antigeen-antistof internalisatie als gE-gI Fc-receptoractiviteit 
geïnhibeerd werden, suggereren deze gegevens dat AV mogelijk andere AACGL-
evasie mechanismen ontwikkeld heeft die waarschijnlijk efficiënter zijn voor 
sommige AV stammen dan voor andere. 
 
 In Hoofdstuk 3 werd het onderliggend mechanisme van het internalisatieproces 
van antigeen-antistofcomplexen in AV-geïnfecteerde monocyten bestudeerd. Tot op 
heden was enkel opgehelderd dat de virale eiwitten gB en gD, die aanwezig zijn op de 
plasmamembraan van AV-geïnfecteerde monocyten, noodzakelijk zijn om het 
internalisatieproces te initiëren. Bijkomend onderzoek was nodig om te achterhalen of 
ook de volgende stappen van het internalisatieproces gemedieerd zijn door het virus 
of dat hiervoor eerder de cellulaire endocytose machinerie verantwoordelijk is. De 
cellulaire componenten die een belangrijke rol spelen tijdens fysiologische 
endocytose processen zijn reeds uitgebreid bestudeerd. De cellulaire component 
actine is vooral belangrijk tijdens de eerste stappen van de endocytose, samen met 
clathrine die de membraaninvaginatie en de vorming van vesikels medieert. Voor 
verder transport van deze vesikels in de richting van de celkern zijn microtubuli en de 
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motorproteïne dyneine onontbeerlijk. In dit hoofdstuk werd op twee manieren 
onderzocht of de cellulaire cytoskelet componenten een rol spelen tijdens de 
verschillende stappen van internalisatie. Hiervoor werden in eerste instantie 
monocyten, op 13 uren na inoculatie met AV, behandeld met verschillende 
inhibitoren gedurende 45 minuten voor en ook tijdens de toediening van AV-
specifieke antistoffen. Deze inhibitoren waren colchicine, cytochalasine D, 
latrunculine B en amantadine-HCl, bekend voor hun inhiberende werking op de 
polymerisatie van microtubuli, actine/clathrine, actine en clathrine respectievelijk. 
Toediening van elk van deze inhibitoren resulteerde in een significante daling van het 
aantal AV-geïnfecteerde cellen met geïnternaliseerde antigeen-antistofcomplexen in 
vergelijking met de niet-behandelde controlecellen. Om de rol van de verschillende 
cellulaire componenten tijdens internalisatie verder uit te diepen, werden daarnaast 
ook immunofluorescentie-dubbelkleuringen uitgevoerd voor virale eiwitten enerzijds 
en cellulaire componenten anderzijds gedurende de verschillende stadia van het 
internalisatieproces. Een duidelijke co-localisatie van virale eiwitten met clathrine 
werd gezien tijdens de eerste fasen van het internalisatieproces. De distributie van 
actine filamenten bleef gedurende het volledige internalisatieproces onveranderd, 
waardoor actine waarschijnlijk een meer passieve rol heeft tijdens het proces. Een 
duidelijke co-localisatie van virale eiwitten met dyneine werd gezien tijdens de latere 
fases van het internalisatieproces en de geïnternaliseerde vesikels hadden nauw 
contact met de microtubuli. Samengevat tonen deze resultaten aan dat na de virus-
gemedieerde initiatie van het internalisatieproces (via gB en gD), de verdere stappen 
gebeuren met behulp van cellulaire componenten en dit op een manier gelijkaardig 
aan de fysiologische receptor-gemedieerde endocytose processen. 
 
 Naast de gevoeligheid voor herkenning door het immuunsysteem is er nog een 
factor belangrijk in de bepaling of een AV-geïnfecteerde monocyt kans maakt om 
interne organen te bereiken, namelijk de tijd dat een monocyt de infectie kan 
overleven. Normaal gezien leidt een AV infectie snel tot celdood waardoor de kans 
vermindert dat het virus interne organen kan bereiken. Daarom werden er in 
Hoofdstuk 4 in vitro experimenten uitgevoerd om het lot van AV-geïnfecteerde 
monocyten met geïnternaliseerde antigeen-antistofcomplexen (immuun-gemaskeerde 
monocyten) na te gaan op langere termijn, meer bepaald door de vitaliteit van de 
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cellen en de expressie van virale eiwitten in deze cellen nader te bekijken. In een 
eerste proefopzet werd de vitaliteit van AV-geïnfecteerde monocyten nagegaan, zowel 
in de aan- als afwezigheid van AV-specifieke antistoffen, tot 194 uren na inoculatie. 
In de aanwezigheid van AV-specifieke antistoffen was 194 uren na inoculatie nog 
ongeveer 30% van de geïnfecteerde monocyten levend in tegenstelling tot 0% levende 
AV-geïnfecteerde cellen in de afwezigheid van AV-specifieke antistoffen. Deze 
resultaten tonen aan dat bepaalde AV-geïnfecteerde monocyten voor ongewoon lange 
tijd overleven in de aanwezigheid van AV-specifieke antistoffen. In een tweede 
proefopzet werd de expressie van virale eiwitten nagegaan in de populatie van AV-
geïnfecteerde monocyten die een AV infectie ongewoon lang overleefden (in de 
aanwezigheid van AV-specifieke antistoffen). Alhoewel alle AV-geïnfecteerde 
monocyten virale eiwitten tot expressie brachten, 96 uren na inoculatie, vertoonde 
ongeveer 75% van de levende immuun-gemaskeerde AV-geïnfecteerde cellen geen 
visueel detecteerbare expressie meer van virale eiwitten vanaf 120 uren na inoculatie. 
Dit toont aan dat onder invloed van de AV-specifieke antistoffen, een subpopulatie 
van AV-geïnfecteerde monocyten een abortieve infectie ontwikkelde. Toediening van 
dexamethasone (een corticosteroïd dat bekend is om herpesvirussen uit latentie te 
reactiveren) was in staat een re-expressie van virale eiwitten te induceren. Deze studie 
toont aan dat internalisatie van antigeen-antistofcomplexen resulteert in een verlengde 
overlevingstijd van de cellen en een onderdrukken van de expressie van virale 
eiwitten in een subpopulatie van de AV-geïnfecteerde monocyten, wat mogelijk helpt 
verklaren hoe AV-geïnfecteerde monocyten dragers kunnen zijn van het virus in het 
bloed van gevaccineerde dieren. 
 
 In Hoofdstuk 5 tenslotte werd aangetoond dat de immuun-gemaskeerde AV-
geïnfecteerde monocyten in staat zijn om het virus over te dragen naar 
endotheelcellen van bloedvaten in vitro in de aanwezigheid van virus-neutraliserende 
antistoffen en dit via adhesie- en fusieprocessen. Om dit aan te tonen werden 
varkensmonocyten geïnoculeerd met een LacZ-dragende AV stam en 13 uren later 
werden FITC-gemerkte AV-specifieke antistoffen toegediend om internalisatie van de 
antigeen-antistofcomplexen te verkrijgen (immuun-gemaskeerde monocyten). Nadien 
werden de monocyten in cultuur gebracht met een monolaag van gecultiveerde 
endotheelcellen in aanwezigheid van virus-neutraliserende antistoffen. Vervolgens 
werden de monolagen op verschillende tijdstippen gefixeerd en gekleurd met X-gal 
Samenvatting  143 
 
om LacZ expressie te visualiseren. Adhesie van AV-geïnfecteerde monocyten aan 
endotheelcellen bereikte een plateau op 60 minuten na co-cultivatie en enkel de 
immuun-gemaskeerde monocyten (dus deze met geïnternaliseerde antigeen-
antistofcomplexen) waren in staat efficiënt te adhereren aan endotheelcellen 
(ongeveer 50% in vergelijking met slechts 4% voor monocyten zonder internalisatie). 
De LacZ overdracht van het cytoplasma van de geïnfecteerde monocyt naar het 
cytoplasma van het onderliggend endotheel werd gebruikt als een maat voor 
monocyt/endotheelcel fusie. Fusie van immuun-gemaskeerde AV-geïnfecteerde 
monocyten met endotheelcellen werd waargenomen vanaf 30 minuten na co-cultivatie 
en bereikte een maximum van 38.0% ± 2.5 gefusioneerde monocyten, 120 minuten na 
co-cultivatie. De transmissie van het virus werd bevestigd door het verschijnen van 
plaques in de monolagen van endotheelcellen. Immunofluorescentie-dubbelkleuringen 
van virale eiwitten enerzijds en enkele van de belangrijkste adhesie moleculen die 
aanwezig zijn op de monocyten anderzijds, aangevuld met een adhesie-inhibitie 
proefopzet, toonden aan dat adhesie van immuun-gemaskeerde AV-geïnfecteerde 
monocyten met endotheel gemedieerd werd door de cellulaire adhesiemoleculen 
wCD11R3 en CD18. Monocyten geïnfecteerd met een LacZ-dragende AV mutant die 
het gen mist dat codeert voor het virale eiwit gH (dat essentieel is voor virus-cel fusie 
en cel-tot-cel spreiden van het virus) waren nog in staat te adhereren aan maar niet 
langer te fusioneren met endotheelcellen. Dit toonde aan dat de fusie virus-
gemedieerd is, hoogstwaarschijnlijk via een mechanisme gelijkaardig aan dat van 
virus-cel fusie. Samengevat, adhesie van immuun-gemaskeerde AV-geïnfecteerde 
monocyten aan en fusie met endotheelcellen kunnen mogelijk verklaren hoe AV in 
staat is de endotheelbarrière van placentale bloedvaten bij gevaccineerde dieren te 
doorkruisen, als een eerste stap om de drachtige baarmoeder te bereiken. 
 
Als algemene conclusie, gebaseerd op de huidige in vitro bevindingen, kan gesteld 
worden dat antistof-geïnduceerde internalisatie van antigeen-antistofcomplexen in 
AV-geïnfecteerde monocyten hoogstwaarschijnlijk een belangrijk mechanisme is dat 
AV mede in staat stelt te circuleren in het bloed van immune dieren, gevaccineerd met 
geïnactiveerde vaccins. Dit proces, geïnitieerd door het virus en vervolledigd door de 
cellulaire endocytose machinerie, laat AV-geïnfecteerde monocyten toe om te 
ontsnappen aan antistof-afhankelijke componenten van het immuunsysteem. 
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Bovendien kunnen deze immuun-gemaskeerde AV-geïnfecteerde monocyten een 
infectie voor ongewoon lange tijd overleven, waarschijnlijk doordat onder invloed 
van de AV-specifieke antistoffen de vermeerdering van AV in deze cellen wordt 
onderdrukt. Tenslotte zorgt het internalisatieproces er ook voor dat AV-geïnfecteerde 
monocyten efficiënt kunnen adhereren aan en virus overbrengen naar endotheelcellen 
in de aanwezigheid van neutraliserende antistoffen, wat een belangrijke eerste stap 
kan zijn voor AV om interne organen van gevaccineerde dieren te bereiken. 
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